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Abstract 
How memory cells form and how they survive are pertinent, unanswered questions in 
the field of immunology. T cell memory develops following an adaptive immune 
response, which is initiated in secondary lymphoid organs. This response involves T 
cell proliferation, effector cell differentiation and the generation of memory cells. It 
has proved difficult to study CD4 T cell responses due to the problems of tracking 
the small number of antigen specific T cells. MHC class II tetramers, which bind to 
the T cell receptor of responding T cells, enable the identification of antigen specific 
CD4 T cells and, therefore, can be used to track memory cells. The importance of 
this system lies in the physiological number of precursor cells, providing a more 
realistic system to study CD4 T cell immunology than T cell receptor transgenic 
studies. 
In this PhD, MHC class II tetramers have been used to track endogenously generated, 
antigen specific CD4 T cells ex vivo. This has enabled the tracking of a CD4 T cell 
response from early activation, into memory, and during recall responses. Long-term 
studies have been carried out to determine the survival of memory cells in both the 
absence and presence of antigen, and to describe the phenotype of these cells. 
Furthermore, this system has been used to answer questions concerning the 
requirements of both naïve and memory cells for the costimulatory signals necessary 
for activation and proliferation. Specifically, the requirements for the interactions 
between the costimulatory molecules, CD40L-CD40 and ICOS-B7h, have been 
examined by comparing T cell priming, memory cell generation and recall responses 
in wild-type and knockout mice. 	 -i.. 
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How memory cells form and how they survive are pertinent, unanswered questions in 
the field of immunology. Both B and I cell memory develop following an adaptive 
immune response that is initiated in secondary lymphoid organs (1), (2, 3). Dendritic 
cells (DC), carrying antigen acquired from the periphery, migrate to this site and 
interact with antigen-specific T cells, resulting in T cell activation and proliferation 
(4). This interaction involves recognition by the I cell receptor (TCR) of antigen 
presented as peptide on major histocompatibility complex (M}IC) molecules and the 
plethora of co-stimulatory molecules, such as CD28-B7. 1 and B7.2, and CD40-
CD40-Ligand (5) (6). B cells can be activated by binding antigen which filters into 
the lymph node via the lymph, or may also be able to capture antigen from incoming 
DC cells (7). Once activated, B cells can interact with primed T cells and this 
provides the signals required by B cells to proliferate and produce antibodies. 
Activated specific CD4 T cells orchestrate the ensuing response by releasing small 
soluble signals called cytokines or via expression of cell surface molecules. 
Following clearance of the antigen the response contracts as the activated T and B 
cells begin to die. This is essential to maintain the homeostasis of T and B cell 
numbers. Although over 90% of the activated cells die, a small number survive as 
memory cells (1), (8), (2). 
These surviving cells, when re-exposed to antigen, form the basis of the rapid recall 
response. The memory response is rapid and effective because memory cells respond 
at lower concentration of antigen, quickly release effector cytokines and are present 
at higher frequencies than naïve cells (9), (10), (11), (12). Moreover, memory T cells 
Introduction 
are thought to re-circulate through the tissues as well as secondary lymphoid organs, 
providing immediate protection from subsequent challenge (13), (14). 
Immunological memory has proved to be a controversial research area. Memory 
cells clearly exist and can be found many years after exposure to antigen. For 
example, a recent human study has found smallpox-specific memory B and CD4 T 
cells 40-50 years after immunisation (15). Over the past decades, with our increasing 
understanding of the immune system, certain aspects have become clear. For 
example, it is now thought that rather than existing as long-lived cells, memory cells 
divide periodically to maintain numbers at a fairly constant level in the face of cell 
death, (16), (17), (18), (19). The requirements for memory cell survival, however, are 
still contentious. How do these few cells survive the massive death that ensues 
during the contraction phase of the immune response? What signals (if any) do 
memory cells require to survive in the long-term? And, finally, are there competitive 
factors within the T cell memory pool that result in differential survival kinetics for 
different T cell clones? 
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1.2. 1 cell activation 
1.2.1. Initial events in T cell activation 
In recent years our understanding of the initial interactions between antigen 
presenting cells (APC) and naïve T cells has advanced greatly. This is partly as a 
result of pioneering experiments tracking live individual T cells in vivo using 
sophisticated microscopy. Confocal and 2-photon microscopy has been used to 
follow cells in whole lymphoid organs providing extended movies detailing these 
initial contacts (20), (21). 
Naïve CD4 T cells are thought to be activated by DC that present antigen in the form 
of peptides in MHC class II molecules. Recent experiments from Marc. Jenkins and 
colleagues has challenged the dogma that the initial DC that activate T cells migrate'  
from the infection or challenge site to the draining lymph node (DLN) or spleen (22). 
Rather, soluble antigen can itself leak through to lymphoid organs where it can be 
picked up by resident DC, which can then interact with specific T cells. A second 
wave of DC, migrating from the injection site, provides the further stimulation that is 
required for full T cell activation. 
Direct visualisation of the T cell-DC interaction using 2-photon microscopy suggests 
that T cells make a number of short-term contacts with DC carrying specific antigen 
(23), (24). After about eight hours, these T cells then slow down and form stable 
interactions with DC; these contacts can last 12 hours and T cells only divide on the 
second day after immunisation (24). These stable interactions may enable the 
formation of an immunological synapse, a tight interaction between two cells that 




T cell activation requires at least two distinct signals between the DC and the T cell 
(3), (4), as illustrated in figure 1.1. Signal one is the interaction between TCR and 
peptide-MHC and defines the specificity of the immune response. Signal two, or 
costimulation, influences the outcome of the ensuing immune response. In the 
absence of costimulation, T cell activation results in an abortive immune response, 
leading to tolerance to the specific antigen (26), (27). However, when antigen is 
presented in the context of costimulation, T cell activation and sustained proliferation 
occurs. This requires maturation of the presenting DC. This is induced by microbial 
molecules that bind pattern recognition receptors, such as Toll-like receptors, on the 
DC (28) and results in an increase in the expression of costimulatory molecules such 
as B7.1,2 and MHC class II on the DC (28), (29). 
There are myriad costimulatory molecules that are categorised into two main 
molecular families. The immunoglobulin superfamily includes CD28, which is found 
on all naïve T and binds to B7.1 and B7.2 expressed on activated DC and B cells (5). 
The CD28 family includes ICOS, which binds to B7h (also known as ICOSL) on 
APC and is required for the maturation of the B cell response (5). PD-1 is also a 
member, but the interaction between it and its ligand, PD-Li, is thought to have a 
negative effect on T cell activation (5). A second major costimulatory family is the 
tumour necrosis factor/receptor (TNF/TNFR) family that includes the molecular 
pairs CD40L/CD40 and OX40L/0X40 expressed on APC and T cells respectively 
(30). These molecular interactions can be important in initial T cell activation and in 
sustaining the T cell response (6). 
These costimulatory molecules act in a positive feedback loop. CD28B7.1/2 signals 
induce the upregulation of ICOS and 0X40 expression on the T cell, and in turn 
Icos signalling can upregulate CD40L expression on T cells (31). For the DC, 
CD40 signals are critical for full DC maturation, inducing the upregulation of 




Costimulatory signals can act in two non-mutually exclusive ways: 1. by amplifying 
the signals and gene expression that TCR signals initiate; or 2. activating a different 
set of genes. CD28 acts as an amplifier of TCR signals as most of the gene 
transcription affected by CD28 signalling is also altered by TCR signals (30). 
However, other costimulatory molecules do have distinct roles in the immune 
response. For example, CD28 is found on naïve T cells and is involved in the initial 
phase of T cell activation (5). CD40L and ICOS, however, are expressed on activated 
I cells, and thus have.a role in sustaining the ensuing T cell response and in inducing 
T cell effector functions (5), (6). 
1.2.2. Effector cell differentiation 
The type of the effector cytokine that is produced by the T cell depends on the 
differentiation pathway that the T cell takes. Classically, differentiation is defined by 
two major pathways: T helper 1 (Thl) and T helper 2 (Th2) (36). Th2 cells secrete 
cytokines such as interleukin (IL-)4 and IL-5 that can aid B cell activation and 
plasma cell differentiation (37). Thi cells, on the other hand, secrete cytokines such 
as interferon-gamma (IFN-y) and TNF-a that can activate macrophages to kill 
engulfed bacteria (38). 
The signals that influence Thi and Th2 differentiation are complex and'dçbatable 
(39), (37). The main differentiation signals are cytokines that are released by the 
presenting DC and also by other cells such as NK cells. IL-12 production by DC 
induces Thl development, while early IL-4 production, from an as yet unidentified 
source, leads to a Th2 response (40). In turn, the production of these cytokines and 
upregulation of costimulatory molecules is influenced by the microbial stimuli in the 
5 
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antigen and/or adjuvant, which can bind Toll-like receptors on the surface of innate 
cells (28), (41). 
Particular costimulatory molecules may be more important in Thi or Th2 responses. 
For example, there are reports that ICOS and 0X40 costimulation are important in 
the differentiation of Th2 cells (42), (43), (44). However, defects in Thi responses 
have been described in the absence of ICOS and 0X40 costimulation was found to 
be required for both Thi and Th2 responses in allergic asthma (45), (46), (47). 
1.2.3. Tcell migration 
T cell activation occurs in secondary lymphoid organs but activated cells must travel 
to the site of inflammation or infection in order to execute the effector arm of the 
immune response. Small soluble molecules called chemokines dictate this migration 
(49). 
Chemokines direct the migration pattern of both naïve, activated and memory T cells 
(50). Naïve T cells are mainly found in the blood and in secondary lymphoid 
organs (the spleen and LN) (51), (52). T cells enter LN from the blood via high 
endothelial venules (HEy). This entry is an active process requiring G-protein 
signalling by the chemokine receptor, CCR7 (53), (49). CCR7 binds to secondary 
lymphoid tissue chemokinë (SLC) secreted by cells in LN and HEV and enables T 
cell to slow down and form contacts with adhesion molecules on the enclQthelial 
cells. This allows CD62L (also known as L-selectin) to bind to its ligand, G1yCAM-
1, on HEy, and thereby enter the LN (54), (52), (55). 
Recently, Matloubian et al have found that T cell exit from lymph nodes is also an 
active process requiring sphingosine- 1-phosphate (Si P) receptor 1 (56). Thus, naïve 
rt 
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T cell migration is a controlled process, delivering I cells to the sites at which they 
are most likely to meet antigen that has been delivered either in the lymph, or carried 
there by DC from the periphery. 
T cell activation involves changes in the expression of chemokine receptors and 
adhesion molecules. CCR7 expression is down-regulated and other chemokine 
receptors, such as CXCR3 and CCR5 that bind chemokines released by inflamed 
tissues, upregulated (57). Activated T cells can also express CXCR5, allowing them 
to migrate to B cell follicles in response to B lymphocyte chemokine (BLC) and 
provide the necessary help for the B cell response (58), (59), (60), (61). 
CD44 binds to hyaluronate and this is also important in migration of T cells to 
inflamed sites (62), (63). It is upregulated on activated cells and remains at high 
levels on memory cells. Activated T cells downregulate CD62L and upregulate 
carbohydrate ligands for CD62P and CD62E (64), (65). These two selectins are 
expressed on inflamed endothelial cells ((66), reviewed in (65)) and enable the 
activated T cell to transmigrate into the inflamed tissue. 
There are reports of tissue specific migration of T cells. For example, I cells 
activated by DC from Peyer's Patches from the gut upregulate the gut tissue specific 
adhesion molecules, a437, and T cells activated in skin DLN express cutaneous 
lymphocyte antigen (CLA), which allows them to home specifically to the skin (67), 
(68). Thus, the site of T cell activation can control the subsequent migration pattern 
of the T cell (69). 
However, elegant studies tracking CD4 and CD8 T cell migration from the groups of 
Marc Jenkins (14) and Leo Lefrançois (13) respectively, have found that activated 
and memory antigen-specific cells can be found throughout the body. Thus, whether 
there are 'tissue specific' memory cells is an area of debate. Ley and Kansas suggest 
that subtle differences in the pattern of expression of adhesion molecules controls 
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where T cells migrate and that currently these distinctions are not fully appreciated 
(65). 
Migration of effector cells brings the response to the site of infection or challenge 
where, for example, effector cytokines are required to activate innate cells, or kill 
infected cells. This leads to a decline in the antigen load and this in turn results in the 
resolution of the immune response. 
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1.3. Memory Cell Generation 
1.3.1. Cell death 
The immune response terminates with the majority of activated cells undergoing cell 
death by apoptosis (2). Memory cells must, by definition, avoid this fate. To 
understand how they achieve this, it is necessary to understand the process of cell 
death. There are two main ways in which T cells can die by apoptosis: activation 
induced cell death (AICD), and as a result of cytokine withdrawal, which Marrack, 
Kappler and colleagues refer to as "activated T cell autonomous death" (ACAD) 
(70), (71). 
It had been thought that T cell death at the end of the immune response was mainly a 
consequence of AICD brought about by the ligation of death receptors such as Fas-
FasL or TNFR-TNF at the cell surface (72), (73), (74). Naïve cells are protected from 
Fas induced death by the expression of a molecule called FLIP (75). This binds to the 
intracellular portion of Fas, preventing the downstream signalling molecules from 
binding and initiating death (see below). T cell activation leads to a decrease in FLIP 
and, this, with concurrent increases in Fas expression induced by IL-2, makes the T 
cell more receptive to death (76), (77). 
Ligation of FasL to Fas results in a cascade of signalling events that leads to the 
activation of enzymes that bring about cell death, see figure 1.2. First, adaptor 
molecules, FADD or TRADD, bind to the intracellular domain of Fas oi'TNFR 
respectively. These adaptor molecules contain death domains that induce a cascade 
of enzyme activation of molecules called caspases. Activation of effector caspases 
results in the inactivation of proteins required to maintain the structure of the cell 
(78), (71), for example, the cytoskeletal proteins, fodrin and gelsolin are cleaved by 
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caspases 3 (79). The caspases also activate enzymes that contribute to the 
destruction of the cell, such as DNAse that cleaves the cellular DNA (79). 
Cell death is also controlled by a separate set of molecules: the Bcl-2 family 
molecules that regulate cell death induced by the withdrawal of growth factors. The 
main growth factors for T cells are cytokines, in particular cytokines in the common 
y-chain receptor family (IL-2, 4, 7, 9, 15, and 21) (80). Despite using this common 
receptor, the cytokines have distinct functions, for example, IL-2 is important for T 
cell proliferation while IL-7 is required for T cell survival (81). The specificity of the 
effect of the cytokine is conferred by binding to additional receptor chains in 
combination with the common y-chain, for example, IL-7 binds to IL-7Ra and the 
common y-chain and this can prpmote the expression of Bcl-2 (82), (83), (84). 
There are three groups of molecules in the Bcl-2 family that share Bcl-2 homology 
(BH) regions: the anti-apoptotic molecules such as Bcl-2 itself, BC1XL and Bcl-3; the 
pro-apoptotic molecules such as Bax, Bak and Bad; and the BH3 molecules that 
contain only one of the BH regions (85), (10). The exact molecular mechanism of 
this form of cell death has not been fully elucidated and is an area of debate, but it is 
clear that the mitochondria, the power-house of the cell, is centrally involved 
(reviewed in (85) and (86)). The process is also illustrated in figure 1.2. 
Bcl-2 is thought to preserves the integrity of mitochondria by preventing the release 
of cytochrome c (78), which, when released can amplify cell death (see below). 
However, if growth factors become limiting, pro-apoptotic molecules such as Bax 
and BH3 molecules (e.g. Bmf and Bim) can migrate to the mitochondria and this 
results in the release of cytochrome c (87), (88), (89). 
The exact molecular mechanism for this action is unclear. The BH3 molecules may 
act upstream of pro-apoptotic Bcl-2 family members such as Bax, binding and 
activating them and this then results in the inactivation of Bcl-2 (90). However, 
Marsden and Stasser argue that the binding of BH3 molecules to Bax or Bak has not 
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been clearly demonstrated and the BH3 molecules may only act indirectly to induce 
apoptosis via the pro-apoptotic molecules (85). Some results suggest that Bax and 
Bak can form pores in the mitochondrial membrane and thus facilitate the release of 
cytochrome c (86). Alternatively, as caspase-2 can induce the release of cytoebrome 
c, the mitcochondrial pathway may be a down-stream consequence of caspase 
activation (91), (85). 
Bcl-2 can also be inactivated via the death receptor pathway as caspase 8 activates 
Bid, another Bcl-2 family molecule, which can then migrate to the mitochondria and 
inactivate Bcl-2 (87). This illustrates that cellular apoptosis act as an amplification 
process: once the programme has been initiated there are positive feedback 
mechanisms that contribute towards cell death. Moreover, the caspase cascade is also 
activated as a result of the release of cytochrome c from the mitochondria. 
Cytochrome c associates with an adaptor molecule called Apaf- 1 and with caspase 9 
(86). These molecules form the apoptosome that can then induce the caspase 
cascade. 
Some recent evidence suggests that there is no role for the caspase enzymes in T cell 
death at the end of immune response. Nussbaum and Whitton found that pan-caspase 
inhibitors did not block cell death in vivo and thus did not alter the transition of 
activated cells into the memory pool (92). However, other investigators have found 
that T cells that undergo caspase independent death appear more necrotic than 
apoptotic (93), (94). 
Despite the molecular convergence of the two mechanisms of cell death, they are 
also distinct processes, for example, increases in Bcl-2 will not prevent Fas induced 
cell death by AICD (72). In vitro activated cells have been found to die via FasfFasL 
induced signalling (95) however, the mechanisms that control cell death in vivo may 
be more complex. Hildeman et a! (70) argue that most of the in vivo evidence for the 
control of cell death by Fas-FasL is based on experiments using repeated exposure to 
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antigen (72), (73), (74). This repeated exposure is fairly non-physiological and leaves 
the activated cells sensitive to cell death upon re-exposure to antigen (75). 
Furthermore, superantigen activated in vivo T cells have been found to die in the 
absence of Fas or TNF signalling, demonstrating that these death-inducing molecules 
are not absolutely required for T cell apoptosis (96), (72). 
There is evidence for the involvement of Bcl-2 family members in in vivo T cell 
death. The contraction phase of the immune response can be prevented by artificially 
increasing BcI2 levels, (72). Moreover, experiments involving immunisation with 
the superantigen, staphylococcal enterotoxin B (SEB), found reduced death in T cells 
deficient in the pro-apoptotic molecules, Bim, Bax and Bak (96), and mice that are 
deficient in both Bax and Bak develop splenomegaly as a result of the accumulation 
of memory T cell that were not deleted following immune responses (97). 
Furthermore, Mitchell et al found increased levels of the anti-apoptotic molecule, 
Bcl-3, improved the survival of activated T cells (98). However, there are also 
reports that neither Bcl-2 nor BclxL offer any protection from cell death at the 
conclusion of the immune response (99), (100). 
These findings prompt a variety of questions about the generation of memory cells. 
Co stimulation, for example via CD28, is known to increase the levels of Bcl-2, 
providing some protection to activated cells early in the response (101). The decrease 
in anti-apoptotic and the increase in pro-apoptotic molecules occur at the peak of T 
cell activation (96), (102). This is perhaps a result of the limitation of IL-2 family 
cytokines as the immune response progresses, or an increase in toxic reactive oxygen 
species that cause intracellular and mitochondrial damage (103). This does not 
explain why the future memory cells survive. Do they increase levels of a protective 
molecule, or decrease expression of a pro-apoptotic molecule? 
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1. 3.2. The transition phase: how activated cells become memory cells 
To investigate these questions, the transition phase of the immune response must be 
examined, tracking antigen specific cells as they journey from activation into the 
memory pool. This is exactly the approach Kaech eta! have taken, examining the 
gene expression of CD8 lymphocytic choriomeningitis virus (LCMV)-specific 
transgenic cells at various time-points after activation (104). 
By studying the expression level of a wide range of genes, Kaech et al found that 
60% of the genes expressed by activated cells at the peak of the response (day 8) 
were maintained in the day 40 memory cells (104). This activated population was 
found to contain the precursors of the memory cells, however, three to four weeks 
were required for these precursors to express the extra genes associated with long-
lived memory cells. For example, the authors describe that Bcl-2 levels were not high 
in the cells that survived past the peak of the response, but increased gradually over-
time. 
By transferring the transgenic cells after various time points post-immunisation, the 
authors measured the ability of the populations to protect naive recipients from 
LCMV infection. Day 8 and day 15 cells were poor at controlling the virus, day 22 
cells protected better, but only cells primed 40 days or more prior to transfer could 
offer full protection. Thus, even at 22 days post-infection, the cells had not fully 
generated into protective memory cells. The authors found that this defect was a 
result of reduced and less sustained ERK (Extracellular signal-Regulated, kinase) 
phosphorylation in the day 8 and day 15 T cells after reactivation in vivo. As ERK 




These data suggests that memory cell formation is a gradual process occurring after 
the flux of the active immune response. Whether this gradual formation requires 
signals from other cells or is an autonomous cellular process is not known An 
argument for the latter may be that CD8 T cell activation is an autonomous process 
as, once activated, CD8 T cells will proliferate and differentiate into effectors in the 
absence of continual activation (106), (107), (108). Moreover, Huster et a! (109) and 
Wong et al (I 10) argue that CD8 memory T cells are generated early in the response 
to Listeria monocytogenes (LM) infection. The differences observed by these 
investigators in comparison to Kaech et al (104) may be due to the different infection 
models used. Wong et al argue that as LCMV infection induces a huge antigen-
specific response, the effect of the memory cells would be masked by the presence of 
large numbers of effector cells that would rapidly eliminate any antigen with which 
the immune mice were challenged. 
Badvinac, Harty and colleagues have also investigated the transition phase. They 
found that IFN-y regulated the contraction of the CD8 T cell response to LM (111), 
(112). By reducing the early IFN-y response by pre-treating mice with ampicillin, the 
authors found that the contraction phase of the immune response did not occur (112), 
leading them to argue that early events in the immune response programme both the 
contraction phase and memory cell generation. 
1.3.3. A role for cytokines in memory cell generation 
There is growing evidence that the cells that become memory cells are marked from 
an early stage during activation. This population has been identified by a'number of 
groups using a variety of markers. Jacob and Baltimore created an elegant system in 
which activated, granzyme expressing CD8 cells are induced to express a stable 
marker (113). They found that only a proportion of activated antigen-specific cells 
expressed the marker, but that the majority of memory cells did, implying that a 
selected group of activated cells become memory cells. 
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More recent work has defined a number of natural markers of "future" memory cells. 
For CD8 T cells, the cells that become memory cells were found to express increased 
levels of IL-15R and/or IL-7Ra (109), (114), (112) and the expression of CD8aa has 
also been found on this population of activated CD8 T cells (115). 
A functional role for IL-7 in memory cell generation has been described by a number 
of groups. Li et a! (116) and Kondrack et a! (117) found that in mice treated with a 
blocking antibody to IL- 7Rct, transferred CD4 transgenic cells did not form memory 
cells and that memory T cells transferred into IL-7 knockout mice were unable to 
survive. A similar role for IL-7 in the generation of memory CD8 cells from 
activated CD8 cells has been described, demonstrating that expression (or re-
expression) of IL-7Ra is functionaly important at this stage (114), (83). 
Schluns and Lefrancois question whether cytokine receptor expression is maintained 
on these cells or is re-expressed either by cells that have received a particular signal 
or stochastically by a proportion of the activated cells (80). Indeed cells that receive 
signals either from the IL-2 family cytokines (118), (119), or through the TCR (120) 
have been found to down-regulate IL-7Ra. Although Xue et al have identified that 
the transcription factor, GABP, a member of the Ets family, is responsible for IL-
7Rcz expression (121), this does not identify the upstream factors required to either 
retain receptor expression, or induce its re-expression. 
The maintenance of IL-7Ra signalling could provide the enhanced survival signals 
necessary to protect the "future" memory cells from the massive cell death that 
marks the conclusion of the immune response. For example, Schluns et al found that 
wild-type transgenic CD8 T cells upregulated Bcl-2 after the peak of the immune 
response, but IL-7Ra deficient T cells did not and few memory cells were generated 
from these cells (83). The signals involved in IL-7R signalling that upregulate Bcl-2 
levels have been studied in vitro, but with conflicting conclusions. Although it is 
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clear that the IL-7R signals via Jaks 1 and 3 and STATS 3 and 5 (122), the 
downstream response is less well defined. Barata et al found that 
phosphatidylinositol-3-kinase (PI(3)K) activation was required and acted via Act 
phosphorylation (123), while Rathmell et al report that IL-7 induced Bcl-2 




1.4. Factors controlling the size and quality of the memory pool 
The marking of the cells that become memory cells will make it easier to identify the 
signals that influence cell survival (112). However, past and current research has 
already identified an array of factors that can influence the number and, perhaps 
quality, of cells that enter the memory pool. These factors include the amount and 
type of antigenic signal and the costimulatory molecules that the T cell encounters 
during activation. 
T cells can undergo exhaustion in response to very large antigenic signals and it 
appears that the continued presence of high doses of antigen can induce death in 
most, if not all, of the responding cells (2). The precise role of antigen in memory 
cell generation is contentious. Harbertson et al suggest that the continuing presence 
of antigen is detrimental to memory cell generation as it induces AICD (124). 
However, Badovinac et al found that LCMV-specific CD8 T cells contracted with 
similar kinetics in mice with a persistent infection and those that had cleared the 
virus (125). 
Removing the infection at an early stage does not appear to have a negative affect on 
memory cell formation. Mercado et a! removed Listeria monocytogenes (LM) 
infection from mice using ampicillin on various days following infection. Despite 
this loss of antigenic signal, an equal number of memory cells were found to form 
(.108). John Harty and colleagues have reported similar findings (125), (126). The 
authors found that both CD8 (125) and CD4 T cells (126) responding totM 
infection expanded to a similar extent in mice treated with ampicillin one to two days 
after infection as in untreated mice. Thus, continued antigen presentation is not 
absolutely required for the generation of memory T cells, suggesting that I cell 
activation and memory cell development may be autonomous processes. 
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However, although the infection had been removed, antigen may remain on APC and 
follicular dendritic cells (FDC). FDC are found in B cell follicles and capture antigen 
via various receptors (127). This antigen depot forms the basis of B cell affinity 
maturation in germinal centres during the immune response (128). FDC appear to 
maintain this antigen for some time, prompting suggestions that it may have a role in 
memory cell maintenance (129), (1). It is, therefore difficult to ascertain whether 
antigen is completely removed from the host and under what circumstances T cells 
have access to it. 
The kinetics of T cell contraction have recently been studied in detail for CD8 T cells 
in a LM model by Badovinac et al (125). The authors have found that although 
different doses of infection result in different levels of expansion of specific T .cells 
(with a higher dose resulting in increased expansion), the contraction phase of the 
response is almost identical, with approximately 75% of the activated cells dying. 
Thus, following a high dose of antigen more memory cells are formed. This confirms 
earlier findings that approximately 5% of the cells in. the primary response survive to 
become memory cells (130), (131). 
Similar to the amplified expansion observed with increased antigen dose, it has been 
found that enhancing the costimulation signal results in increased primary expansion 
and a consequential enlargement in memory. For example, adding agonistic anti-
0X40 and/or lipopolysaccharide (LPS) to ovalbumin (OVA) peptide leads to 
increased proliferation of transferred naïve OVA specific TCR transgenic T cells, 
and a consequential increase in the number of cells which survive over time (9), 
(132), (133). Similarly, an increase in IL-12 (134) or TLR signalling (135) can 
increase the number of memory cells that are generated. 
Comparably, the availability of APC can affect the size of the initial expansion. 
Linton et al found decreased primary proliferation of transferred OVA specific T 
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cells in MT mice (which have no B cells) and that this was reflected in a reduced 
memory pool (136). This suggests that as the immune response progresses and 
activated DC start to die, B cells may play an important role in maintaining the 
response. However, van Essen et al suggest that the initial I celiclonal burst is 
unaffected by the lack of B cells and that decreased T cell memory in iiMT mice is a 
result of reduced maintenance of memory T cells (137). In contrast London eta! 
found no differences in T cell memory in [tMT mice (138). There could be a number 
of possible explanations for these differences, for example in the strains of mice 
used, the dose and type of antigen, or in the experimental procedures. 
One issue arising from these studies is whether these factors (dose, co-stimulation, 
type of APC) only result in an increased pool of cells from which memory cells 
develop or whether they provide a different signal that improves cell survival. The 
TNF/TNFR family of molecules enhance survival by increasing the expression of the 
anti-apoptotic Bcl-2 family of molecules (2) and both 0X40 and CD27 (both 
members of the TNF family) signals have been found to be important in the 
generation of memory T cells (139), (140), (141) (142). 0X40 deficient I cells were 
found to undergo fewer divisions than wild-type T cells and were also more prone to 
die as levels of Bcl-xL and Bcl-2 were greatly reduced (139). CD27 signalling has 
been found to enhance the survival of primed antigen specific CD8 T cells in 
response to influenza infection and thereby could enhance the number of cells that 
enter the memory pool (142). 
The formation of memory cells requires T cell activation and is enhanced following a 
strong response, although too much activation can be detrimental. Whethr memory 
cells receive a specific signal or cellular interaction which improves their chance of 
survival, or whether memory cell generation is a much more stochastic event, is still 
open to question. It makes teleological sense that an infection that requires a strong 
primary response (either because it is present at a high dose or appears very 
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dangerous) results in the development of a large cohort of memory cells that can act 
promptly on secondary challenge. 
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1.5. Heterogeneity within the memory pool 
There has been much debate in the memory field as to whether memory T cells must 
first go through an effector cell stage before passing into the memory pool (143), 
(144), (145), (146), (147). The description of the various signals that can influence T 
cell memory generation, suggests that there is not one particular route into survival. 
There are, however, two classical models of T memory cell generation: the linear 
differentiation pathway and the branching or non-linear pathway (145), (144), (147), 
see figure 1.3 In the linear pathway of differentiation, memory T cells develop from 
differentiated effector cells, while in the branching pathway, memory cells are 
generated from activated but not fully differentiated cells. There is evidence for both 
models. Some investigators have found that resting memory T cells can be formed 
from effector cells (148), (149), while others describe memory cell generation in the 
absence of differentiation of effector cells (150), (151), (110). 
To investigate the different pathways of development, Manjunath et al developed a 
transgenic mouse in which naïve and activated T cells express GFP (green 
fluorescent protein) (147). GFP expression, however, is lost upon complete 
differentiation of the CD8 T cells. This has allowed them to track in vivo transferred 
effector cells and cells that have been activated, but not fully differentiated, in vitro. 
Cells activated in the presence of high IL-2 differentiated completely losing GFP 
expression, while culture with IL- 15 induced cells that were activated but remained 
GFP. Both sub-types were found to survive as memory cells for at least 10 weeks 
following transfer in vivo, demonstrating that memory cells may develop'along both 
pathways. 
The survival of these two memory cell sub-types reflects the division of memory T 
cells into T central memory cells (T crn) and T effector memory cells (T ern) ( 146). Tcm 
are found in secondary lymphoid organs as they express the chemokine receptor, 
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CCR7, which binds SLC released by cells in LN (48). T ern cells are similar to naïve 
cells in that they are thought to secrete only IL-2 and re-circulate through the 
lymphoid organs (80). They do express the memory marker CD45RB 10, however, and 
they are more sensitive to stimulation than naïve cells. Tern are generally found in 
tertiary tissues, such as the liver and lungs, do not express CCR7, and secrete effector 
cytokines such as IL-4 or IFN-y (14), (13). Thus, immediate protection may be 
provided by Tern patrolling the tissues while T ern cells act as a back up, quickly 
generating effector cells should a secondary infection persist and induce a full blown 
immune response. This division, which was initially based on human peripheral 
blood T cells (146), has also been described in mice (147), (14), (13), although 
Unsoeld et al found no differences in cytokine production by CCR7 and CCRT 
memory T cells (152). Furthermore, Roberts and Woodland found that despite the 
presence of two phenotypically different populations, both Tcm and Tern cells were 
capable of proliferating in response to re-exposure to antigen (153). 
The description of two sub-groups could explain why memory T cells have been 
reported to develop from both effectors and non-differentiated cells. Lefrançois and 
Masopust propose a number of possible developmental pathways for differentiation 
of the two populations (154). Tcrn and Tern could develop separately from activated 
and differentiated cells respectively, or T ern may become Tern upon terminal 
differentiation. Alternatively, a molecule in the tissues, such as a chemokine, could 
induce differentiation into Tern upon entry of the activated T cell into that tissue. 
They also suggest that both sub-groups could divide and differentiate into each other 
to maintain numbers at a fairly constant level. 
'4 
In support of this, Wherry et al describe the transition of naïve CD8 T cells into T em  
cells that can then differentiate into Tcrn cells (143). Upon transfer to new hosts, it 
was found that the protection to challenge with LCMV was largely contained in the 
Tcm phenotype cells. The authors suggest that the Tern phenotype is a transient state 
with cells becoming "true" memory cells upon differentiation into T crn . In a similar 
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vein, Wu et al found that, after transfer to naïve hosts, Tern phenotype cells quickly 
disappeared but that T. cells survived for at least three weeks (155). 
Lanzavecchia and colleagues have suggested an inclusive model in which the level 
of activation signal (via the TCR and costimulatory molecules) determines the fate of 
the activated cell (156). A strong signal leads to full differentiation and subsequent 
death while a lower signal results in differentiation and formation of Tern cells, and a 
lower signal still leads to Tcm development. This corresponds with Sprent and Tough 
hypothesis that T cells that arrive late in a response, and therefore receive a lower 
signal as a result of decreased antigen and reduced IL-2 levels, are more likely to 
become memory cells than die by AICD (2). 
There has been no real conclusion to the debate about whether memory cells are 
generated from a linar or branching pathway. Rather a middle-ground has been 
reached: memory cells can be generated from either effector cells or non-
differentiated cells, suggesting that memory cell generation is not a narrow path and 
generally occurs following T cell activation that takes place in the context of 
costimulation. This conclusion does not, however, take into account recent findings 
in the CD8 T cell memory field. 
In some infection models, CD4 T cell help is not required for CD8 T cell activation, 
proliferation and differentiation (157), (158), (109), (159). However, recall responses 
in these mice are defective (160). Thus, activation does not always correlate with 
efficient memory cell generation. There is some debate as to when and how CD4 T 
cells act to help the memory CD8 T cells. Shedlock and Shen found that CD4 T cells 
were required during the primary response (157). Bourgeois et a! (15 8) and Huster et 
al (109) suggest that CD4 T cells provide help via binding of CD40L to CD40 
expressed on the activated CD8 T cell. However, Sun et al found that CD8 T cells 
primed in wild-type mice then transferred to CD4 deficient hosts lost their ability to 
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respond rapidly and make effector cytokines (159). Thus, in this system, CD4 cells 
were required during the maintenance of the memory cells. 
That a normal primary expansion and effector cell differentiation can occur in the 
absence of the generation of memory CD8 T cells is intriguing. It implies that the 
generation of functional memory cells is a separate process to cell activation and 
differentiation, perhaps requiring a different set of signals and/or cellular 
interactions. Moreover, ifCD4 T cells are required to maintain CD8 memory T cells 
this indicates that an important cellular interaction is required for the long-term 
functional survival of memory I cells. 	 - 
24 
Introduction 
1.6. Memory Cell Survival 
1.6.1. Factors controlling memory cell survival 
The enhancement of the recall response, compared to the primary response, is a 
consequence of a number of factors. First, there is an increase in the precursor 
number of antigen-specific cells, and second memory cells are functionally distinct 
from naïve cells, able to make effector cytokines without several rounds of 
proliferation and respond to lower doses of antigen (145) or reduced levels of 
costimulation (161), (9), (12), (145). 
Therefore, memory cells represent a separate population to naïve cells and this 
suggests that the two populations will require different survival signals (162), (163). 
It is evident that naïve T cells require periodic contact with MHC molecules (18) and 
IL-7 to survive (164), (165), (166). The signals required for the survival of memory 
cells are, however, less clear. 
It had been thought that persisting antigen provided low levels of TCR stimulation, 
and thereby maintained memory cells (1), (167), (168). However, memory cells can 
survive in the absence of antigen in a number of different systems (169), (170), 
(171), (172), (138), (173). Antigen may be required for the maintenance of functional 
memory cells at least in Leishmania infections: Stobie et al found that mice cleared 
of this persistent infection were no longer protected from re-challenge (174). 
It has also been suggested that memory cells may recognise cross reactive self or 
environmental antigen which could provide low level ICR signalling (2). Studies 
involving the transfer of memory T cells into MHC class 1(175) or class II knockout 
mice (172), suggest that CD8 and CD4 T cells respectively, do not require any TCR- 
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peptide-MHC contact, although some CD8 T cell cells may require contact with 
MHC molecules to survive (18). However, in these experiments the transferred cells 
do not have to compete with endogenous CD8 or CD4 T cells due to absence of cells 
in MHC deficient hosts. It may not be surprising, therefore, that the cells persisted. 
Furthermore, although T cells can survive in MHC knockout mice, it has been 
proposed that they may be functionally impaired. Kassiotis et al found that T cells 
maintained in the absence of MHC signals could not provide help to B cells or 
initiate skin graft rejection (176). This highlights a major concern in memory T cell 
studies that use either antibodies or tetramers to measure the number of surviving 
cell, but do not investigate the functional response of these cells. Additionally, the 
appropriateness of using in vitro activated cells (which are removed from the 
complex micro-environment of the host), as a correlate to in vivo cells can be 
questioned. For example, Veiga-Fernandes et al found that in vitro activated cells 
divided less but differentiated more than in vivo activated memory cells (12). 
Although TCR signals do not appear to be necessary for memory T cell survival, 
other factors, such as soluble molecules, may play important roles. A role for IL-15 
in the maintenance of memory CD8 T cells has been widely accepted and IL-7 may 
also contribute (80), (83), (82). IL-l5 (177) and IL- l5Ra (178) knockout mice are 
deficient in memory phenotype CD8 T cells and IL- 15 induces the division of 
antigen-specific memory cells in vitro and in vivo (179), (180), (181), (182). 
Surprisingly it has been found that expression of the high affinity IL- 1 5Rct chain by 
activated and memory CD8 T cells is not required for their survival (17). This may 
be because the parts of the receptor involved in signal transduction are the common 
y-chain and IL-15R13 (183), (184). Although there are reports that IL- l5Rcx binds to 
TRAF-2 and that this contributes to I cell survival by blocking TNFR induced 
apoptosis (185). IL- l5Ra does have to be expressed, however, by as yet unidentified, 
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accessory cells that present IL-15 to memory CD8 cells (186), (187). This 
demonstrates that memory CD8 cells require specific cellular interactions in order to 
survive. 
IL-l5 does not appear to affect CD4 memory T cells, but a similar role for IL-7 has 
been described. Seddon et al found that contrary to previous reports (188), (164), IL-
7 was required for the homeostatic proliferation of CD4 T cells in lymphopaenic 
hosts, but only in the absence of TCR signals. This result prompted a re-evaluation of 
the requirement for IL-7 for the survival of memory CD4 T cells. Previously, it had 
been thought that anti-IL-7 antibodies did not diminish the memory CD4 T cell pool 
(189) and that memory CD4 T cells could persist in the absence of the common y -
chain which forms part of the IL-7 receptor (164). More recently, Lenz et al found 
that anti-IL-7Ra blocked the basal proliferation of antigen specific CD4 memory 
cells and that in vitro exposure to IL-7 results in an increase of Bcl-2 levels in these 
cells (82). 
These data mean that naïve and memory CD4 and CD8 T cells all depend to some 
extent on IL-7 for their survival. It had been thought that the naïve and memory T 
cells pools were regulated separately (8), (81), (190). However, it now appears that 
IL-7 is a master regulator of T cells: critical for development of thymocytes (164) 
and in determining the size of the naïve (164) and memory T cell pools (83), (82), 
(82); it is perhaps not surprising, therefore, that memory CD4 T cells may require IL-
7 for long-term survival. However, there are additional factors that control the size of 
the separate pools. Specifically, naïve CD4 and CD8 T cells require contact with 
self-MHC class 11 (19 1) and class I respectively (18), (192), and IL-l5 plays a key 
role in the long-term survival of CD8 memory T cells (181), (179). Whether there is 
an additional factor that contributes to CD4 memory cell maintenance is a question 
that remains to be answered. 
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1. 6.2. Survival of memory cells in competitive environments 
Many of the studies outlined above have been conducted in either lymphopenic mice 
or in mice that are not challenged with other infections. The immune system has to 
contend with a constant onslaught of micro-organisms and the memory pool must 
either stretch to accommodate new entrants or somehow reduce its numbers. 
The fate of memory cells in a competitive environment has been studied in viral and 
bacterial models of infection. Both studies have focussed on the CD8 T cell 
response, but also briefly examine the CD4 response. Welsh, Selin and colleagues 
have used a long-term study employing several different viruses to investigate 
memory T cells (193), (194), (195), (196), (197). Following the finding that some 
viruses share cross reactive epitopes, they have shown that the hierarchy of T clones 
responding to LCMV can be altered by infecting the mice with a range of other 
viruses. LCMV specific memory CD8 T cells which do not respond to the cross 
reactive epitopes are found to decrease, while those that receive a boost following 
infection with a different virus, remain at a stable level. 
Similarly, Smith et al found that immunising mice with bacillus Calmette-Guerin 
(BCG) reduced their ability to reject a tumour to which they were previously immune 
(198). This attrition in the face of new infections prevents the CD8 T cell pool from 
becoming saturated, especially as it has been shown that 50% of the pool can be 
specific for a particular viral epitope (131), (199). 
These two studies of multiple infections found distinct effects on the survival of 
antigen specific CD4 T cells. In the viral model the number of CD4 T cells was 
found to decrease only slightly following the subsequent infections (195). The 
authors suggest that this may be due to more pressures on the CD8 T cell memory 
pool as so many cells are activated during the primary response. However, in the 
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bacterial model, the numbers of antigen-specific CD4 T cells were found to be 
dramatically reduced following BCG infection (198). 
In contrast, in a single infection model using LCMV, Homann et al found stable 
levels of CD8 T cells but decreasing numbers of CD4 T cells over the one to two 
years examined following infection (19). This was accompanied by  decrease in 
Bcl-2 expression in the CD4 T cells that was not observed in the memory CD8 T 
cells. Despite this loss in CD4 T cells, the mice were still protected from secondary 
infection one and a half years after priming. Therefore, it appears the CD8 memory 
pool alters in response to new infections, providing space for the cells that have 
proved most useful, while the CD4 memory pool may decline slowly overtime, even 
in the absence of external pressures, and thereby provide space for new memory 
cells. 
However, the attrition observed in the models described above may not be a direct 
consequence of competition between memory CD8 T cells for space within the 
memory pool. In follow-up papers, both groups have found that cytokines released 
during the subsequent response induce the death of the original memory population. 
Welsh's group found that memory cells decline as early as two days after the new 
infection (200) and this may be a result of increased levels of type I IFNs (201). 
Similarly, Chapdelaine eta! described that an increase in IL-is caused the observed 
attrition of memory CD8 T cells in the BCG model (202). As type I IFN induce the 
expression of IL- 15 (180), the mechanisms described by these two groups may be the 
same. 
As described above, IL- 15 and type I IFNs can induce the division of memory cells 
in vitro and in vivo (179), (180), (181), (182). However, Welsh's group did not find 
that the memory CD8 T cells had divided prior to their death, although they may 
have been activated by bystander activation. Bystander activation can occur when 
cytokines such as IFN-y, IL-12 and IL- 15, made by innate cells such as NK cells, 
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induce memory CD8 T cells to make IFN-y (203), (180). This early and rapid 
increase in IFN-y may be important in defence against infection, for example by 
activating macrophages increasing their phagocytic and killing ability. Less work has 
been carried out into bystander activation of CD4 memory cells (204), (180), (203). 
Although Ebrel et al found that synthetic double stranded RNA induced bystander 
proliferation of both CD4 and CD8 memory cells (203), Zhang et al found 
proliferation only in memory CD8 T cells (180). Recently, Jiang eta! have described 
that LM infection induced bystander activation followed by apoptosis of both CD4 
and CD8 T cells (205). In the absence of a ICR signal these cells die, which Jiang et 
al argue, provides space for the ensuing antigen-specific response (205). 
These results lead to questions about how IL- 15 and type I IFNs can simultaneously 
maintain the memory CD8 I cell pool but also cause the death of memory cells. The 
answer to this may lie in the context of exposure to the cytokines: during an immune 
response, IL- 15, perhaps in concurrently with other signals, brings about the 
apoptosis of T cells which do not receive a TCR signal, while in the steady-state, IL-
15, which may have to be presented by accessory cells to CD8 memory T cells (17), 
(186), acts as a survival signal. 
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1.7. Maturation of the T cell Immune response 
The maturation of the immune response has been studied in great detail for B cells. 
The processes of somatic hypermutation and selective survival of high affinity B 
cells occurs in germinal centres during the immune response (127), (206), (128). It 
has been suggested that the T cell response also undergoes affinity maturation as an 
increase in speed and efficiency is observed in the secondary response (138), (207). 
Although the internal signalling molecules of memory cells have been found to differ 
from naïve cells, perhaps allowing them to respond at lower concentrations of 
antigen (145), it appears that higher affinity clones are found to dominate the 
secondary response (208), (209), (210). This selection of high affinity cells could 
occur via several mechanisms: 1. by selective preservation of high affinity cells into 
the memory pool; 2. selective survival of high affinity clones during the memory 
phase (indicating a role for antigen in memory maintenance); 3. selective activation 
of high affinity clones in the secondary response; or 4. a combination of all three 
(210). However, as it is difficult to measure directly the affinity of the ICR for 
MHC-peptide, the role of other molecules, for example adhesion molecules, in 
increasing the cell's overall avidity must be considered (207). 
Several investigations into affinity maturation have been conducted which seem to 
favour mechanism 3. Rees et al immunised mice with varying doses of antigen and 
found that high affinity clones were only selected when antigen was limiting, but this 
effect was only apparent in the recall response (211): This suggests that when limited 
antigen was available, high affinity clones were preferentially activated in the 
secondary response, providing an extra survival boost for these cells. 
Similarly, Busch and Pamer describe the selection of high affinity clones in the recall 
response and suggest that maturation results from this discriminating expansion 
(208). However, they did not examine the repertoire of the memory cells following 
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the primary response and so cannot rule out mechanisms one and two outlined above. 
In contrast to these reports, Fasso et al suggest that selection of high affinity clones 
occurs during the primary response, but also that there is a role for outgrowth of a 
small population of clones in the recall response (209). 
A mechanism for this selection of higher affinity cells in the secondary response has 
been proposed by Kedi eta! (212). The authors found that high affinity CD8 OT-1 
OVA specific TCR transgenic cells prevented the host OVA specific response by 
inducing the down-regulation of M1HC-peptide complexes on APC. Thus, only cells 
with high affinity TCR could interact with MHC-peptide molecules and proliferate in 
secondary responses. 
The increase in affinity of responding T cells may enhance the speed of the 
secondary and future responses, but it could result in a narrowing of the T cell clones 
that recognise a particular micro-organism, leaving the host open to challenge by a 
mutated version of the pathogen. Such a narrowing of the repertoire has not been 
reported, rather the TCR of cells in the primary and recall responses have been found 
to be the same (213), (214). Moreover, Slifka and Whitton argue that there may be 
no functional advantage in increasing the affinity of the TCR for peptide-MHC and 
that high affinity interactions may prevent serial triggering of the TCR, which may 
be important in T cell activation (207), (215). Therefore, whether T cell affinity 
maturation takes place or not is open to debate. 
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1.8. Immunological Memory and Infectious Disease 
Recall responses are faster and more effective than primary responses. Thus, when a 
host is re-exposed to a pathogen they are either less likely to become ill or will the 
resolve the infection more quickly. This phenomenon underpins the effectiveness of 
vaccines that "prime" the host with either an attenuated form, or portion of the 
pathogen to generate antigen-specific memory cells. Vaccines can, therefore, only be 
effective if they induce memory cells that are both long-lived and protective thus 
understanding how memory cells are generated and survive is important for the 
development of effective vaccines. 
The type of memory cell that a vaccine should induce is a topic of debate (144). 
Some investigators have found that T ern are not long-lived cells and, therefore 
suggest that vaccines should aim to induce Tcm cells (143), (155). However, Tcrn are 
found in the secondary lymphoid organs and are not poised at the peripheral sites that 
pathogens mainly invade the host. Thus, T ern cells may be required for full protection. 
For example, Zinkernagel and colleagues have found that, although antigen-specific 
memory CD8 cells can persist in the absence of antigen, these cells are unable to 
protect the host from a re-challenge with the same virus (168), (216), (217). They 
argue, therefore, that antigen is required to maintain T ern memory cells in an activate 
state allowing them to respond promptly to re-infection. 
This effect has been described by a number of groups investigating mouse parasite 
infection models. For example, Belkaid et al found that IL- 10 knockout mice 
completely clear Leishmania infection and in doing so are no longer protctedfrom 
re-challenge (218). This suggests that long-lived memory cells had not been 
generated. In wild-type mice, the infection is not cleared as regulatory T cells (acting 
via IL- 10) prevent effector CD4 T cells from eliminating the parasite. This results in 
long-term exposure to antigen and this appears to maintain Tern cells. Zaph et al, 
however, dispute the claim that no "true" memory cells are formed in Leishmania 
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infected mice (219). The authors found that while T ern cells could not survive in the 
absence of the persistent infection, T. cells not only survived but also provided 
some level of protection to the mice. 
Similarly, true protective memory cells do not appear to either,be generated or 
survive for long periods of time following malaria infection. Anecdotally, it has been 
observed that people who leave areas of endemic malaria lose any protection they 
have, and can be severely infected on return to these areas. This complex multi-stage 
parasitic infection does induce an immune response (220), however, protection in 
rats induced by immunisation with irradiated sporozoites is lost following treatment 
to remove all the remaining parasites (221). This perhaps suggests that antigen is 
required to maintain the potentially short-lived Tern cells that protect from re-
infection by these parasitic infections. These studies suggest that long-lived 
immunity to infections may require several administration of a vaccine. 
In some cases the persistence of antigen can result in exhaustion of the responding 
CD8 T cells. For example, some strains of LCMV that cause persistent infections in 
mice result in the clonal exhaustion of antigen-specific CD8 T cells (222). However, 
in other viral infections that cause persistent infections, such as herpes virus, CD8 
memory cells are constantly exposed to antigen and yet remain functional. Khanna et 
al found that in mice infected with herpes simplex virus, antigen-specific CD8 
memory cells were retained at the infection site for at least 80 days and these cells 
may prevent reactivation of the virus (223). The cells had an activated phenotype 
with most cells expressing the early activation marker CD69 indicating recent 
exposure to antigen. 
In a study of the response of CD8 I cells to murine cytomegalovirus, Karrer et al 
also found that a proportion of antigen-specific cells were activated in LN during the 
latent phase of the infection (224). The authors .found that the number of antigen- 
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specific memory cells actually increased after day 40 post-infection; by one year 
after the infection 20% of all CD8 cells were specific for one viral epitope. These 
cells had an active phenotype and could make IFN-'y six hours after exposure to 
antigen ex vivo. Therefore, as in the study by Khanna et a!, these T cells may be 
actively involved in preventing re-activation of the virus. Similarly, Sendai virus-
specific memory CD4 cells described by Cauley et al in the lungs of infected mice 
had a very activate phenotype in terms of CD25 and CD69 expression (225). The 
authors suggest that only most differentiated cells were able to migrate to the lung, 
however, these memory cells do not persist beyond 100 days after infection. 
This phenotype of viral-specific CD4 and CD8 cells is more reminiscent of activated 
cells than memory cells and calls into question the definition of memory cells. Can 
cells that are actively involved in an immune response in a particular tissue be 
considered part of the re-circulatory pool that forms a rapid response to re-challenge? 
Moreover, can cells that require this contact with antigen for survival be classified as 
memory cells? 
These questions have been addressed in a recent paper from Rafi Ahmed's group 
(226). The authors studied the memory cells generated following infection with two 
different strains of LCMV, one that induces an acute immune response that 
completely clears the virus and one that results in a chronic infection. CD8 memory 
cells generated by the acute infection survive in the absence of antigen and 
proliferate in response to IL- 15 and IL-7 in vivo. In contrast, cells from mice with 
chronic infections could not survive in the absence of antigen after transfer to naïve 
hosts. The authors suggest that this is because the memory cells do not express IL- 
1 5Ra or IL-7Ra and thus cannot receive survival signals from these cytokines. 
The authors argue that memory cells from hosts with persistent infection did not 
differentiate into classic long-lived memory cells based on the ability of memory 
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cells to proliferate in response to IL- 15, changes in IL-2 production and the re-
expression of the lymphoid homing molecules, CD62L and CCR7. These differences 
suggest that there may be two pools of memory CD8 cells: one that is maintained by 
exposure to IL- 15 but survives independently of antigen, and the other that requires 
antigen but not IL-15. Schiuns eta! did indeed find that some memory CD8 cells are 
not dependent on IL- 15 for survival (227). These cells, therefore, exist in separate 
niches within the CD8 memory pool and thus do not compete with one another for 
survival resources. The existence of these distinct pools may, therefore, increase the 
number of pathogens for which the host has protective memory. 
The data described above suggest that the pathogen which the immune system is 
exposed to can determine the type of memory cells generated. For example, in 
persistent infections, the cells that survive the primary response may retain an 
effector phenotype as they are exposed to antigen and are involved in protecting the 
host from re-activation of the "dormant" pathogen. In this sense then, these cells are 
memory cells: protecting the host from full-blown infection by responding rapidly to 




1.9. Systems for studying T cell memory 
Tracking the cells involved in immune responses provides an essential opportunity to 
improve our understanding of immunology. Memory T cells can be tracked in a 
number of different ways. Markers of antigen experience, such as high expression of 
CD44 and reduced expression of CD45Rb, can be used to follow the "memory" 
population in either unmanipulated or immune mice (228), (229), (230), (161). The 
major shortcomings with this approach is that the analysed cells are undefined in 
terms of antigen specificity and, or contain a heterogeneous 
I
mix of cells, including T 
regulatory cells which are defined by the same phenotypic markers. Moreover, in the 
majority of these systems mice that have not been intentionally immunised with 
antigen are studied, thus responding cells cannot be tracked during activation and 
into the memory phase. 
Antigen-specific memory cells have proved difficult to study due to the small 
number of cells specific for a particular antigen, and because the markers which have 
been described, such as CD45RB 10, L-selectin'°, CD44hi,  are not stably or 
consistently expressed (229). Antigen specific cells can be tracked, and markers of 
memory used to indicate the phenotype of the cells. There are two commonly used 
ways of doing this: 1. by immunising mice with superantigens which activate 
families of T cells (211), (98), (132); and 2. by transferring a population of antigen 
specific TCR transgenic cells into wild-type mice (14), (231), (9), (132), (136). 
Superantigens, for example staphylococcal enterotoxins, bind directly toMHC 
molecules and to the variable region of the f-chain of the TCR. This bypasses the 
processing of antigen by the APC and presentation of peptide in the class II groove. 
The superantigen binds to T cells expressing the same beta chain, which can be 2-
20% of T cells (232). These activated cells can then be tracked using a monoclonal 
antibody to this region of TCR. 
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This system enables antigen-specific cells to be identified and tracked during and 
after an immune response to an antigen from a pathogenic micro-organism. The 
mechanism of T cell activation is, however, distinct from that in most immune 
responses and thus the results from studies using superantigens may not be wholly 
representative of T cell activation. 
TCR transgenic cells have provided a wealth of information about how the immune 
response functions, particularly during the early events of T cell activation (22), 
(233), (24). About 5-10% of the transgenic cells express additional V-a chains as a 
result of incomplete allelic exclusion. This gives rise to cells with additional 
specificities such that these transgenic cells can recognise other antigens. This can 
lead to questions about the survival of memory cells in the absence of cognate 
antigen, as the cells may be able to recognise a self or environmental antigen. This 
problem can be overcome by crossing the transgenic mice to Rag knockout mice in 
which, due to the disruption of the Rag gene responsible for gene recombination, the 
a-chains cannot be expressed. 
The TCR transgenic cells can be transferred into wild-type mice. This provides a 
small population of antigen-specific cells that can be activated and tracked during the 
immune response and the memory phase. The cells can either be tracked by 
monoclonal antibodies that recognise the TCR or by antibodies that recognise 
congenic markers such as Ly5.l or Thy 1.1. 
Although transgenic cells have proved invaluable as a research tool in T cell 
immunology, there are several concerns about using them to study T cell memory. 
First, even though in most studies a small population of transgenic cells are 
transferred into wild-type mice, the precursor frequency is still much greater than in 
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endogenous responses. Thus, the ensuing T cell response may have different kinetics 
and require different signals to an endogenous response. 
A further problem is that most TCR transgenic cells recognise peptides from model 
antigens such as OVA or pigeon cytochrome c (PCC). In recent years several 
strategies have been used to overcome this problem. To study the CD8 T cell 
response to viral or bacterial infections, the OVA peptide that OT-1 TCR transgenic 
T cells recognise, has been genetically incorporated into infectious micro-organisms 
such as vesicular stomatitis virus (83) or LM (234). This allows the response to a 
virus or bacteria to be tracked with established tools. 
A second approach has been to develop TCR transgenic mice with T cells that 
directly respond to bacterial antigens. The SM! mice developed by Stephen 
McSorley and colleagues have T cells that recognise a peptide from the flagellum of 
Salmonella typhimurium (235). In this example however, the transgenic cells cannot 
be used to track the T cell response to Salmonella infection as they are competed out 
by the host response to other antigens from the bacteria (236). 
This obstacle illustrates an additional problem with transgenic cells. In a primary 
immune response a number of T cells with different specificities will be activated by 
the different epitopes within the antigen. These cells may compete for antigen and 
costimulation and this will induce a population of memory cells containing a range of 
TCR specificities. This phenomenon has been widely studied in the CD8 response to 
virus such as LCMV and influenza and is known as epitope dominance (193), (237). 
Transferring a population of monospecific cells into wild-type mice can skew the 
response to this one epitope and TCR specificity. Thus, the resulting memory pool 
does not reflect that in the endogenous response in wild-type mice. 
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The same arguments hold for experiments in which transgenic cells are activated in 
vitro prior to transfer (231), (124). This provides a large source of antigen-
experienced cells that can easily be manipulated. However, these cells cannot 
represent memory cells generated in the complex in vivo microenvironment. 
Similarly, memory cells generated after the transfer of transgenic cells into Rag 
knockout mice that are then immunised, cannot represent memory cells from wild-
type mice. Rag knockout mice contain neither T nor B cells and memory cells 
generated in Rag deficient mice exist in a very different environment to those in 
wild-type hosts. 
Given these deficiencies in the experimental protocols for the study of T cell memory 
it is necessary to study the activation, generation and survival of memory cells in 
vivo under physiological conditions. To achieve this, and to overcome the problems 
of studying monoclonal populations of transgenic cells, endogenously activated 
antigen-specific T cells must be studied. To do this, molecules that bind the TCR of 
antigen-specific cells are required: in other words M}IC-peptide molecules. As the 
TCR interacts with the MHC-peptide complex with low affinity, the MHC complex 
must be multimerised to increase affinity by binding biotinylated MHC molecules 
with steptavidin to form tetramers. MHC class II tetramers are probably composed of 
a range of multimers due to heterogeneous cross-linking of streptavidin-PE in 
commercial preparations (238). However, these molecules will be referred to as 
tetramers throughout this thesis. 
MHC tetramers enable the accurate and quantitative measurement of antigen specific 
cells responding to an immune challenge (239), (240). Class I MHC tetrámers were 
first used by Altman et alto identify human influenza specific C138 I cells ex vivo 
(24 1) and have been widely used to study the dynamics of CD8 T cells responses in 
vivo (242), (131), (240). For example, it has been shown that the percentage of CD8 
T cells responding to LCMV infection contains a greater percentage of antigen- 
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specific cells than was previously calculated using other methods such as limiting 
dilution assays (131). 
MHC class II tetramers have also been produced (243), (244) and have been used in 
a number of studies, for example to identify T cell epitopes (245) or to investigate 
the activation of T cells (246). However, the use of class II tetramers to study 
antigen-specific CD4 T cell responses has been more limited. This is probably for 
two main reasons: 1. class II tetramers have proved more difficult to produce and 2. 
the responding CD4 populations are much smaller than CD8 populations (247), 
(240), (248), (249). To get round the problem of the low number of antigen specific 
cells, Day et al enriched the tetramer positive cells by using anti-fluorescent beads 
followed by magnetic purification. However, this also selects for high affinity cells 
and may not provide a full picture of the cells present (249). 
There are other "tricks" to improve the generation of and staining by class II 
tetrarners. Cunliffe et al added a flexible linker peptide between the class II peptide 
and MHC chain that improved the binding of the peptide to the class II groove (250). 
Reddy et al have optimised the time, temperature and pH of the staining procedure 
and also describe how pre-treatment of the cells with neuraminidase, which cleaves 
sialic acid from the cell surface, can enhance tetramer staining (251), although this 
latter "trick" also increases the level of non-specific binding by the tetramer (252). 
Cameron et al have highlighted a potential problem with using class II tetramers 
(238). The authors found that tetramer binding required endocytosis and.cytoskeletal 
rearrangements. Therefore, the activation state of the cell may affect the level of 
tetramer binding and in vitro anergised cells could not bind the tetramer. However, 
Reddy et al have stained putative anergic T regulatory CD4CD25 self-reactive T 
cells with class II tetramers (253). Moreover, staining by tetramers may be dependent 
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on the integrity of lipids rafts in the cell membrane (254) or may be affected by 
persistent exposure to antigen, which can downregulate the TCR (255). 
Mallet-Designe et al have described an alternative approach to identifying antigen 
specific cells (247). They have incorporated MHC-peptide molecules into a lipid 
bilayer and found that these liposomes bound OVA specific T cells with much 
greater avidity than class II tetramers composed of the same MHC-peptide 
molecules. The authors suggest that only two MHC molecules within the tetramer 
could bind any one T cell while the linear display of MHC molecules on the 
liposome increased the number of MHC molecules that could interact with TCR to 
between 60-200. 
Flow cytometry has been the tool of choice for most of these studies, enabling the 
accurate quantification of responding cells. However, microscopy offers an 
alternative view, enabling the identification of the location of antigen specific cells 
and providing information about the interactions between different cell types. For 
example, Garside et a! tracked OVA-specific transgenic T cell and HEL-specific 
transgenic B cells in wild-type mice immunised with HEL conjugated to OVA. By 
identifying the two transgenic cells, the authors were able to show when and where 
the cells interacted during the immune response. To study the distribution of 
transgenic memory cells, Reinhardt et al stained whole mouse sections with 
antibodies that recognise the transferred cells and could locate the cells in many of 
the mouse's organs (14). The precise quantification of this sort of experiment is now 
possible using laser scanning cytometry (256). 
MHC tetramers have been use to identify antigen specific cells in tissue sections 
(257), (258), (223) (259). Class I tetramers that recognise a peptide from herpes 
simplex virus type 1, have been used to demonstrate the presence and position of 
antigen specific CD8 T cells in the sensory neurons where the virus has been found 
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to persist (223). Similarly, class II tetramers have been used to identify CD4 T cells 
that recognise a component of the myelin sheath, proteolipid protein, in the central 
nervous system (257). Combining this technology with laser scanning cytometry 
would provide an opportunity to track the exact location of antigen-specific 
endogenous cells and provide information about their cellular interactions. However, 
the technical challenges of identifying the small number of antigen specific cells will 
certainly prove challenging. 
1.10. Conclusion 
Memory T cells have proved a difficult and controversial area of study. Problems 
with identifying and tracking these cells in vivo has meant that various non-
physiological systems, such as transfers into immunodeficient mice, are relied upon 
to provide the basis of our knowledge. With the increasing use of transgenic cells 
and tools such as tetramers, a greater understanding of memory will be achieved, and 
with this; better vaccines could be developed. 
The current picture in memory T cell immunology is still, however, a confused one. 
There are many questions still to be asked and answered. For example, what allows 
some cells to survive while those around them are dying: is it an ability to escape cell 
death, either by up-regulating survival factors such as the anti-apoptotic Bcl-2 family 
molecules, or by expressing death inducing receptors such as Fas at reduced levels? 
Or is there a specific survival signal which some cells receive? Does this lead to the 
increase in IL-7Ra and IL-15Rct expression? Or are cells that avoid (or arrive too 
late to receive) repeated antigenic stimuli allowed to survive? 
Moreover, what of memory cell maintenance? The many experiments carried out in 
artificial systems (whether because cells are transferred into immunodeficient mice, 
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or the cells themselves are activated in vitro without being exposed to the complex 
array of signals which occur during a response) do not provide an accurate evaluation 
of what actually occurs in vivo. The basal proliferation of memory cells provides an 
answer to the ability of these cells to persist; but whether this division occurs by 
default or requires certain signals, remains open to question. 
Thus, the signals required (or not required) to maintain memory cells remain 
unknown and the competitive (or not) environment of the memory T cell pool 
remains a mystery. What is required is for the composite parts of memory cell 




The aims of this PhD have been to track antigen-specific memory cells and to ask 
questions about the requirements for memory cell generation and survival. 
Specifically, class II tetramers have been used to follow CD4 T cells through the 
activation, contraction and memory phases of the immune response and to identify 
the requirements for the costimulatory interactions between CD40L-CD40 and 
ICOS-B7h in these three phases. The survival of either TCR transgenic or polyclonal 
memory cells has also been studied in mice that have a competitive memory pool to 
attempt to establish factors that may influence memory T cells. 
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019 F cell 
Figure 1.1 T cells are activated by interacting with APC: T cells 
express TCRs (dark blue) and co-receptors (CD4 or CD8, red) that 
bind to MHC-peptide molecules (light blue) on APC. Activation 
also requires interactions between costimulatory molecules, 
providing signals for both the T cell and the APC. For example, 
CD28 expressed by all T cells binds to B7.1 and B7.2 on APC and 
enhances the ICR signal; and CD40L on activated T cells binds to 
CD40 on DC, providing signals to activate the DC. 
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T cell 	 Effector cell 
activation 	 differentiation 









Figure 1.3 Pathways of memory cell generation: Once activated, naïve T cells 
proliferate and can form effector T cells (red). Memory cells may either be 
generated from effector T cells (linear pathway) or memory T cells may be 
generated from activated, but non-differentiated cells. 
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Figure 1.2 Pathways of T cell apoptosis: T cells can be induced to undergo 
apoptosis either by ligation of death receptors such as Fas or by the 
withdrawal of growth factors. Ligation of Fas by FasL results in trimerasation 
and recruitment of FADD. This results in the activation of the proenzyme 
caspase 8. Caspase 8 activates the rest of the caspase cascade and also the Bcl-
2 family member Bid. Bid inactivates Bcl-2 thereby amplifying apoptosis. The 
withdrawal of growth factors results in the movement of pro-apoptotic Bcl-2 
and BH3 molecules to mitochondria where they inactivate Bcl-2. This leads to 
the release of cytochrome c, which forms the apoptosome with Apaf-1 and 
caspase 9. The apopotsome then activates the caspase cascade. Adapted from 
references 71 and 78. 
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2. Materials and Methods 
2.1. Mice 
All mice were bred and maintained in specific pathogen free conditions at the 
Animal Facility at the University of Edinburgh. Mice were used at 6-12 weeks of 
age; sex and age matched mice were used within experiments. All experiments were 
performed under home office regulations. 
The mice used and the conditions they were kept in are detailed below in table 2.1. 
Some of the mice were screened to check for the presence of transgenes or absence 
of molecules and details are given in table 2.1. 
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Strain Screening Conditions Reference 
maintained in  
BALB/c None Normal cages 
with water  
C57BL/6 None Normal cages 
with water  
CD40 KO Stain for Normal cages  
CD40 with Borgal 
expression by 
FACS  
CD40L KO PCR for Normal cages  
CD40L and with Borgal 
neomycin 
genes  
ICOS KO PCR for ICOS Normal cages Made by Ma 
and neomycin with water Cervera in 
genes David Gray's 
lab 
DO 11.10 Stain for Normal cages  
expression of with water 
KJI.26 by 
FACS  
OT-11 Stain for Normal cages  
expression of with water 
Va2 and Vb5 
byFACS  
(C57BL/6xBALB/c)F I None Normal cages 
with water  
p.MT Stain for B220 Filter topped  
orCDl9by cages with 
FACS Borgal  
Table 2.1: Summary of mice used, the conditions they were maintained in and screening 
requirements. 
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2.2. Media 
Ex vivo cells were prepared and washed in Iscove's Modified Dubleco's Medium 
(IMDM) (Sigma-Aldrich, Poole, UK) containing 5% foetal calf serum (FCS) (Bioest, 
Nuaillé, France) supplemented with 2mM L-Glutamine (Gibco BRL, Life 
Technologies, Paisley, UK), 100U/ml penicillin, 100g/ml streptomycin (Gibco) and 
50tM 2-mercaptoethanol (BDH Merck, Poole, UK). This media is referred to as 5% 
FI$]YAI 
In vitro activation of Hl9env-specific cells and transgenic cells was done in 5% 
IMDM. 
Tetramer staining was done in 10% IMDM (IMDM containing 10% FCS) 
supplemented with 2mM L-Glutamine, 1 OOU/ml penicillin, 1 OOtgIml streptomycin 
(Gibco) and 50tM 2-mercaptoethanol (BDH). Transgenic cells and DC were stained 
in FACS buffer (PBS containing 2% FCS and 0.05% sodium azide). 
Phosphate buffered saline (PBS) for FACS staining was made using PBS tablets 
(Sigma) and Dubleco's PBS used for cell transfers (Sigma). 
DC were grown in RPMI (Sigma) supplemented with 2mM L-Glutamine (Gibco), 
100U/ml penicillin, 100tg/ml streptomycin (Gibco) with either 10% FCS or 0.5-1% 
mouse serum (Harlan Sera Labs, Loughborough, UK or Cedarlane, Hornby, Ontario, 
Canada). 
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Cell separation using magnetic beads was done in MACS buffer: HANKS (Sigma) 
with 2% FCS and 100U/ml penicillin and l00.tg/m1 streptomycin (Gibco). 
2.3. Immunisations. 
For class II tetramer studies, mice were immunised with 1O0ig of Hl9env (N-
EPLTSLTPRCNTAWNIRLKL-COOH) or ovalbumin peptide (OVA) (N-
ISQAVHAAHAEINEAGR-COOH) (both from ABC, Imperial College, London, 
amino acid codes given in the one letter code) emulsified in Complete Freund's 
Adjuvant (CFA) (Sigma). 50tl were injected subcutaneously (s.c.) into each hind-leg 
unless otherwise stated. The CFA emulsification was done using a sonicator. 
For bone marrow derived DC immunisations, mice were immunised with 1x10 6 DC 
or as indicated in the figure legend, either intravenously (i.v.) in the tail vein in 200p1 
or s.c. in the hind-legs (50p1 in each leg). 
In the multiple immunisation experiment, mice were immunised with lOOpg KLH 
intraperitioneally (i.p.) (Calbiochem, La Jolla CA, USA); 100pg OVA protein 
(Sigma) or OVA-DNP (kindly provided by Alison Crawford) both precipitated in 
alum and injected i.p.; and l0tg of secreted proteins from Nippostrongylus 
brasiliensis, kindly provided by Adam Balic was injected i.p. (265). 
In DO 11.10 and OT-11 studies, adoptively transferred mice were immunised one day 
after cell transfer with OVA-peptide. The peptide was precipitated in 9% aluminium 
potassium sulfate dodecahydrate (Sigma) solution and washed three times in PBS 
prior to use. The (C57BL/6xBALB/C)F1 mice were immunised with 100tg of alum 
precipitated OVA-peptide i.p.. 
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In the pre-immunisation studies, BALB/c mice were immunised with lOOpg OVA 
protein precipitated in alum i.p. with 10 days in-between each injection and the final 
injection given 10 days prior to the DO 11.10 cell transfer. 
2.4. Bone marrow derived DC. 
DC were derived from bone-marrow progenitor cells according to the procedure 
developed by Inaba et a! (266) and the protocol followed (e.g. concentration of LPS 
used for activation and concentration of peptide used) had been optimised by Dr. 
Georgia Perona-Wright during her PhD in David Gray's laboratory. 
The bone marrow was flushed from .the tibias, femurs and humeruses using medium 
and gentle pressure from a 5m1 syringe and a 25 gauge needle. Cell clusters were 
dispersed by passage through an 18 gauge and then a 26 gauge needle. Red blood 
cells were removed using lysis buffer (Sigma) and the remaining cells were seeded 
into 24 well plates at 3.75x10 5  in lml in RPMI (Sigma) containing 10% FCS, 5% 
GMCSF (supernatant from GM-CSF producing cell line supernatant (267)) 
supplemented with 2mM L-Glutamine (Gibco) and 100U/ml penicillin and 100g/ml 
streptomycin (Gibco). Cells were grown for 7 days and washed on days 3 and 6 to 
remove non-adherent granulocytes and lymphocytes. Washing involved swirling the 
plates before removing lml from each well and replacing it with fresh medium that 
contained 0.5-1% mouse serum (Harlan or Cedarlane, Canada) instead of FCS. This 
was done to reduce unwanted immune responses to FCS antigens absorbed onto the 
DC surface. 
Loosely adherent DC were harvested on day 7 by more vigorous washing, leaving 
firmly adherent macrophages on the plate. The DC were then counted and replated at 
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1x106  cells per well with 0.1p.g/ml LPS (Sigma) and incubated for 12-13 hours at 
37°C, 5% CO2. After they had been re-harvested, the DC were incubated with 
Hl9env or OVA peptide at 50tg/m1 for 90 minutes at 37°C, 5% CO2. The DC were 
then washed extensively in PBS before transfer into mice. 
The purity of the DC was determined by staining the cells with anti-CD lic-
Allophycocyanin (APC) (BD-Pharmingin, San Diego, CA, USA), anti-MHC class II-
FITC (M5114, in house) and the level of activation determined by staining with anti-
B7. 1- Phycoerythrin (PE), anti-B7.2-PE, anti-CD40-PE and anti-OX-40-biotin with 
SA-PE(all from BD-Pharmingin) and also anti-B7h-PE (eBioscience, San Diego, 
CA, USA). The antibodies used for FACS staining are summarised in table 2.2. 
Before addition of antibodies, DC were incubated at 4°C for 15 minutes with anti-
FcRecptor (2.4G2, in house) to prevent non-specific binding of antibodies'. After 
washing with FACS buffer, the DC were incubated with the diluted primary 
antibodies for 15 minutes, the cells were washed and secondary staining done if 
necessary. After further washes, the samples were acquired on a FACS Caliber 
(Becton Dickinson, Mountain View, CA, USA) and analysed by FlowJo software 
(TreeStar, California, USA). The purity of the cells was between 70-95% 
CD 11 c+ve, MHC class II +ve, figure 2.1. The activation state of the DC following 
LPS treatment is also shown in figure 2.1. The cells expresses increased levels of 
CD40 and B7.2 (and also B7. 1, data not shown) and also express low levels of 
OX40L. LPS stimulation did not alter the expression of B7h. 
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2.5. Class II Tetramer staining. 
Single cell suspensions were prepared from spleens and LN by mashing between two 
pieces of gauze (Wm Ritchie, London, UK) and erythrocytes were lysed using Red 
Blood Cell Lysis Solution (Sigma). Approximately 1-2 x10 6 cells were plated in 
round bottom 96 well plates and washed in 10% IMDM (Sigma) before the addition 
of PE-labelled class II tetramers diluted in 10% IMDM. Tetramers were made as 
described (268). See chapter three and figures 3.1 and 3.2 for details of the 
constructs used to make the tetramers and an outline of how they are made. A single 
batch of M}IC class II monomers was used throughout this PhD although these were 
tetramerised with steptavidin-phycoerythrin (SA-PE) at different times. New batches 
of tetramer were tested before use and compared to the previous batch; comparable 
staining was always obtained. The staining protocol had been standardised in Ton 
Schumacher's lab. 
The cells were incubated at 37 0C, 5% CO2 for 3 hours with gentle agitation every 20-
30 minutes to prevent clumping of cells. APC labelled anti-CD4 (BD-Pharmingen), 
R. Phycoerythrin (RPE)-Cy5 labelled anti-F4/80 (Serotec, Kidlington, Oxford, UK) 
and FITC-labelled anti-CD44 (142.5, in house) or FITC-labelled anti-CD62L (MEL-
14, in house) or FITC labelled anti-IL-7R a (CD 127, eBioscience) were added and 
incubated for 10-15 minutes at room temperature. Cells were washed 3 times in 
FACS buffer. Propidium iodide (P1) (BD-Pharmingen) was added prior to 
acquisition. 200 000 live events were collected on a FACS Calibur Flow Cytometer 
(Becton Dickinson) and analysed using FlowJo software (TreeStar). Tetramer 
positive cells were identified by gating on CD4 positive and live lymphocytes, 
excluding macrophages (see figure 3.4). 
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Experiment Staining Reagent Clone Source Dilution 
Tetramer +ve Class II tetramer Schumacher lab 1/10 
cells Pharmingen 
CD4-APC In house 1/400 
CD44-FITC 142.5 In house 1/100 
CD62L-FITC Mel-14 Serotec 1/100 
F480-RPE-Cy5 Pharmingen 1/400 
Ly5. 1 eBioscience 1/200 
IL-iRa . Pharmingen 1/100. 
P1  1/400 
DOl 1.10 cells TCR-specific-biotin KJ1.26 In house 1/100 
OT-Il cells Va2-FITC or PE Pharmingen 1/200 
Vb5-biotin Pharmingen 1/200 
SA-PE Calbiochem 111500 
SA-guantum red  Sigma 1/100 
DC markers CD! 1 c-APC Pharmingen 1/200 
MHC class II-FITC M5114 In house 1/100 
B7.2-PE Pharmingen 
CD40-PE Pharmingen 1/100 
0X40-biotin Pharmingen 1/100 
B7h-PE eBioscience 1/100 
1/100 
Chimera B220-PerCP Pharmingen 1/300 
reconstruction CD40-biotm  Pharmmgen 1/100 
Intracellular IL-2 Pharmingen 1/100 
cytokines IFN-y Pharmingen 1/100 
IL-10  Phanningen 1/100 
Table 2.2: Summary of FACS staining reagents: The staining reagents were either used at standard 
dilutions or were tested when they were first used. Antibodies made in house were titrated before use 
and diluted for use at 1/100. 
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2.6. In vitro activation. 
For reactivation of Hi 9env-specific cells, single cell suspensions, prepared as above, 
were plated in flat-bottom 96 well plates at lx 106  cells per well and incubated for 3 
days at 37°C and 5% CO2 with Hl9env peptide at 1tg/ml in 5% IMDM. 
For in vitro activation of DO 11.10 cells prior to transfer, single cells suspensions of 
the LN (popliteal, inguinal, auxillary, brachial, superficial cervical, iliac and 
mesenteric) and spleens from DO 11.10 mice were prepared. Red blood cells were 
removed from spleens using lysis buffer (Sigma). 1-2x 106  cells were incubated in 
imi in 24 well plates with 2-3x10 6 irradiated BALB/c splenocytes with 0.5tgIml 
OVA peptide at 37°C, 5% CO2 in 5% IMDM. 
Three days later, the cells were harvested and dead cells removed by layering the 
cells in lml of medium onto lml of lympholyte (Cedarlane). The cells were spun at 
2000 rpm for 20 minutes with the brake off. The live cell layer was then recovered 
and the cells washed extensively to remove lympholyte and FCS prior to transfer. In 
some experiments the cells were labelled with CFSE. 
For the activation of DO 11.10 and OT-11 cells, single cells suspensions of the lymph 
nodes (popliteal, inguinal, auxillary, brachial, superficial cervical, iliac and 
mesenteric) and spleens from DO 11.10 and 01-1I mice were prepared. Red blood 
cells were removed from spleens using lysis buffer (Sigma). A CD4 purification was 
then carried out either by positive or negative selection using magnetic beads (see 
below). In some experiments the CD4 cells were labelled with CFSE. 
CD4 purified lymph node and spleen cells were plated in 96-well flat bottom plates 
at 4-5x104 cells with 4-5x105 irradiated APC from either BALB/c or C57BL16 mice. 
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In the mixed cultures, the total number of cells was maintained, giving: 2-2.5x10 4 
DO 11.10 and OT-II cells and 2-2.5x1 05  of each APC type. Cells were either 
activated over a range of doses of OVA peptide (0.05ng/ml-0.5.tg/ml) or with 
0.005tWml which had been determined to be the optimal concentration for these 
experiments (see figure 4.5). The division of the transgenic cells was either measured 
by thymidine incorporation (see below) or by dilution of USE measured by flow 
cytometry in conjuncture with markers for the transgenic cells. 
2.7. Preparation of cell suspensions for Adoptive Transfer 
Lymph nodes (popliteal, inguinal, auxillary, brachial, superficial cervical, iliac and 
mesenteric) from DO 11.10 or OT-11 mice were taken and a single cell suspension 
prepared in 5% IMDM. Cells were washed in PBS (Sigma), resuspended at the 
correct concentrations and passed throughparachute silk before transfer. In 
DO 11.1 0/OT-II co-adoptive transfer experiments, the percentage of transgenic cells 
was confirmed by FACS and equal numbers of transgenic cells transferred into 
recipient mice. A total of4-5x10 6  cells were transferred into each mice as this had 
been determined the optimal number in DO 11.10 transfers into BALB/c mice by Dr 
Georgia Perona-Wright during her PhD in David Gray's laboratory. In some 
experiments cells were labelled with CFSE prior to transfer. 
2.8. FACS staining of transgenic cells 
The division and/or presence of DO 11.10 and OT-11 cells was examined by staining 
the cells with anti-CD4-APC and antibodies that recognise the specific TCRs: 
DO11. 10:  KJ1.26-biotin and SA-PE; OT-11: Va 2-PE or FITC and Vb5-biotin and SA-
quantum red or SA-PE. Cells were transferred from in vitro cultures into V-shaped 
plates, washed with FACS buffer, stained with the primary antibodies at 4°C for 15 
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minutes, washed twice in FACS buffer and then incubated with the secondary 
antibodies (SA-PE or SA-quantum red) for a further 15 minutes. After two more 
washes in FACS buffer, the cells were resuspended then acquired on a FACS Caliber 
and the data analysed using FlowJo software (TreeStar). 
To identify the transgenic cells ex vivo, single cells suspensions of splenocytes were 
prepared and red blood cells removed using lysis buffer (Sigma). 1 -2x 1 06  cells were 
plated into V-shaped plates and stained as above. 
2.9. Thymidine assays 
Proliferation was measured by the addition of 0.5tCi of 35Ci/mmol [3H]-thymidine 
(ICN, Basingstoke, UK) to each well 16 hours before the end of the three day 
culture. Plates were harvested on filter mates (Printed Filtermat A; Wallac, Turku, 
Finland) using a 96 well MachiliM Tomtec harvester (Waillac). The mats were dried 
on a hot plate and a solid scintillation wax sheet melted into them (Meltiles tm A; 
Wallac). When the wax had re-solidified, the mats were read using a Trilux 1450 
Microbeta liquid scintillation and luminescence counter and software (Trilux, 
Arnsberg, Germany). 
2.10. Irradiation of spleens 
4 
Before single cell suspensions were prepared, spleen were placed in a bijou in a 
small volume of media and irradiated with a 'y-source for 90 seconds. 
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2.11. Intracellular cytokine staining. 
Cells were plated at 4-5x 106  cells per well in 24 well plates and incubated for 4 hours 
with Phorbol 12-myristate 13-actectae (PMA) (final concentration of lOng/ml) and 
lonomycin (at 1 ig/ml) (both from Sigma) in the presence of 'Golgi Stop' (Becton 
Dickson) diluted at 111500. Cells were transferred into V-shaped 96 well plates, 
washed with FACS buffer, before staining at 4°C with APC labelled anti-CD4 (BD-
Pharmingen) for 15 minutes. After washing, cells were fixed for 20 minutes with 
Cytofix then washed in Cytoperm (Becton Dickinson). Anti-cytokine antibodies 
(anti-IL-2-PE, anti-IFN gamma-FITC and anti-IL lO-PE all from BD-Pharmingen) 
diluted in Cytoperm were added for 45 minutes. The cells were washed in cytoperm 
3 times, resuspended in PBS and acquired on a FACS Caliber. 
2.12. USE labelling 
USE (caroxyfluoroscein diacetate succinimidyl ester) (Molecular Probes, Leiden 
The Netherlands) is a membrane permanent dye that binds covalently to cytoplasmic 
proteins and is distributed equally to each daughter cell upon division, thus the mean 
fluorescence halves progressively as the cells divide (269). USE was tested each 
time a new batch was made up and used within 6 months of being made. Splenocytes 
and, or lymph nodes cells were resuspended at 1x10 7 cells per ml in warmed, serum 
free HANKS (Sigma) containing l.tM CFSE. After 7-9 minutes incubation at 37°C, 
the USE was quenched with an equal volume of FCS, and cells washed 2-3 times 
with serum positive medium. If cells were to be transferred in vivo, further washes 
with PBS were done. 
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2.13. CD4 cell purification 
2.13. 1.Positive selection. 
Single cell suspensions of splenocytes and or LN cells were incubated with anti-CD4 
mirobeads according to the manufacture's instructions (Miltenyi Biotec, Bergisch 
Gladbach, Germany) in MACS buffer (HANKS with 2% FCS) at 4°C for 15-20 
minutes with occasional gentle agitation. After washing with MACS buffer, the cells 
were resuspended in imi and loaded onto a LS MACS column prepared and used 
according to the manufacture's protocol. Briefly, the cells were loaded onto the 
column, which was then washed with MACS buffer. The column was then removed 
from the magnet and the remaining cells flushed out in MACS buffer using the 
supplied plunger. Purities using this method were routinely over 90% CD4 positive, 
figure 2.2. 
2.13.2.Negative Selection: 
Cells were prepared as for positive selection but incubated with a cocktail of 
antibodies: M5114 (anti-class II), 53.6.78 (anti-CD8) and 187.1 (anti-Kappa) all 
labelled with biotin and prepared in house. The dilution of antibody depended on the 
batch and had been titrated each time. After incubation at 4°C for 15 minutes, the 
cells were washed twice in MACS buffer then incubated with steptavidin-conjugated 
microbeads (Miltenyi) for a further 15 minutes. After washing, the cells ',were loaded 
onto a CS MACS column in a varioMACS magnet (Miltenyi). A single column was 
used for up to 2x10 8  cells. The column was washed with 20-30m1 MACS buffer and 
unbound cells collected. Purities using this method were routinely over 80%, also 
shown in figure 2.2. 
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2.14. Ly5.1 cell transfers 
Ly5. 1 positive mice were immunised as above with either peptide pulsed DC or 
peptide in CFA. Spleens and, when mice were immunised with CPA, lymph nodes, 
were taken 2-4 weeks after priming. A single cell suspension was prepared and a 
CD4 purification carried out as above. The purified CD4 positive cells were then 
washed with PBS, resuspended and injected in 200.tl PBS into the tail vein of 
C57BL16 mice. As described in chapter 3, the number of cells transferred was varied 
to optimise the system. 
The mice were immunised the following day with peptide-CFA, and the percentage 
of te&amer positive, Ly5. 1 positive cells in spleens and draining lymph nodes 
examined after 5-7 days. The tetramer staining was done as above but the cells were 
stained with anti-Ly5.1-FITC (BD-Pharmingin). 
2.15. Bone Marrow Chimeras. 
Recipient mice were lethally irradiated with 115OcGy from a y caesium source 24 
hours prior to bone marrow reconstruction as described (270), (60). Bone marrow 
was removed from donor mice and depleted of T cells using anti-Thyl microbeads 
(Miltenyi) on a MACS magnetic column (Milteny) according to the manufacturers 
instructions. Between 3x10 6 and 5x106 cells were injected into the irradiated 
recipients. 
Mixed chimeras were made by reconstituting with 80% [tMT bone marrow and 20% 
CD40 knockout bone marrow (see figure 5.13). Thus, B cells can only develop from 
the CD40 knockout bone marrow, and were, therefore, CD40 deficient. Control 
wild-type chimeras were made with 80% [tMT bone marrow and 20% C57BL/6 bone 
marrow. The chimeric hosts were then left for eight weeks to allow full 
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reconstruction from the donor cells. Reconstitution was confirmed by FACS of 
splenocytes when the chimeras were sacrificed, see figure 2.3. 
2.16. Tracking of Ly5.1 DC ex vivo 
Bone marrow DC were prepared as above but using cells from Ly5. 1 positive mice. 
The cells were either injected i.v. or s.c. into C57BL/6 mice (Ly5.2). Two or five 
days after transfer the DLN or spleens were taken and treated as described by 
Vremec and Shortman (271). The organs were separated into small portions using 
needles. The small pieces of organ were incubated at 37°C, 5% CO2 for 30-40 
minutes in an enzyme mix containing collagenase IV (Worthington, Lakewood, NJ, 
USA) at a final concentration of 0.5mg/ml and DNAse 1 (Sigma) at a final 
concentration of 50pg/mI in HANKS serum free medium as protein can disrupt the 
activity of collagenase. The pieces of organ were then mashed between two squares 
of gauze to prepare a single cell suspension and the red blood cells removed from 
spleens using lysis buffer (Sigma). 
CD 11 c positive cells were then enhanced using anti-CD 11 c magnetic beads 
(Miltenyi). This was carried out according to the manufacture's instructions. Briefly, 
the cells were incubated with the anti-CD 11 c microbeads for 15 minutes at 4°C, 
washed and then loaded onto a MS column. The column was washed, removed from 
the magnet and the remaining cells flushed out. The cells were then stained with anti-
CD1 lc-APC (Pharmagin), anti-MHC class II-FITC (M1554, in house) and anti-
Ly5.l-PE (BD-Pharmingin) see figure 5.10. 
2.17. Antibody production, biotinylation and FITC conjugation 
Hybridomas were grown in culture flasks in 5% IMDM at 37°C, 5% CO2 until 
transferred to roller bottles where they were cultured in 2% IMDM and bubbled with 
5% CO2. The contents of the roller bottles were filtered to remove cells and the 
immunoglobulin was precipitated with ammonium sulfate (Sigma). Precipitates were 
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dissolved in PBS and dialysed against PBS for several days. Antibodies were 
purified by binding to a 1 or 5m1 Hitrap protein G column (Amersham Bioscience, 
Bucks, UK) at pH 7 and eluted at pH2.8 using an AKTAprime (Amersham 
Bioscience). The antibody was dialysed with PBS until the pH was neutral. 
GMCSF supernatant was prepared by growing the cell line in tissue culture flask in 
5% IMDM with Geneticin (G418 sulfate) (Gibco) at a final concentration of lmg/thi 
to select for the GM-CSF producing cells. Before transfer into roller bottles, the cells 
were washed twice in 5% IMDM to remove the G418. The cells were grown in 
500m1 of 2% IMDM in roller bottles for 4-5 days in the absence of G418 sulfate. The 
cells were then transferred into 50m1 Falcon tubes and the cells separated from the 
supernatant by centrifugation and the supernatants pooled. Each batch of GM-C SF 
was tested and titrated before use. 
Purified antibodies were conjugated to biotin by reacting with 204tg EZ-LinkTM 
NHS-LC-Biotin (Pierce, Cheshire, UK) in demethyl. formamide (DMF, Sigma) per 
mg of antibody. FITC conjugation was carried out by reacting 1mg of antibody with 
SOng FITC (Sigma) in 0.05M carbonate-bicarbonate buffer, pH9. In both cases, 
conjugated antibodies were dialysed against PBS. 
2.18. Statistics. 
Data are expressed, when appropriate, as mean and standard error of the mean 
(SEM). Significance was assessed using unpaired t-tests using GraphPad Prism ® 
software (version 3.0, GraphPad software, San Diego, CA, USA). P values below 
0.05 were considered significant. 	
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Tracking CD4 T cells 
Tracking CD4 T cell activation, memory cell survival and recall 
responses 
3.1. Introduction 
The first aim of this PhD was to study the generation and maintenance of 
endogenously generated CD4 memory T cells using class II tetramers. Altman and 
colleagues first developed MHC class II tetramers in 1993 (243). However, in the 
succeeding decade there has been only limited use of class II tetramers (272), (273), 
(274), (249), (275), (276) and scant use of them in mouse CD4 memory studies 
(257), (209), (211). This reflects the complication in producing the tetramers and the 
small responding populations (277), (247), (240), (248). 
This chapter demonstrates that antigen-specific cells can be enumerated using class II 
tetramers following immunisation with peptide in adjuvant. Furthermore, the 
memory population can be tracked overtime and the survival of the cells monitored 
in both the presence and absence of antigen. 
Previously, the CD4 recall response has generally been examined using in vitro recall 
assays (9), (161), (278). This chapter details in vivo recall responses, examining how 
they differ from the primary response. To study memory cell reactivation in more 
detail, an adoptive transfer system was established to ask questions about the 
importance of precursor frequency and recruitment of naïve cells into the secondary 
response. Thus, class II tetramers have been used to provide a complete picture of the 
CD4 T cell response from early activation, entry into the memory pool and 
reactivation. 
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3.2. Results 
3.2.1. Class II tetramer can be used to enumerate antigen specific cells 
MHC class II tetramers were obtained from Ton Schumacher's research lab at the 
Netherlands Cancer Institute in Amsterdam (268). The tetramer constructs, as shown 
in figure 3. 1, were designed to enhance the production of the tetramers: the T cell 
epitope (Hi 9env) was covalently attached to the extracellular domain of the beta 
chain (antigen link in figure 3.1); heterodimerization in the insect cells was promoted 
by the addition of leucine zippers to the CO OH-terminus of both chains; a His-tag 
was attached to the a-chain to aid purification of the tetramers; and a biotin-tag 
added to the beta chain to allow tetramer formation. Figure 3.2 illustrates the 
generation of the tetramers. They are produced in insect cells transfected with the 
constructs. The His-tag then allows for purification using affmity-based 
chromatography. The tetramers were finally generated by the addition of 
streptavidin-PE, which has four binding sites for biotin. Monomers were removed by 
gelfiltration chromatography, and the tetramers stored at -20°C in glycerol. 
The class II tetramers recognise the immunodominant epitope from the Moloney 
murine leukemia virus (MMLV). MMLV is an onco-retovirus that induces sarcomas 
in infected mice. The tumour is infiltrated by large numbers of lymphocytes and 
granulocytes and control of the tumour is mediated by both CD4 and CD8 T cells 
(268). Figure 3.3 shows representative staining from a mouse infected with the virus 
to allow comparison with class II tetramer staining after peptide inimuniation. This 
staining, and the accompanying class I tetramer staining, was done by Koen Schepers 
at the Netherlands Cancer Institute in Amsterdam. Control staining of cells from the 
spleen and LN of a naive mouse are also shown. The CD8 response to the 
immunodominat epitope is much larger than the CD4 T cell response in the spleen, 
draining lymph nodes (DLN) and the tumour site. 
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This reflects the importance of CD8 T cells in the immune response against the 
tumour (268) and demonstrates the difference in the clonal expansion of CD4 and 
CD8 T cells as has been reported (248), (19). 
In order to identify the small population of responding cells, several gates were 
drawn on the cells acquired on the FACS, as shown in figure 3.4. First, a live 
lymphocyte gate was drawn using forward and side scatter characteristics. This 
removed cell debris from the analysis. As the class II tetramers stick to macrophages 
and dead cells, these two populations were removed from the analysis to reduce 
background staining. This was achieved by staining macrophages with RPE-Cy5 
labelled anti-F4/80, and dead cells with propridium iodide, then gating out any FL3 
positive cells. A CD4 gate was drawn on the remaining cells and these are then 
analysed for tetramer staining in conjuncture with a marker of memory or activation, 
typically anti-CD44 or anti-CD62L. 
In this PhD, the CD4 response to the single immunodominant eptitope in MMLV 
was studied to remove the complications of the viral immune response. To define 
whether class II staining after peptide immunisation was achievable, wild-type 
C57BL/6 mice were immunised s.c. in the hind-leg with Hl9env peptide emulsified 
in complete Freund's adjuvant (CPA). CFA was chosen as it is a strong adjuvant that 
induces good CD4 T cell responses (279), (280). Spleens and the DLN of mice were 
taken and stained as described in materials and methods. 
Samples of tetramer staining on day 9 after immunisation with peptide-CFA are 
shown in figure 3.5. Background staining was set by the level of tetramer staining in 
mice immunised with an irrelevant peptide 0VA323339, in CFA. Typically this was 
less than 0.1% of CD4 cells, also shown in figure 3.5. The amount of class II 
tetramer staining after virus infection and peptide immunisation is broadly 
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comparable, (compare figures 3.3 and 3.5). Thus, the peptide immunisation system 
could be used to track antigen-specific CD4 T cells ex vivo. 
To confirm that the small number of responding cells were antigen-specific, 
splenocytes from immunised mice were labelled with the intracellular dye CFSE and 
activated in vitro with peptide. CFSE is divided equally between daughter cells and 
thus the fluorescence is reduced by half with each division (269). Figure 3.6 shows 
the proliferation of tetramer positive cells after culture with Hi 9env peptide, 
demonstrating that the small population identified ex vivo was real and that the 
tetramer positive cells were functional. Splenocytes from mice primed with OVA-
CFA and cultured with Hl9env peptide did not contain tetramer positive cells. This 
demonstrates that naïve Hl9env-specific cells are not present at a high enough 
frequency to be detected after activation in vitro. 
3.2.2. Tracking Tcell activation and memory cell survival 
A time course of the responding T cells was carried out to determine the peak of the 
response to CFA and to follow the memory population over time. Asin the previous 
section, mice were immunised with the peptide, H19env, in the potent adjuvant, 
CFA, which forms an antigen depot at the injection site (280). Unless stated, mice 
were immunised subcutaneously (s.c.) in the hind leg that primarily drains to the 
inguinal LN. The spleens and DLN were taken at various time points after 
immunisation and stained with class II tetramers. 
4 
The primary response peaks at between days 8 to 10 post-immunisation at 0.25-0.5% 
tetramer positive cells, (all percentages of tetramer positive cells are given as a 
percentage of CD4 cells), (figure.3.7a,b). This is followed by a contraction phase that 
leaves, in the spleen, about 0.15% tetramer positive cells corresponding to 
approximately lx104 cells, (figure 3.8). Tetramer positive cells were visible ex vivo 
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in the DLN at the longest time-point examined, day 229 after immunisation with 
peptide-CFA, figure 3.8a. However, tetramer staining in the spleen was at 
background levels at this time-point, figure 3.8b. 
3.2.3. Phenotypic analysis of activated and memory tetramer positive cells 
The phenotype of the tetramer positive cells was examined at various time-points 
after immunisation to track activation and memory cell generation. Figure 3.9a 
shows representative staining of activated (day 7 and day 9) and memory cells (day 
176) from the DLN of peptide-CFA immunised mice. In terms of CD44 and CD62L 
expression the tetramer positive cells at day 7, before the peak of the response, 
contain a mixed population of cells, perhaps indicating that that the Hi 9env naïve 
cells were not activated synchronously. By day 9, the peak of the response, all the 
tetramer positive cells were CD44' and CD62L 1° and the tetramer positive cells 
maintained this expression at all time-points examined; in memory cells, the low 
expression of CD62L is indicative of Tern cells. 
The expression of IL-7Rcx was also examined as IL-7 has been shown to have a role 
both in the generation and long-term survival of CD4 memory cells (117), (116), 
(82), (228), (114). The activated DLN cells at day 7 and day 9 (figure 3.9a,b) down-
regulated the expression of IL-Ma, although even at day 9 a significant proportion 
of tetramer positive cells expressed the receptor. 
Virtually all the tetramer positive memory cells were IL-7Ra positive, however, as 
shown in figure 3.9b, it took several weeks for the majority of tetramer positive cells 
in the DLN to express normal levels of IL-Ma. At day 14 most of the DLN tetramer 
positive cells were still IL-7Ra' °, while the splenic tetramer positive cells at this time 
were mainly IL-7Ra positive. Even at day 32, only about 60% of the DLN tetramer 
positive cells were also IL-7Ra positive, compared to 80% in the spleen. This 
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distinction may indicate that the cells in the DLN were still exposed to antigen at this 
time, more than three weeks after immunisation. 
3.2.4. Antigen specific T cell response to exogenous peptide-pulsed DC 
transfer 
CFA immunisation forms a depot of antigen that persists for a long period of time 
(residual CFA was still visible at the last time-point, day 229). To examine the T cell 
response initiated with an adjuvant that does not persist, mice were immunised with 
peptide-pulsed, LPS activated bone marrow derived dendritic cells (peptide-DC). 
DC were grown as described in materials and methods and provided a homogenous 
and easily reproducible cell population for immunisation, (see material and methods 
for phenotypic analysis of the DC). The DC were either transferred into mice 
intravenously (i.v.) into the lateral tail vein or s.c. into the hind leg. 
First, mice were immunised with different numbers of peptide-DC to ascertain the 
optimal number of DC to immunise with, figure 3.lOa. Antigen specific cells could 
be seen and, as expected, the number of responding cells corresponded to the 
increase in the number of DC injected. The background staining was set by 
immunisation with the same DC pulsed with the irrelevant peptide, OVA: Optimal T 
cell activation was found after the transfer of lxi 06  DC and thus this dose was used 
in subsequent experiments. 
'1 
A time course of the response was carried out using lx 106  DC per mouse, injected 
i.v., figure 3. lOb. Tetramer positive cells could not be detected after day 20 post-
immunisation. Therefore, antigen-specific memory cells could not be tracked ex vivo 
after this time. 
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3.2.5. The recall response is faster and larger than the primary response 
The restimulation of tetramer positive cells in vitro enables the identification of 
antigen-specific cells more readily and provides a way in which the recall response 
can be examined. However, this does not reproduce the complex microenvironments 
and interactions that take place in vivo. Therefore, in order to study the recall 
response in vivo, mice that had been immunised with peptide-DC were boosted with 
peptide in CFA. 
This response was faster and larger compared to the primary response, as shown in 
Figure 3.11 a. The peak of the primary response to peptide-CFA at day 8 was 
between 0.25-0.5% of CD4 cells; the memory response at day 5 was usually above 
0.7% of CD4 cells. Again, the background staining was set by staining cells from 
mice immunised with OVA peptide-pulsed DC and boosted with OVA-CFA. 
This recall assay can be used to denote the survival and functional capacity of 
tetramer positive cells. The rapid recall response can be measured up to 160 days 
post-primary immunisation demonstrating that antigen-specific memory cells had 
survived for this length of time. However, the size of the recall response was reduced 
at day 168 compared to day 90, figure 3.1 lb. Moreover, at day 266, a recall response 
was only measurable in 2 out of the 6 mice tested, and the response in these mice 
was only found in the DLN and was much lower than at earlier time-points. These 
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3.2.6 T cells in the recall response bind class II tetramer at higher intensity 
than cells in the primary response 
Over the course of an immune response B cells are known to increase their affmity 
for antigen by somatic hypermutation followed by selection of high affinity cells 
(206), (127), (128). Less, however, is known about the maturation of the I cell 
response, or even whether it occurs at all (214), (213), (207). This is mainly due the 
technical difficulties in calculating the affinity of the TCR for peptide-M}IC. 
It is thought that the intensity of tetramer staining can be used to provide a "crude" 
measurement of TCR affinity for peptide-M}IC (272), (210). Thus, T cells that bind 
the tetramer with high intensity are thought to have a greater affinity for the peptide-
MHC complex than low staining cells. Figure 3.12a illustrates how the tetrarner 
positive population can be divided into high and low staining cells for this analysis. 
Tracking tetramer positive cells in mice immunised with peptide-CFA provides an 
opportunity to test whether affinity maturation occurs after a single exposure to 
antigen and in the presence of persistent antigen. The intensity of tetramer staining of 
cells from mice immunised 176 days previously was compared with that of cells 
from mice immunised 9 days prior to analysis. As shown in figure 3.12b, no 
difference in the intensity of tetramer staining was found, demonstrating that affinity 
maturation had not occurred in mice that had received only one immunisation with 
Hi 9env-CFA. 
The same comparison was made with tetramer positive cells from mice immunised 
with DC then boosted with peptide-CFA. Here (figure 3.12), it can be seen that a 
greater percentage of the antigen-specific cells from the boosted mice bind the 
tetramer at high intensity compared to cells from mice killed at day 9 post primary 
CFA immunisation. This suggests that the observed "affinity maturation" occurs 
during the recall immune response by a process of clonal selection, with higher 
affinity cells activated in preference to lower affinity cells. 
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3.2.7. The transfer of memory cells to naïve hosts can allow a closer 
examination of the recall response 
The memory response is more rapid than the primary response. This is thought  to be 
for two main reasons: 1. because of the increased precursor frequency of antigen-
specific cells and 2. a result of qualitative differences between memory and naïve 
cells that allow the former to be activated more readily (1). To investigate these 
differences, and to ask whether the recall response is only composed of memory cells 
or whether naïve cells are also activated, a transfer model was established. 
Wild-type Ly5. 1 congenic mice were primed with either peptide-pulsed DC or with 
Hl9env-CFA. The mice were rested for 2-4 weeks before their spleen and! or LN 
were taken. A C134 enrichment by magnetic cell separation (MACS) of the spleen 
and LN cells was carried out to increase the frequency of tetramer positive cells in 
the transferred cell population. The cells were transferred into wild-type C57BL/6 
(Ly5.2) mice, which were then immunised with peptide in CFA the following day. 
Spleens and LN were removed for tetramer staining after 5 to 7 days. This protocol is 
illustrated in figure 3.13a and an example of the tetramer containing CD4 cells that 
were transferred is shown in figure 3.13b. 
In the first experiment (experiment 1) the Ly5.1 mice had been immunised with 
peptide-DC and left for 3 weeks. C57BL/6 mice received between 5x10 5-5x106 
Ly5.1 CD4 cells, which corresponded to between 700 and 7000 tetramer positive 
cells. After immunisation of the recipient mice, no tetramer positive-Ly5.1 positive 
cells were detected. 	 UM 
However, by measuring the tetramer positive host response after the transfer of 
different numbers of CD4 cells, an effect was apparent. In mice that received the 
greatest number of Ly5. 1 cells, the host tetramer positive response was reduced 
compared to that in mice receiving less or no cells, figure 3.14. Thus, it appeared that 
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the transferred cells reduced the host response, however, this effect was only 
apparent in spleen, and not in the DLN. 
The inability to detect Ly5.1 positive, tetramer positive cells could have been 
because so few specific cells had been transferred. Therefore, in a second 
experiment, Ly5.1 mice were first challenged with Hi 9env-CFA and cells taken at 
an earlier time point, week 2, to ensure that a higher frequency of antigen-specific 
cells were transferred into recipient mice. 
The recipient C57BL/6 mice received almost 20 000 tetramer specific cells and were 
immunised with peptide-CFA then sacrificed on day 6. As in the first experinient, no 
tetramer positive Ly5.1 cells were detected. Disappointingly, no effect on the host 
response was observed in this experiment. 
In a final attempt to find the antigen-specific transferred cells, a further transfer was 
carried out (experiment 3). There was a possibility that cells from mice immunised 
14 days previously may be effector cells and more prone to apoptosis than memory 
cells (281). Therefore, this time the cells were purified from Ly5.1 mice that had 
been immunised 4 weeks previously with peptide-CFA. The recipient C57BL/6 mice 
received 5000 tetramer positive cells. In this experiment tetramer staining was 
carried out on day 7 after immunisation as it was thought that this may allow time for 
the smaller number of antigen-specific cells to reach a detectable level. 
The results of this last experiment are detailed in figure 3.15. Tetramer binding cells 
could not be detected in mice that received tetramer positive Ly5. 1 cells and were 
immunised with PBS-CFA. In recipient mice that were immunised with 1419env-
CFA, Ly5. 1 positive, tetramer positive cells were detected in both the DLN and 
spleen. However, a similar percentage of tetramer positive-Ly5. 1 negative (host) 
cells were detected in these mice. Thus, the host response was equivalent to the recall 
response by the Ly5. 1 tetramer positive cells. Although there was a trend towards an 
increase in the total tetramër positive response in the draining lymph node of mice 
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that received Ly5.1 tetramer positive cells compared to mice that received naïve 
Ly5.1 cells, there was no significant difference here and the response in the spleen 
was equivalent. Therefore, this result did not display the major characteristics of the 
recall response detailed earlier in this chapter. 
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3.3. Discussion 
The experiments described in this chapter demonstrate that class II tetramers can be 
used to follow the generation and subsequent survival of endogenous CD4 memory 
cells. Tracking these cells ex vivo provides an opportunity to test whether antigen-
specific memory cells are maintained as a stable population for the life-time of the 
host, or whether numbers decrease with time. Moreover, the functional response of 
the memory cells can be examined using the in vivo recall assay. 
3.3.1. The generation of memory cells 
Tetramer positive cells could be enumerated after either immunisation with peptide-
pulsed DC or with peptide-CFA. However, there were several differences in the 
kinetics of the responses to the two immunisation protocols. First, the peak of the 
response induced by peptide-pulsed DC was earlier than that resulting from 
immunisation with peptide-CFA. This is probably because immunisation with 
peptide-CFA means that APC must acquire antigen and migrate to lymphoid organs 
before T cells can be activated. DC immunisation obviously bypasses the first two 
stages of this process and thereby hastens the T cell response (170), (282). 
The second main difference was that tetramer positive cells in mice that had been 
immunised with peptide-DC could not be detected after day 20. There could be two 
explanations for this: 1. the peak of the response after peptide-CFA immunisation 
was greater than after peptide-DC immunisation; 2. the contraction phasi was greater 
after peptide-DC immunisation. From examining the kinetics of the T cell responses 
(Figure 3.7 and 3.9), it is apparent that peptide-CFA immunisation induces a greater 
expansion than that induced by peptide-DC immunisation. Thus, a greater primary 
expansion results in a larger memory pool as has been previously described (125), 
(131), (132). In peptide-DC immunised mice, the T cell expansion was not large 
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enough to generate a population of memory cells above the background level of 
staining. 
3.3.2. The tetramer positive cells have a Tern  cell phenotype 
During T cell activation, the expression of various surface markers alters. The 
tetramer positive cells upregulated CD44 and downregulated CD62L during 
activation, such that by day 9 they were all CD44 and CD62L 1°, a classic response 
to activation. The level of expression of IL-7Ra has been shown to reduce as a result 
TCR and cytokine signals (120), (119), (118). During activation, the majority of 
tetramer positive cells did downregulate receptor expression, however, even at the 
peak of the response, about 20% of tetramer positive were IL-7Ra positive. This 
correlates to findings by several other groups that the activated cells that continue to 
express IL-7Ra are the cells that go on to become memory cells (109), (114), (112). 
However, in the DLN, IL7R&0  tetramer positive cells were still visible at day 32, 
although the majority of tetramer positive cells in the spleen were IL-7Ra positive 
by day 14. 
This may indicate that the cells in the DLN were still exposed to antigen at this time-
point, inducing some of them to downregulate expression of the receptor. 
Alternatively, there may be two populations of memory cells that survive the initial 
contraction phase (day 10-15): one population that expresses IL-7Ra and survives in 
the "longer lived" memory pool; and a shorter lived population of IL7Rab0  tetramer 
positive cells. Certainly all the memory cells at later time-points were IL-7Rct 
positive. 
In a study of IL-7Ra expression on LCMV specific CD8 cells, Kaech et al found a 
similar gradual increase in antigen-specific cells that were IL-7Ra positive (114). 
The authors report that only by day 40-50 were all the antigen-specific cells IL-7Ra 
positive This corresponds to the slow acquisition of memory characteristics describe 
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by this group (104) and the fact that stable levels of antigen-specific cells were not 
reached until around day 40 (114). The authors also suggest that the two populations 
may represent different memory pools or that IL_7Rab0  cells may differentiate into 
IL-7Ra positive cells. They argue that it is not clear whether a proportion of cells do 
not downregulate the receptor on activation or whether some activated cells re-
expresses it. However, they do suggest that cells that receive reduced levels of 
activation, and consequently do not divide as much as terminal differentiated cells, 
may remain IL-7Ra positive and generate the longer lived memory pool. 
At later time-points the tetramer positive cells were all CD44hi , CD62LL0 and IL 
Ma". The homogeneity in marker expression of the memory cells is contrary to 
studies by Donna Farber and Susan Swain who have described heterogeneity within 
an antigen-specific memory pool based on CD62L staining (283), (284). Farber 
argues that this heterogeneity is a result of differential activation of the cells, with 
full activation inducing a T ern phenotype and a reduced signal inducing Tcm cells 
(285). However, in these studies, a fairly large number of transgenic cells are 
transferred either to wild-type, or to lymphopenic mice. The importance of the 
system used in this PhD lies in the physiological number of precursor cells, 
providing a more realistic system to study CD4 I cell memory than TCR transgenic 
studies. It may be that, as there are only a small number of naïve H19env-specific 
cells, all these cells are activated to a similar extent in the immunisation protocols 
used in this study. It would be interesting to prime mice with lower doses of peptide 
and track the phenotype of these cells and investigate whether the resultant memory 
cells had a more heterogeneous phenotype. 
-1, 
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3.3.3. Antigen-specific memory cells are not long-lived 
A detectable decline of the tetramer positive cells was observed such that by day 229 
after peptide-CFA immunisation, tetramer positive cells were not visible in the 
spleen. Similarly, in mice immunised with peptide-pulsed DC, a small response was 
only found in 2 out of the 6 mice examined 260 days after immunisation. Thus, both 
in mice that had a source of persistent antigen (peptide-CFA immunised) and those 
without (peptide-DC immunised), life-long populations of antigen-specific memory 
cells were not formed. The cells did survive for a considerable time, however, and 
could be reactivated: demonstrating the two classical characteristics of memory. 
The stability of CD4 memory and the signals required to maintain these cells has 
long been a source of debate (167), (216), (176), (172). Although memory cells can 
survive in the absence of antigen and M}IC II molecules (172) they are dependent on 
TCR signals via MHC II to maintain their function (176). Zinkemagel and colleagues 
argue that merely recording the survival of memory cells is not sufficient to 
demonstrate the persistence of protective memory (216). Rather, only by challenging 
the putatively immune mice with infections can productive memory be established. 
From such experiments (168), (216), they claim antigen is required to maintain the 
ability of the memory cells to migrate to the tissues where infections occur. 
The Tern phenotype of the tetramer positive cells described in this PhD may explain 
the decline in survival over-time. Wu et al suggest that Tern are not long-lived cells 
(155). The authors transferred CD4 TCR transgenic T ern and 1cm cells into naïve 
recipients and tracked the cells. They found that Tern cells disappeared within 8-10 
days, but Tcm cells survived for at least three weeks. This rapid disappearance of the 
Tern cells does no correlate with the survival of tetramer positive cells for at least 229 
days in this PhD. 
That the CD4 memory cells decline in this study supports findings by Homann et a! 
and Cauley et al who observed a similar phenomenon (19), (225). Tracking the 
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immune response to LCMV using both class I and class H tetramers, Homann et al 
found that although the antigen-specific CD8 cells formed a stable memory pool, the 
number of CD4 memory cells never stabilised and declined from the peak of the 
response onwards. LCMV infection is cleared by wild-type mice and there is no 
obvious source of persistent antigen in this model. However, the authors could not 
rule out that antigen may remain, for example trapped on follicular dendritic cells. 
Regardless, any survival signals were insufficient to maintain the memory CD4 cells 
over the lifetime of the host. 
There have been reports of stable populations of memory CD4 T cells. London et al 
found memory DO 11. 10 cells 6 months after the transfer of a large number of in 
vitro activated transgenic cells (138). Furthermore, using limiting dilution assays to 
enumerate antigen specific CD4 cells, Varga et al described the relatively stable 
persistence of LCMV specific CD4 memory cells for at least a year (286). The 
differences found in this PhD and by Homann et a! (19) may be due to, the more 
physiological numbers of cells examined over a longer time period and the more 
direct measurement of antigen-specific cells, using class II tetramers rather than in 
vitro restimulation assays. 
If antigenic signals are not sufficient, or even required, to maintain memory cells, 
then what signals are important? Recent studies from a number of groups have 
described an important role for IL-7 in both the generation and survival of memory 
cells. Lenz et al found that giving anti-IL-71ta to mice immune to LCMV resulted in 
a decrease of antigen specific cells (82). Moreover, the administration of 
recombinant IL-7 to immune mice caused an increased rate of turnover of the 
memory cells in vivo; in vitro experiments showed that this was accompanied by a 
rise in the expression of the survival molecule, Bcl-2. The authors suggest that IL-7 
plays a homologous role to IL- 15 for CD8 memory cells, which maintains memory at 
a population level by inducing the proliferation of memory cells (181), (182), (230), 
(227). 
Tracking CD4 T cells 
Li et al (116) and Kondrack eta! (117) showed TCR transgenic memory cells could 
not survive in 11L-7 deficient hosts, leading them both to argue that IL-7 is required 
for the transition of effector cells to long-lived memory cells. In contrast to Lenz et 
a! (82), these two studies did not find that IL-7 induced proliferation of the memory 
cells, suggesting that there may be differences between transgenic and endogenously 
generated memory cells. 
This PhD did not assess the requirement for IL-7 in long-term survival; although 
memory cells were found to express IL-7Ra. This, and the data from Homann et a!, 
suggests that even if IL-7 does induce the periodic proliferation of CD4 memory 
cells, this is insufficient to maintain them for the life-time of the host (19). 
This is in contrast to CD8 memory cell studies were the long-term survival of 
memory cells has been described by. a number of groups (173), (287), (288), (19). 
This is perhaps best exemplified by Homann et al who, as stated above, describe the 
decline in antigen specific CD4 memory cells in mice that have a stable CD8 
memory pool (19). 
This prompts the question: why should memory CD4 cells be less well maintained 
than CD8 memory T cells? It may just be a result of the difference in the clonal 
expansion of responding CD4 and CD8 cells. The CD8 T cell response is generally 
larger than the CD4 T cell response (248), (19). This is particularly evident in LCMV 
infection where IX107  CD8 T cells can respond to the infection (289). Thus, a greater 
memory pool (5% of the activated cells, about 5x10 5 cells) is formed that may be 
large enough to endure the loss of cells over-time. Moreover, there has been 
considerable evidence demonstrating that IL- 15 can prevent this slow decline in CD8 
memory cells by inducing their proliferation (181), (182), (230), (227). Whether IL-7 
acts in a similar was for CD4 T cells remains open to question. 
Teleologically, it is interesting to question the importance of immunological 
memory. In the case of B cells, the advantage of maintaining long-lived plasma cells 
01 
Tracking CD4 T cells 
is obvious: antibodies can bind and inactivate viruses and bacteria before they have 
change of establishing an infection. Similarly, memory CD8 T cells can rapidly kill 
infected cells and thereby prevent the spread of viruses and intracellular bacteria. 
Indeed, Homann et al found that despite the reduction in LCMV specific CD4 
memory cells, immune mice were still protected from re-challenge (19). What role 
CD4 cells can play in protecting the host from subsequent infection will depend on 
the type of infection. For example, rapid responses from CD4 T cell may be critical 
for protection from intracellular bacteria, such as tuberculosis. 
3.3.4. Recall responses differ from primary response in terms of speed, size 
and binding to the class II tetramer 
The rapid recall response is one of the fundamental tests of cellular memory. 
Moreover, it provides an immediate response to re-infection: Tern cells patrolling the 
tissues are strategically placed to make cytokines upon re-infection and T cm can 
promptly proliferate in secondary lymphoid organs, and thereby back-up the Tern 
response. In this chapter, the recall response has been studied for two main reasons: 
to demonstrate the differences between the primary and secondary response; and 
to establish the functional survival of CD4 memory cells after immunisation with 
peptide-pulsed DC. 
Although tetramer positive cells could not be detected ex vivo in the peptide-DC 
immunised mice after 20 days, memory cells were present. This was confirmed by 
examining the recall response by challenging primed mice with peptide-CFA. Rapid 
recall responses were evident at least up to 160 days post-immunisation, however, 
after this time, the recall response was less evident with only 2/6 mice responding at 
day 266 after priming. 
Many in vivo experiments tracking the CD8 T cell recall response have been 
published (290), (153), (291), (288), (292). However, in vivo CD4 recall studies are 
much more scarce. London et al demonstrated the rapid kinetics of memory 
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DO 11.10 cells responding in wild-type hosts (9) and Dawicki et al have shown that 
0X40-OX40L interactions are important in CD4 secondary responses (291). 
However, most CD4 recall studies have been carried out in vitro where the 
conditions of reactivation can be more strictly defined (9), (161), (278). This allows 
questions to be asked about differences in costimulatory requirements and the type of 
APC that can activate memory cells in comparison to naïve cells. Although such 
experiments can increase understanding of memory, in vivo recall assays are vital to 
fully appreciate the kinetics and requirements of CD4 memory. 
The recall response was clearly faster and larger than the primary, confirming the 
classical definition of the memory response. There have been in vivo reports, 
however, that for CD4 memory T cells the magnitude of the secondary response does 
not exceed that of the primary response. Merica eta! found that an unidentified 
substance in the host prevented maximal T cell proliferation of memory DO 11.10 
cells, although the memory cells did respond faster than naïve cells in terns of both 
entry into the cell cycle and cytokine production (293). The full proliferative capacity 
of the memory cells could be restored upon transfer to a naïve recipient. However, 
this also induced the reversion of the cells to a naïve phenotype based on CD45Rb 
expression. 
In a study of the response to the central nervous system autoantigen, proteolipid 
protein (PLP), Bischof et al found the size of the secondary response to be equivalent 
to the primary response (257), although, the secondary response was faster than the 
primary. In both these studies, the precursor frequency was higher than normal, 
either artificially via the adoptive transfer of a large number of transgenic cells, or 
because the SJL mice used by Bischof et al contain a large number of P12 specific T 
cells (294). This large precursor frequency may affect the kinetics and magnitude of 
the primary response and any differences could be carried into the memory pool. 
A further difference between the primary and the secondary response in this PhD was 
the intensity of tetramer staining. Tetramer positive cells activated in the recall 
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response bound the tetramer at higher intensity than tetramer positive cells either in 
the primary response or memory cells. The fmding that this increase in intensity of 
staining, which correlates to an increase  in ICR affinity for peptide-MHC (272), 
(210), was only found in the secondary response, supports similar findings in the 
literature (211), (208). Busch and Pamer argue that this is due to the successful 
competition of high affinity cells for peptide-MHC on APC (208). These cells 
proliferate and become the majority population in the recall response. Kedl et al 
suggest that, at least for CD8 T cells, this competition between T cell clones for the 
same antigen can be partly be explained by high affinity cells inducing the loss of 
antigen from APC (212). 
The increase in the intensity of tetramer staining has also been shown to be due to the 
localisation of TCR in rafts rather than an actual increase in the affinity of the 
interaction between TCR and peptide-MIIC (207). Regardless, the change in 
intensity of staining indicates a change in the cells involved in the recall response 
compared to those in the primary response, a change that may partly explain the 
increased speed of the recall response. 
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3.3.5. Transfer of antigen-specific memory cells 
These properties of the memory response predict that the recall response is composed 
of reactivated memory cells, which, due to this increase in affinity, would prevent the 
activation of naïve cells. From the literature it is known that a large number of 
antigen-specific cells can block the host response (295), (289). For example, elegant 
studies by Kedi et al describe that the transfer of high affinity specific OT-1 cells into 
naïve hosts reduces the host response to OVA (295). To test this prediction, the 
transfer experiments depicted in figure 3.13 were carried out. 
It was thought that by transferring memory H19env-specific T cells into naïve mice, 
the reactivated memory cells could be tracked and that these cells would influence 
the magnitude of the host response. However, the experiments involving the transfer 
of Ly5. 1 tetramer positive cells proved to be inconsistent. 
The main deficiency in this set of experiments was the small number of antigen-
specific cells transferred into the C57BL/6 hosts especially as only approximately 
10% of transferred cells arrive in the spleen (289). Ly5.1 tetramer positive cells were 
only visible after boosting with H19env-CFA in the third experiment, even though 
only 5000 tetramer positive cells were transferred in this experiment compared to 20 
000 in experiment two. There could be two possible explanations for this: 1. the 
cells transferred were memory cells rather than activated cells that may be more 
prone to apoptosis (281); 2. in the final experiment the response was examined 7 
days after immunisation, allowing the small number of cells to proliferate above the 
detection limit of the class II tetramers. At this time-point, the primary response is 
usually visible, so it may not be surprising that the host response was eqfiivalent to 
the "recall response" by the Ly5.1 positive cells. 
Although the Ly5. 1 tetramer positive cells were visible, this response did not 
resemble the recall response in boosted C57BL/6 in terms of size and speed. It is not 
possible, therefore, to state whether, in general, recall responses are composed 
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entirely of memory cells or if naïve cells also participate. As reducing the numbers of 
antigen-specific cells removes the recall phenotype, this result does suggest that the 
increase in precursor frequency after an immune response is vital to the rapidity of 
the recall response. Given more time, a complete kinetic analysis of the Ly5. 1 
transfer system could have been carried out. Once an optimal protocol was 
established, other experiments could be done. For instance, it would be interesting to 
examine whether the "secondary" memory pool is composed of the reactivated 
memory cells or the newly activated naïve cells, or a mixture of the two. 
3.3.6. Conclusion 
CD4 memory cells have remained elusive: the small population has proved difficult 
to enumerate without using TCR transgenic cells or carrying out experiments in 
lymphopenic mice. Tracking endogenously generated CD4 memory cells in intact 
hosts is vital to advance these studies; to envision what actually happens to CD4 
memory T cells. 
The results described in this chapter demonstrate that this is possible. The activation 
and survival of antigen-specific cells can be examined ex vivo. These tools and 
protocols can be used to ask questions about the generation and survival of memory 
cells. In the following chapter the ability of both polyclonal and transgenic memory 
cells to survive in competitive memory pools is investigated. In the final results 
chapter, the individual molecules involved in the various stages of the T cell 
response: activation; memory cell generation; survival; and recall responses are 
dissected using the class II tetramers. 
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Figure 3.1 Schematic drawing of MIHC class H tetramers, and 
constructs used to generate them:The constructs which form the a and 
IE molecules contain a number of modifications to improve the generation 
of the class II tetramers, see text and Figure 3.2 for details. 
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Figure 3.1 Schematic drawing of MHC class H tetramers, and 
constructs used to generate them:The constructs which form the a and 
molecules contain a number of modifications to improve the generation 
of the class II tetramers, see text and Figure 3.2 for details. 
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Figure 3.2 Schematic drawing of the generation of MHC class II tetramers: 
The a and 3 chains are produced in insect cells which secrete them as monomers 
containing the peptide, Hl9env. The His tag on the a chain enables purification by 
affinity based chromatography and the biotin tag allows for tetramerisation with 
PE labelled streptavidin. Finally, the tetramers are purified from any remaining 
monomers by gel filtration chromatography. 
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Figure 3.3: Example tetramer staining from mice infected with 
MMLV: C57BL16 mice were infected with MMLV. 8 days later, spleens, 
DLN and the resulting tumour site were taken and stained with class I, 
class 11 tetramers and anti-CD44, anti-CD4 or CD8, F4/80 and P1. Cells 
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Figure 3.4 Gating analysis for tetramer positive cells: To analyse 
tetramer positive cells, first a broad lymphocyte gate was drawn. FU 
positive cells (macrophages and dead cells) were gated out. Of the 
remaining cells, only CD4 positive cells were analysed for tetramer 
staining in conjuncture with activation marker expression- The number 
shows the percentage of cells in the gates. 
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Figure 3.5 Class II tetramers can be used to enumerate antigen specific 
cells: C57BL/6 mice were immunised with H19env peptide (top row) or 
OVA peptide (bottom row) emulsified in CFA. DLN were taken after 9 
days and stained with class 11 tetraniers and labelled antibodies as described 
in materials and methods. Cells are gated on C134 +ve, lymphocytes, 
excluding P1 +ve and 174/80 +ve cells. Numbers show the percentage of 
tetramer positive cells out of CD4 cells in the rectangle gate. Each plot is 
from an individual mouse. 
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Figure 3.6 Division of tetramer positive cells in vitro: CFSE labelled 
splenocytes from C57BL/6 mice immunised with Hl9env-CFA or OVA-
CFA, were activated in vitro with Hl9env peptide for three days. The cells 
were then stained with class II tetramers as described in materials and 
methods. Cells were gated as in Fig. 3.4. The numbers show the percentage 
of cells in the top left quadrant, tetramer +ve, CFSE low. 
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Figure 3.7 Activation and contraction phase of the tetramer 
positive immune response: C57BL/6 mice were immunised with 
Hl9env peptide emulsified in CFA. Mice, three - four per group, 
were sacrificed at various time points post-immunisation and cells 
from the draining lymph node were stained with class II 
tetramers() Control mice were immunised with OVA-CFA (A). 
Graph a) DLN, b) spleen. Percentage of tetramer positive cells out of 
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Figure 3.8 Long term survival of tetramer positive cells: C57BL/6 
mice were immunised with HI 9env peptide emulsified in CFA. 
Mice, three - four per group, were sacrificed at various time points 
post-immunisation and cells from the draining lymph node were 
stained with class II tetramers() Control mice were immunised 
with OVA-CFA (A). Graph a) DLN, b) spleen. Percentage of 
tetramer positive cells out of total CD4 cells is shown and the error 
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Figure 3.9a Memory cells have a homogeneous phenotype 
compared to activated cells: C57BL/6 mice were primed with 
HI 9env-CFA and sacrificed at various time-points after 
immunisation. LN cells were stained with class II tetramers and 
cells gated as in Figure 3.4. The first column shows cells from day 
7 (early in the primary response), second column day 9 (the peak 
of the primary response), and third column staining at day 176 
(memory cells). First row shows CD44 staining, middle row IL-
7Ra, and bottom row CD62L on the y axis, tetramer staining in all 
rows on the x axis. Numbers show the percentage of the total 
tetramer positive cells that are CD44, IL-71tci, or CD62LI0 
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Figure 3.9b Memory cells in the DLN take several weeks to acquire full 
expression of IIL-7Ra: the level of expression of IL-7Ra on tetramer ±ve cells 
in the DLN and spleen was examined 9, 14 and 32 days after immunisation 
with peptide-CFA. Cells are gated as in figure 3.4 The number shows the 
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Figure 3.10 The transfer of peptide-DC primes tetramer positive T 
cells: Bone marrow DC were activated with LPS, pulsed with H19env 
or OVA peptide and injected iv. at various doses (a) or 1x10 6 DC per 
mouse (b) into C57BL/6 mice. On day 6 (a) or at various days post- 
transfer (b), spleens were removed and cells stained with class II 
tetramers and labelled antibodies. Background staining was set by 
staining cells from mice immunised with OVA pulsed DC. In a) each 
point represents one mouse and the line shows the mean of each group, 
in b) each point is the mean of 4 mice and the error bar shows the 
SEM. 
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Figure 3.11 The recall response is larger and faster than the primary: 
C57BL/6 mice were immunised with Hl9env pulsed DC, rested for 90, 168 
or 266 days then boosted with H19env-CFA. Cells from the spleens and 
DLN were stained with class H tetramers and analysed as in figure 3.4. 
Example staining of lymph node cells from the recall response (after 91 
days), primary response, and background staining at day 5. 
Percentage of tetramer positive cells, out of CD4 cells, in the DLN of 
boosted (C57BL/6 mice immunised with DC, rested then boosted with 
Hl9env-CFA and sacrificed on day 5); Day 5 (primary response to Hl9env-
CFA), Day 9 (peak of the primary response to HI9env-CFA); OVA 
(background staining from mice primed with OVA pulsed DC, then boosted 
with OVA-CFA). Each point represents one mouse and the line shows the 
mean of the group. 
100 
Memory 	 Primary Recall 
a) 
1) 
Tracking CD4 T cells 
,,- 


















Figure 3.12 Tetramer positive cells in the secondary response bind 
the tetramer at a higher intensity than tetramer positive cells in 
the primary response: 
Example tetramer staining of memory cells (day 176 after 
immunisation with H19env-CFA); cells during the primary response 
(day 9); and cells from a mouse immunised with HI 9env pulsed DC 
then boosted with HI 9env-CFA. 
Percentage of cells binding the tetramer at high intensity (as shown 
in a) after immunisation protocols as described in a). Each point 
represents one mouse and the line shows the mean of each group. 
b) 
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Figure 3.13 Ly5.1 tetramer positive cell transfer into C57BL/6 mice: 
Protocol: Ly5. 1 mice were primed with H19env-pulsed DC or with 
Hi9env-CFA. 24 weeks later a CD4 selection was carried out on spleen 
and LN cells, and cells containing tetramer positive cells (red) transferred 
into C57BL/6 mice. 
Example tetramer staining prior to transfer ofHi9env primed or naïve 
Ly5.1 mice 
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Figure 3.14 Effect on the host response after transfer of tetramer 
positive Ly5.1 cells: 
Experiment 1 of the Ly5.1 transfer system: 1x10 6-5x106 Ly5.1 cells 
containing tetramer +ve cells were transferred into C57BL/6 hosts that 
were immunised the following day as in Fig. 3.14a. Control groups were 
either given naïve Ly5.1 cells or no cells and primed with Hl9env-CFA. 
Background staining was set by immunisation with OVA-CFA. Percentage 
of host (Ly5.2) tetramer positive cells in the DLN (a) and spleen (b). Each 
point represents one mouse and the line shows the mean of each group. 
103 
Tracking CD4 I cells 
a) Ly5.1 tet +ve 
HI 9-env-CFA 
0.13%  
' 	I 0.150ND: 







Class II tetramer 














0.4 1 - 





















Figure 3.15 LyS.I tetramer positive cells can be found after transfer into 
C57BL/6 mice: Experiment 3 was set up as in 3.13. Spleens and DLN of 
recipient mice were taken 7 days after immunisation. a) Representative staining 
of DLN cells. Percentage of total tetramer +ve cells, out of CD4 cells, in the 
DLN (b) and spleen (c). Each point represents one mouse, and the line shows 
the mean of each group. 
C) 
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Is there competition within the CD4 memory pool? 
4.1. Introduction 
The factors required for the survival of T cells is an area of much debate (296), (81), 
(297), (298). Naïve T cells have been found to require signals via self-MHC 
molecules and IL.-7 to survive in vivo (18), (164), (165), (166); although, there has 
been a report that naïve cells can survive in the absence of self-MHC (299). The 
survival of memory cells is more controversial. Over a decade ago, a series of papers 
from Gray and colleagues proposed that in the absence of cognate antigen, memory 
CD8 and CD4 T cells, and also B cells, could not survive when they were transferred 
into naïve hosts (167), (129). However, more recent studies have described the long-
term survival of memory cells in not just the absence of specific antigen, but also in 
recipients that were deficient in MHC molecules (169), (170), (171), (138), (173). 
(175), (172). Therefore, memory cells can survive in the absence of any TCR 
signals. 
As discussed in the introduction, such experiments are necessarily carried out in 
immunodeficient hosts where T cells do not have to compete for survival signals. 
Such survival signals determine the "space" within the memory pool and could 
include the availability of MHC molecules presenting self or foreign peptide, or the 
level of a cytokine such as IL- 15 or IL-7. The availability of these signals is fmite as 
both the naïve and memory pools are maintained at a fairly constant level (8), (81). 
Therefore, the long-term survival of memory cells should be examined in,  hosts that 
are challenged with other antigens or infections in order to track the maintenance of 
memory cells in a competitive environment. 
The survival of memory CD8 T cells in competitive environments has been 
examined by a number of investigators (198), (193), (300). It has been found that 
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non-cross-reactive memory T cells survive less well after subsequent infections of 
immune mice, suggesting that antigen can play a role in the survival of memory T 
cells in competitive environments by providing a TCR specific boost (198), (193). 
There has only been limited study into the survival of CD4 memory cells in mice 
intentionally immunised with further antigens, thus, this is a field that requires 
further investigation. 
In this chapter, the survival of memory cells was examined in mice that had been 
manipulated to have competitive memory pools. In the first two systems, outlined 
below, TCR transgenic CD4 T cells were used and in the third system, the class II 
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4.2. Results 
4.2.1. Survival of DO] 1.10 memory cells in mice with endogenous OVA-
specific T cells 
The first system examined the survival of DO 11.10 cells in mice that had previously 
been immunised one to three times with OVA. This would induce endogenous OVA-
specifc memory cells that may compete with the transferred DO 11.10 cells for 
antigen and for survival (see figure 4.1). BALB/c mice were immunised with OVA 
protein in alum either once, twice or three times intraperitoneally. Multiple 
immunisations should lead to an increase in the size of the OVA-specific memory 
pool and may also increase the affinity of these cells (295). The mice then received 
5x 1 06  DO 11.10 cells that had been activated in vitro and the long-term survival of 
these cells examined. The DO 11.10 cells were activated in vitro so that their survival 
could be compared in naïve mice, which contained no antigen, and in the pre-
immunised mice. 
Initial experiments were set up to establish whether activated cells survived 
following transfer into naïve and pre-immunised mice. DO 11.10 cells were activated 
for 3 days with 0.5.tgIml OVA323..339 peptide in vitro prior to transfer. 5x10 6 USE 
labelled activated or naive DO 11.10 cells were then transferred into mice that had 
either been immunised 10 days previously with OVA-alum or were naïve. Five days 
later, spleens and LN were taken and the percentage of DO 11.10 cells examined by 
FACS (using the clonotypic antibody, KJ1.26), and the division of thesetells 
analysed by dilution of CF SE. 
Figure 4.2a shows representative staining from the spleens of either pre-immunised 
or naïve mice that received either activated or naïve cells. The cells were present at 
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this time and the activated cells had continued to divide after transfer into either 
naïve or immunised mice, figure 4.2b. Thus, the activated DO! 1.10 cells survived 
after transfer into either naïve or immunised mice. 
The long-term survival of activated DO! 1.1 0 cells was then examined in mice with 
endogenous OVA-specific T cells. The activated cells were transferred into four 
groups of mice: naïve mice; and mice immunised with OVA-alum once, twice or 
three times. Thus, if the endogenous memory pool did compete with the transferred 
DO 11.10 cells this would be more apparent in mice pre-immunised three times 
compared to mice just pre-immunised once, as depicted in figure 4.1. 
The percentage of surviving DO 11 .10 cells was examined 6 weeks after transfer in 
the four groups, figure 4.3. The percentage of DO 11.10 cells did not differ between 
the different groups. Therefore, the endogenous memory cells did not affect the 
survival of the DO 11.10 cells. Moreover, as the activated cells survived equally well 
in naïve mice as they did in immunised mice, the presence of antigen was not 
required for survival of the memory cells for 6 weeks. 
4.2.2. Do memory cells compete for contact with MHC molecules? 
One of the problems with the first system described above was that only one 
population of memory cells could be tracked: the endogenous memory pool could 
not be directly measured. This, and questions about the survival signals delivered via 
MHC molecules as opposed to antigenic signals, prompted the development of the 
following system.  
This second set of experiments used both DO 11.10 and OT-Il cells, thus enabling the 
tracking of two potentially competing populations of cells. These two transgenic 
cells recognise the same peptide in OVA: OVA323339, however, DOl 1.10 mice are 
on the BALB/c background (I-A ") and OT-Il mice are on the C57BL16 background 
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(I-A"). DO! 1.10 cells respond to lower amounts of OVA323..339 than OT-il cells (301) 
and are thought to have greater affinity for their self-MHC complex than OT-11 cells 
(296). The latter is based on the finding that DO 11.10 cells proliferate extensively 
following transfer into I cell deficient or irradiated hosts (302). OT-il cells, 
however, do not divide much after transfer into immunodeficient hosts (296). As the 
extent of proliferation in this system is thought to be induced by recognition of self-
peptide on MHC molecules, it is suggested that DO 11.10 cells have greater affinity 
for self-MIHC than OT-II cells do for their respective MHC molecules (303), (304). 
If signalling via TCR recognition of MHC, either containing antigenic peptide or 
self-peptide, is important in memory cell survival, it could be argued that memory 
DO1l.10 cells would survive better than OT-11 memory cells. Therefore, 
experiments were conducted to compare the survival of DO 11.10 and OT-Il cells in 
separate mice and in the same host, see figure 4.4. 
Initial experiments were carried out in vitro to characterise the activation 
requirements of the two cell populations. CD4 purified DO 11.10 and OT-11 cells 
were activated with OVA peptide either with irradiated BALB/c or C57BL/6 APC. 
In some experiments all four cell populations were combined in the same well. The 
proliferation of the two cell populations was investigated by both thymidine 
incorporation and by USE dilution measured using flow cytometry. 
By thymidine incorporation, it can been seen that DO 11.10 cells proliferate at 10-
fold lower concentrations of OVA peptide in the presence of BALB/c APC 
compared to the OT-11 response in the presence of C57BL/6 APC, figure 4.5a. 
Moreover, DO 11.10 cells respond to OVA peptide presented on IAb  in a dose 
dependent manner and to lower concentration of OVA peptide compared to the 01-
II cell response to OVA peptide presented by IAb.  However, there was no response 
of 01-I1 to OVA in the presence of BALB/c APC, thus OT-II cells could only 
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recognise OVA323..339 presented by IAb.  Interestingly, in the mixed culture 
(DOl 1. 10, OT-11 T cells, BALB/c and C57BL/6 irradiated APC) the extent of cell 
proliferation was similar to that found after activation of OT-II to OVA323-339 
presented by C57BL/6 APC alone. To determine the extent of proliferation of each 
of the cell types in the mixed culture, the transgenic cells were labelled with the 
intracellular dye USE and their division monitored by flow cytometry. 
As shown in figure 4.5b and c, DOl 1.10 cells proliferated faster than OT-II cells 
when the cells were cultured separately with their respective APC. This was less 
clear in cultures in which the two transgenic cells were cultured together with both 
C57BL/6 and BALB/c APC. In this case, the OT-11 cells proliferated to a similar 
extent as the DO 11.10 cells; this effect was observed at all the antigen doses tested 
(0.005-5 jig/ml). The reasons for this are two-fold: 1. the DO 11.10 cells proliferated 
less in this culture than when incubated alone and this is probably because they 
respond less well to OVA323339 presented by the mixed population of APCs 
compared to presentation just by BALB/c APC. The second difference was that the 
OT-II cells proliferated slightly more in the mixed culture than when activated on 
their own, this may be because the OT-11 cells make use of the IL-2 generated by the 
DOl 1.10 T cells. 
Once (C57BL/6xBALB/c)F1 mice were available, in vivo experiments could be 
carried out. USE labelled transgenic cells were transferred into mice that were 
immunised the following day with 0VA323339-alum. Figure 4.6 shows representative 
staining of splenocytes from a mouse that received both OT-Il and DO 11.10 cells 
five days after immunisation, and the USE profile of the transgenic cells. Both cell 
types were found to proliferate, however, OT-11 cells did not expand to the same 
extent as DO1 1.10 cells. 
Experiments to investigate the survival of memory populations of the two transgenic 
cells in (C57BL/6xBALB/c)F1 were carried out. However, no OT-11 cells could be 
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found in either control mice that only received OT-Il cells, or in mice that received 
both sets of transgemc cells. Other members of the lab, who were tracking OT-11 
cells in wild-type C57BL/6 mice, encountered a similar problem: OT-11 cells could 
not be identified 15-20 days after transfer. This defect may have been a result of 
minor histocompatibility differences between the OT-Il cells and the host mice 
resulting in the rejection of the OT-Il cells. Experiments using OT-Il mice back-
crossed an additional four times are currently underway in the lab to investigate this. 
4.2.3. Survival ofantigen-specflcpolyclonal memory cells in mice immunised 
with multiple antigens 
The two transgenic systems used for examining competition within the memory pool 
had not proved fruitful for a number of reasons. Once it had been established that the 
class II tetramers could be used to track endogenously generated CD4 memory cells 
over a considerable period of time, experiments were set up to track the survival of 
Hi9env-specific T cells in hosts immunised with a number of other antigens. It was 
thought that subsequent immunisation would result in the generation of memory cells 
that could compete for survival with the Hi9env-specific memory cells, for example. 
by using up a limiting factor such as a cytokine. Thus, in Hl9env immunised mice 
subsequently immunised with several different antigens, it was thought that H19env 
specific cells would survive less well (figure 4.7). Although this meant that only one 
population of memory cells could be identified, the system involved tracking small 
populations of endogenous memory cells in the absence of persistent antigen. 
Mice were first immunised with H19env pulsed wild-type DC. This immunisation 
protocol was chosen over CFA immunisation for two main reasons. First, CFA 
immunisation results in the formation of a depot of antigen and it was thought that, if 
an effect on long term cell survival was to be observed, there would be more chance 
of measuring it in the absence of putative survival signals via retained antigen. 
Second, the read-out Of the experiment was by challenging the mice with Hi 9env- 
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CFA to assay the recall response, as had been done in previous experiments. This 
demonstrated not just the maintenance of memory cells but also that they were 
functional. 
In the first experiment, three groups of mice were immunised with Hi 9env pulsed 
DC. The mice were left for 6 weeks to allow the memory cells to form before two of 
these groups were immunised with OVA protein precipitated in alum. After a further 
4 weeks, one group was immunised with KLH. The mice were rested for a further 4 
weeks then they were boosted with Hl9env-CFA to evaluate the recall response by 
comparing it to the primary response in age-matched naïve mice. Table 4.1 
summaries this immunisation protocol. 
Group Immunisation 1 Immunisation 2 Immunisation 3 Immunisation 4 
1 H19env-DC  H19env-CFA 
2 H19env-DC OVA-Alum  H19env-CFA 
3 H19env-DC OVA-Alum KLH H19env-CFA 
4  OVA-Alum  H19env-CFA 
5  KLH H19env-CFA 
6  H19env-CFA 
7  OVA-CPA 
Table 4.1: Immunisation protocol for multiple immunisation experiment. 
Groups 4 and 5 were included to rule out any complications with cross-reactivity 
between Hi 9env-specific cells and the other antigens. Any cross-reactivation would 
provide extra survival signals for the Hi 9env-specific cells rather than inducing 
competition. If OVA or KLH had proved to be cross-reactive, the response to the 
H19env-CFA challenge would have resulted in a response greater than the primary 
response in group 6. Group 7 is the normal background control for tetramer staining. 
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The results of this experiment, as detailed in figure 4;8a, suggest that there had been 
no affect on the Hl9env-specific memory pool in mice that had been immunised with 
OVA and KLH. In turn, this implies that, in this system, there had been little or no 
competition within the CD4 memory pool. 
The experiment was repeated with some alterations to the protocol: mice were 
immunised with more antigens, and they were left for a longer period of time to see 
if this would provide time for the competition to become apparent. The extra antigen 
used was secreted proteins from Nippostrongylus brasiliensis (NES). This mix of 
proteins induces a Th2 response in immunised mice (265). Table 4.2 summaries the 
















1 H19env-DC  Hl9env-CFA 
2 Hl9env-DC KLH DNP-OVA  H19env-CFA 
3 H19env-DC KLH DNP-OVA NES H19env-CFA 
4  KLH  H19env-CFA 
5  NES  Hl9env-CFA 
6  H19env-CFA 
7  OVAp-CFA 
Table 4.2: Immunisation protocol for second multiple immunisation experiment. 
Again, all the groups were challenged with Hi 9env-CFA 5 days prior to tetramer 
staining. As in the first experiment, no difference were found in the recall response 
between mice immunised with three different antigens or only primed with H19env 
pulsed DC, figure 4.8b. This further suggests that no competition had taken place 
within the CD4 memory pool. 
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4.3. Discussion 
The experiments described in this chapter set out to examine whether CD4 memory 
cells competed for survival with each other. Using several different experimental 
systems, based on either transgenic or polyclonal populations, no evidence for 
competition in the CD4 memory pool was found. However, there were deficiencies 
in these systems that prevent overall conclusions from being reached. 
4.3.1. Survival of memory D011. 10 cells in mice with endogenous OVA-
specific memory cells 
The experiments using transgenic cells were inconclusive. In the first system, 
involving the transfer of activated DO 11.10 cells into pre-immunised mice, the 
existence of host OVA-specific memory cells did not affect the survival of the 
transferred cells. This may suggest that the memory cells do not need to compete for 
antigen in order to survive. However, there could be other explanations for this 
result. 
DO 11.10 CD4 T cells respond to low doses of antigen and are thought to have a high 
affinity receptor for the peptide-MHC complex, and for self-MHC (301), (305). 
Therefore, the transgenic cells may recognise their antigen and or self-MHC with 
greater affinity than the endogenous memory cells, and thereby their maintenance 
would be unaffected by the presence of the endogenous memory cells. 
Furthermore, the "set-up" of this system may not "encourage" competition in the 
immunised mice. By increasing the number of immunisations, the amount of antigen 
also increases. The mice were immunised with OVA precipitated in alum, an 
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adjuvant that is thought to at least partly act by forming a depot at the injection site 
(280). Thus, in mice immunised three times, there will be more antigen than in mice 
only primed once. This may have the effect of reducing competition rather than 
inducing it. Although this problem could be solved by immunising with an adjuvant 
that does not induce a depot of antigen, this would have removed the potential 
competition factor. Regardless of the reason why there was no difference in survival 
of the DO 11.10 cells, the result corresponds to findings by various groups (172), 
(175), (169), (170), (171), (138), (173): memory cells were able to survive in the 
absence of specific antigen. 
4.3.2. Do memory cells compete for MHC molecules for survival? 
The second set of experiments, using both DO 11.10 and OT-11 transgenic cells, did 
not shed any light on competition in the CD4 memory pool as the OT-Il cells 
disappeared from the adoptive transfer hosts. Nevertheless, the preliminary 
experiments, mainly carried out in vitro, do support findings in the literature showing 
that DO11. 10  cells respond to lower doses of OVA323..339 than OT-Il T cells (301). 
This was true whether the peptide was presented to DO 11.10 cells by IAd  or I-A'. 
A further interesting point is that the difference in proliferation of DO 11.10 and OT-
II cells was less apparent when the populations were cultured together with both sets 
of APC (compare the USE profiles in figure 4.5b and c). This suggests that one 
population of activated T cells can affect a different clonotype. What effect such 
interactions could have in vivo has been investigated by other groups: Both Alpan et 
al and Creusot et al found that memory or activated T cells could influence the 
cytokine production by naïve cells when both populations were activated 
simultaneously (306), (307). Kedl et al investigated the competition between CD8 T 
cells specific for the same antigen but with differing affinities (212). The authors 
found that high affinity T cells prevented the activation of the lower affmity T cells 
by down-regulating peptide-MHC complexes on APC. This does not correlate with 
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the in vitro results in this PhD. If this was the case, it might be predicted that 
DO 11.10 T cells would reduce the proliferation of OT-Il cells in the same well. 
Instead the OT-il proliferated slightly more than they did in individual cultures. This 
may reflect differences between CD8 and CD4 T cells or may be because, in a tissue 
culture well, the availability of peptide-MHC complexes was not limiting. This may 
not be the case in vivo where OT-11 cells proliferated less than DO 11.10 cells in the 
same host at day 5 after immunisation. In this instance, the DO! 1.10 cells may 
monopolise the available peptide-MEC complexes. 
4.3.3. Survival ofpolyclonal memory cells in mice immunised with other 
antigens 
Given the deficiencies in the experiments using transgenic cells, a protocol was set 
up to answer similar questions using the class II tetramers. As described above, this 
experiment tracked the functional survival of 1-119env-specific memory cells in mice 
that had been immunised with a number of different antigens. 
The recall response was equivalent in mice immunised with just H!9env-pulsed DC 
and the various groups of mice also immunised with additional antigens. Therefore, 
the H! 9env-specific memory cells were able to survive despite the presence of other 
memory cells. In hindsight, it may have been better to track the survival ofHl9env-
specific cells ex vivo as the recall assay may not be subtle enough to distinguish 
between the differential survival of the memory cells in the various groups. This 
would have required immunising the mice with H 1 9env-CFA, which, as this 
adjuvant forms a stable depot of antigen for some time, would have meant that the 
Hl9env-specific memory cells had continuous access to antigen and this may have 
provided occasional TCR signals that could enhance cell survival. 
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Taking together the results from the first experiment, involving the transfer of 
DO 11.10 cells into pre-immunised mice, and the class II tetramer based experiment, 
the following two interpretations are possible. 1. that there is no competition within 
the CD4 memory pool; or 2. the memory pool was not saturated by the experimental 
systems employed. 
The best evidence for competition within the CD8 memory pool comes from the 
work by Selin and Welsh and colleagues (193), (196), (197), (308), and Smith et a! 
(198). In both cases, the decline of antigen-specific memory CD8 cells was found 
following subsequent infection of immune mice with different pathogens. Both 
groups also studied CD4 T cell memory in the same systems. Although Selin and 
colleagues found no decline (195), Smith et al found a dramatic reduction in memory 
CD4 cells after infection with BCG (198). 
However, as described in the introduction, this perceived competition may actually 
be a result of infection-induced apoptosis of memory cells rather than direct 
competition for a survival factor within the memory pool (309). It is interesting to 
note that a reduction in antigen specific CD4 memory cells was found after bacterial 
infection (198) but not after viral infection (193), suggesting that the factors that 
induce apoptosis in CD4 and CD8 I cells may be distinct, and dependent on the type 
of infection. 
This prompts the question of if and why this attrition could be beneficial for the 
immune system. Welsh and colleagues and Jiang et al suggest that the apoptosis of 
cells in secondary lymphoid organs, just prior to the expansion phase of the immune 
response, clears space for this antigen-specific expansion (200), (205). Moreover, the 
loss of some memory cells may provide space in this pool for newly generated cells, 
especially considering the large numbers of memory cells following some viral 
infections in mice (131). The apoptosis induced attrition would, therefore, prevent 
the saturation of the memory pool. 
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This attrition does, however, come at a price, and could result in loss of immunity to 
some pathogens. The memory cells that would have the best chance of survival in 
this system would be those that received a periodic signal via their TCR. Thus the 
host would be most likely to maintain memory cells for pathogens to which it was 
regularly exposed. 
McNally et al did not observe any alterations in the TCR repertoire following 
infection-induced apoptosis, suggesting that the immune system is able to maintain a 
diverse TCR repertoire despite this death (201). This corresponds to findings by Troy 
and Shen that indicate that the immune system can somehow recognise the extent of 
diversity within the I cell pool (310). The authors found that TCR transgenic cells 
could proliferate after transfer into a different TCR transgenic mouse, indicating that 
there was "space" in this host, but that the cells could not divide if they were 
transferred into a TCR transgenic host of the same clonotype. How the immune 
system can recognise the diversity of the T cell repertoire is not yet understood but 
this knowledge could potentially shed more light on how T cell pools are regulated. 
4.3.4. Conclusion 
The experiments carried out in this chapter do not conclusively rule out competitive 
homeostatic deletion within the CD4 memory pool. However, the results are in line 
with findings in the literature. The mechanism of attrition in the CD8 memory pool 
has been found to be infection-induced apoptosis rather than direct competition for 
"space". This lymphopenia induced by infection can also affect CD4 T cells (198), 
(205). Thus, it would be interesting to track the survival of Hl9env-specific cells 
after subsequent infections. Such experiments were not carried out in the PhD for 
two main reasons. First, because of the practical complications of infecting the 
Hl9env immunised mice. Second, and more importantly, in this set of experiments, I 
first wanted to define whether there was competition in the memory pool for 
survival, rather than increased death of the memory cells as a result of infection. Had 
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competition been apparent, this could have led to experiments in which the limiting 
factor could have been identified. 
However, it may be that there is less need for this form attrition in the CD4 memory 
pool as the peak of CD4 T cells clonal expansion is much smaller than in many CD8 
T cell responses (19), (126), (311), (248). There are, therefore, fewer requirements 
for competition as the CD4 T cell pool would be less likely to be saturated than the 
CD8 memory pool. Moreover, as described in the previous chapter, antigen-specific 
memory CD4 cells declined overtime in mice that were not intentionally challenged 
with other antigens. Therefore, the memory pool would be unlikely to become 
saturated, unlike the CD8 memory pool in which memory cells survive for a more 
considerable time and at higher frequencies (173), (287), (288), (19). 
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Figure 4.1 Do transferred DOl1.1O cells survive less well in mice that 
contain endogenous OVA-specific memory cells? 
By increasing the number of immunisations, the endogenous pool of OVA 
specific T cells (green) should increase and thereby, potentially, create a more 
competitive memory pool in which the DO 11.10 cells (blue) may have to 
compete for residual antigen on APC. 
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Figure 4.2 Transfer of activated DO11.iO cells into immune mice: 5x106 
DOl 1.10 cells were activated in vitro with 0.5tgIml OVA peptide for 3 days 
then transferred into BALB/c mice which had been immunised with 1001g 
of OVA-alum i.p. 10 days previously (a) or naïve mice (b), or naïve cells 
transferred into naïve mice (c). Percentage of DO 11.10 cells, out of CD4 
cells, in the spleen are shown, cells gated on live lymphocytes. d) Division of 
activated KJ 1.26 cells in immunised (blue line) or naïve mice (green line), 
red line: naïve cells in naïve mice. 
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Figure 4.3 Survival of activated DOl 1.10 cells in naïve of pre-
immunised mice: DOl 1.10 cells were activated in vitro for 3 days 
with 0.5gIml OVA peptide before transfer into naïve mice, or into 
mice pre-immunised I to 3 times with OVA-alum i.p. as indicated. 
Mice were sacrificed after 6 weeks and the percentage of surviving 
DOl 1.10 cells in the spleen enumerated by FACS by staining with 
KJ 1.26 and anti-CD4. Each symbol represents one mouse and the 
line shows the mean of the group. This experiment was only done 
once. 
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DOl 1.10 cells alone 
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Both populations survive equally 	DOl1.lO cells out-compete OT-11 
Figure 4.4 Do memory DOl 1.10 cells survive better than memory OT-11 
cells? After co-transfer, DOl 1.10 (blue) and OT-El (green) cells may survive 
equally well, suggesting that there is no competition for antigen or MHC. 
Alternatively, DOl 1.10 cells may survive better, suggesting that antigen or MHC 
contacts may be important in the survival of memory C134 T cells. 
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Figure 4.5 In vitro division of DOl 1.10 and 01-I1 cells: a) CD4 purified 
DO! LlO or 01-I1 cells were cultured at various doses of OVA peptide for three 
days with either irradiated BALB/c or C57BL/6 splenocytes or in a mixed culture 
of all four cell population as indicated. 
b) and c) CD4 purified CFSE labelled DO 11.10 (red-fill) and 01-11 (blue line) 
cells were activated individually (b) with respective APC or together with 
C57BL/6 and BALBIc APC (c), for 4 days in vitro with 0.005tgIml OVA peptide. 
The cells were then stained with anti-ICR and anti-CD4 antibodies and analysed 
by FACS. 
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Figure 4.6 In vivo response of D011-10 and OT-11 cells: USE 
labelled DOl 1.10 and 01-Il cells were transferred into 
(C57BL/6xBALB/C)F1 mice which were then immunsied with 100.tg 
OVApeptide-alum i.p.. Splenocytes were stained with anti-ICR and 
anti-CD4 antibodies on day 5 after immunisation. Cells are gated on 
live cells (DO] 1.10) or live CD4+ve cells (01-11) and the number 
shows the percentage of trarisgenic cells out of total CD4 cells. 
DOl 1.10 (red-fill) and 01-11 (blue line). 
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Figure 4.7 Does immunisation with multiple antigens result in a reduction in 
H19env specific T cells? 
After immunisation with other antigens, Hl9env specific cells (blue) may have to 
compete with other memory cells (red, green and purple) for survival factors (APC 
and soluble molecules - small green circles). 
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Figure 4.8 Competition in the CD4 memory pool: percentage of 
tetramer positive cells out of CD4 cells in the DLN of mice 
immunised as in tables 4.1(a) and 4.2 (b). Each point represents one 
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Requirements for costimulation 
Requirements for costimulation in the generation, survival and 
recall responses of CD4 T cells 
5.1. Introduction 
Recent advances in microscopy have offered a new view of I cell activation in vivo. 
Movies detailing the interactions between T cells and APC demonstrate that it is only 
after sustained interactions between these two cell types that T cells become fully 
activated and committed to cell division (24), (23). This requires cross-talk between 
the T cells and APC involving a complex array of costimulatory molecules. The 
relative importance of a wide range of costimulatory molecules in the initial 
activation of T cells has been widely studied in various models for both CD4. and 
CD8 I cells. However, the importance of these molecules in the generation of 
functional memory cells and the re-activation of these cells has only received limited 
attention. This is especially true for CD4 recall responses, which have largely been 
studied in vitro (9), (161), (278). Experiments tracking antigen-specific memory cells 
from activation, through memory and during recall responses in vivo are, therefore, 
required to dissect the precise roles of individual costimulatory molecules during 
these different phases of the T cell response. 
5.1.1. CD40 
CD40 is a member of the TNFR family and is expressed on activated DC and B cells 
(30). It binds to CD40L on activated T cells and forms part of the intricate cross-talk 
between T cells and APC (312); figure 5.1 illustrates these interactions. iWhile the 
importance of CD40-CD40L interactions for efficient B cell response is well defined 
(313), the role this interaction may play in T cell responses is unclear. 
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The ligation of CD40 on DC by CD40L results in maturation of the DC, promoting 
further upregulation of the B7 molecules and inducing the expression of other 
molecules such as OX40L (32), (33), (314), (34). This serves to amplify and sustain 
the ensuing T cell response. Moreover, this signal is important for the secretion of 
IL-12 by DC, enabling them to influence the differentiation of the responding T cells 
(32), (33), (35), (315). 
Various studies in CD40 and CD40L knockout mice have provided insights into the 
role of CD40-CD40L interaction in T cell priming. While some studies have shown 
reduced CD4 and CD8 T cell priming (316) others have found a defect only in the 
CD4 response (317) or no defect at all in the T cell response (318).. These variations 
perhaps reflect the different immunisation strategies used and inherent differences 
between viral infections and protein based immunisations. Moreover, the CD4 T cell 
response has primarily been examined indirectly using in vitro proliferation assays. 
Studies involving the adoptive transfer of CD40L knockout TCR transgenic cells 
have also provided contradictory results: Howland et al found that the knockout cells 
could proliferate but that the response was aborted at an early stage (34). In contrast, 
Grewal et a!, found that CD40L knockout cytochrome C specific T cells did not 
proliferate at all in immunised wild-type mice (319). 
The importance of the CD40L-CD40 interaction in T cell activation has been 
demonstrated by tolerance studies. For example, transfer of peptide-pulsed CD40 
deficient DC results in tolerance of specific T cells rather than activation (320) and 
administration of an activating anti-CD40 antibody resulted in priming of tumour 
specific C138 T cells, rather than tolerance, following the intravenous injection of 
peptide (321). Therefore, T cell activation is likely to be limited in the absence of 
CD40 or CD40L, but the requirement for this interaction in the survival and 
reactivation of memory cells is a question that remains unanswered. 
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5.1.2. ICOS 
ICOS is a member of the CD28 costimulation family, and, like CD40L, is expressed 
on activated T cells (322), (323), see figure 5.1. The phenotype of both ICOS and 
B7h knockout mice has demonstrated the importance of this interaction in the B cell 
response in both the generation of germinal centres and class switching (31), (324). 
However, the role and requirement for this interaction in T cell responses is less 
clear. 
Little is known about the importance of the interaction between ICOS on activated T 
cells and B7h on DC. There have been reports that DC do express B7h, but 
expression does not appear to be upregulated following activation with a number of 
stimuli (LPS, TNF-a, IFN-y, also see materials and methods) (325), (326), (327). 
Moreover, Witsch et al found that DC actually downregulated expression of B7h 
following culture with activated T cells and that this was dependent on the 
expression of ICOS by the T cells (326). This interaction may be important, 
however, for IL-10 production by T cells as blocking ICOS-B7h interactions in in 
vitro cultures of T cells and DC reduced the levels IL- 10 made by the T cells (326). 
Early work using anti-ICOS antibodies and fusion proteins suggested that ICOS 
signalling was important in the development of the Th2 response (328), (329). This 
has been confirmed to some extent by in vivo findings (330), (331). For example, 
Mak et al described a reduced allergic asthma response, a classic Th2 disease, in B7h 
knockout mice and the authors suggested that this resulted from the dimished 
production of the Th2 cytokines, IL-4 and IL- 13 (330). 
Despite this role for ICOS in Th2 responses, there have been descriptions of a wider 
role for ICOS costimulation (30). McAdam et al found that stimulating T cells using 
anti-CD3 and B7h-Ig caused increased production of IFN-y, IL-4 and IL-10 (42). 
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This suggested that ICOS costimulation was important in effector responses rather 
than T cell proliferation. However, Dong et al found decreased IL-2 production from 
ICOS knockout T cells in vitro and this resulted in reduced T cell proliferation (332). 
Similarly, in work with human T cells, Aicher et al found that blocking ICOS also 
resulted in decreased proliferation in both mixed lymphocyte reactions and in 
responses to tetanus toxoid (327). 
Examining T cell proliferation in vivo has not resolved this debate. Although Nurieva 
et al and Mak et al did not find reduced I cell proliferation in the absence of ICOS 
signalling (333), (330), Smith eta! showed that adoptively transferred DOl 1.10 T 
cells proliferated less in the presence of a blocking ICOS fusion protein in both Thl 
and Th2 inducing environments (45). In support of this role for ICOS signalling in 
Thi responses, Mittrucker et al found that treating mice with an ICOS fusion protein 
resulted in increased susceptibility to LM infection, a classic Thl infection (46). 
Therefore, the precise role of ICOS costimulation in T cell responses is far from 
clear. The different results described above probably reflect the varying protocols 
used: ICOS fusion proteins, antibodies and different knockout mouse strains. As with 
CD40-CD40L interactions, T cell responses in the absence of ICOS-B7h interactions 
need to be examined directly ex vivo to establish when, and in what circumstances, T 
cells require costimulation via ICOS. 
As detailed in the previous chapters, class II tetramers can be used to track antigen-
specific T cell responses during various stages: priming, memory cell survival and 
recall responses. This tool provides the opportunity to study the role of specific 
costimulatory molecules during these different stages. In this chapter the role of 
CD40L-CD40 and ICOS-B7h costimulation during these stages will be examined by 
tracking the antigen-specific T cell response in CD40L, CD40 and ICOS knockout 
mice. 
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5.2. Results 
The role of CD40-CD40L in T cell responses 
5.2.1. CD40-CD40L costimulation is required to prime CD4 T cells 
To evaluate the role of the costimulatory interaction CD40L-CD40 in T cell priming, 
wild-type C57BL/6, CD40, and CD40L knockout mice were primed with H19env 
peptide in CFA. After 8 days, the spleens and draining lymph nodes (DLN) were 
taken and stained with class II tetramers to determine the extent of CD4 T cell 
priming. As expected, a population of antigen specific cells were induced in 
C57BL/6 mice. However, the tetramer staining in CD40 and CD40L knockout mice 
was not above background (C57BL/6 mice immunised with OVA peptide in CFA), 
figure 5.2. This suggested that T cell priming had not occurred in the absence of 
CD40-CD40L costimulation. 
It was possible that T cell proliferation was delayed in the absence of this 
costimulatory signal. Thus, the spleens and draining lymph nodes of mice immunised 
15 days previously with peptide-CFA were examined. Again, no antigen specific 
cells could be detected at this time point, or at the later time points examined (weeks 
4 and 6, data not shown). 
To test whether priming had occurred at a level below detection by the tetramers, 
spenocytes from the mice were activated in vitro with peptide. The splenocytes were. 
labelled with the intracellular dye USE to allow visualisation of the. division of the 
tetramer positive cells. After three days of culture, USE low tetramer positive cells 
were found in the C57BL/6 samples, but the staining in CD40 and CD40L knockout 
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samples remained at background levels (Hi 9env peptide stimulation of splenocytes 
from OVA peptide immunised C57BL/6 mice), figure 5.2b and c. 
5.2.2. Wild-type dendritic cells restore priming in CD40, but not CD40L 
knockout mice. 
This defect in the initial priming of CD4 T cells in CD40 and CD40L knockout mice 
meant that the survival and activity of memory cells in the absence of CD40L-CD40 
signals could not be evaluated. To overcome this problem, wild-type bone marrow 
derived DC were used to try to restore priming in the CD40 and CD40L knockout 
mice. 
Bone marrow derived DC were activated with LP  and pulsed with Hl9env peptide 
in vitro, before they were transferred s.c. (DC-s.c.) into C57BL/6, CD40 and CD40L 
knockout mice. Six to seven days later, DLN cells and splenocytes were stained with 
class II tetramer to measure the primary response. The response in both the spleen 
and DLN was equivalent between C57BL/6 and CD40 knockout mice, figure 5.3. In 
CD40L knockout mice, in which wild-type DC cannot restore the genetic defect, 
tetramer staining remained at background levels. 
5.2.3. The absence of CD40-CD40L interactions in the recall response does 
not affect the proliferation of memory T cells 
Restoring T cell priming with wild-type DC in the CD40 knockout mice llowed the 
survival and activity of the memory cells in the absence of CD40 to be evaluated. 
Exogenous DC do not survive for long after transfer into mice, (see later and refs. 
(170), (3 34)) and thus I cells in DC-primed mice would not have contact with 
antigen, or CD40 in the CD40 knockout mice. The recall response was examined, as 
in chapter three, by boosting the DC-primed mice with peptide-CFA after 4 to 18 
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weeks post-DC transfer. Spleens and DNL cells were taken five days after the re-
challenge and stained with class II tetramers. 
In both the spleen and DLN, the recall response was found to be equivalent between 
C57BL/6 and CD40 knockout mice, even in the absence of CD40-CD40L 
costimulation in the recall response in the latter group (figures 5.4 and 5.5). 
Moreover, in both groups the response was above the primary response in C57BL/6 
mice to peptide in CFA, demonstrating that this was a memory response. 
Tetramer staining above background levels was detected in the DLN and spleens of 
CD40L knockout mice that had first been primed with wild-type DC, then boosted 
with peptide-CFA. However, this response was deficient compared to that in 
C57BL/6 or similarly treated CD40 knockout mice. Thus, a small number of antigen-
specific cells had been primed in the CD40L knockout mice by DC immunisation 
and could respond to the peptide-CFA boost. 
5.2.4. Initial immunisation of CD40 knockout mice with DC intravenously 
does not restore the secondary response in the DLN 
Initially, the recall response had been examined in CD40 knockout mice that had 
been primed with wild-type DC injected i.v. into the tail-vein (DC-i.v.). In C57BL/6 
mice boosted with peptide-CFA, a recall response was found, as above, both in the 
spleen and in the inguinal LN that drains the CFA injection site. However, in CD40 
knockout mice that had been primed with DC-i.v. then boosted with peptide-CFA, a 
recall response was only measurable in the spleen. In the inguinal LN, tetramer 
staining remained at background levels, figure 5.6. Thus, when mice were primed 
with DC-i.v. a memory response in the draining lymph node did not occur in the 
absence of CD40. The difference in the sites of the recall response following priming 
with DC- s.c. or -i.v. are summarised in table 5.1: 
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Strain Initial DC Recall Recall 
immunisation response in response in 
spleen DLN 
C57BL/6 s.c. 4 	iI I 	I 	I 	I 
(1.49) (1.44) 
C57BL/6 i.v. ++ 
(0.24) (0.42) 
CD40 KO S.C. I 	I 	I 	I -I 	I 	I 	I 
(1.36) (1.54) 
CD40 KO i.v. ++ - 
(0.17) (0.055) 
wild-type DC then boosted with peptide-CFA: The relative percentage of tetrarner positive cells in 
the different lymphoid organs have been compared using + symbol with increasing number of + 
indicating an increase in the percentage of tetramer positive cells present. The means of tetramer 
positive cells, given as a percentage of CD4 cells, is shown in brackets. This data is from figures 5.5 
and 5.6. 
There are a number of explanations for this defect in the recall response in the DLN 
of the CD40 knockout mice: 
Memory T cells in the CD40 knockout mice were unable to enter LN. 
Distinct APC populations exist in LN and spleen, the former unable to 
activate memory cells in the absence of CD40 costimulation. 
Antigen could reach the spleen, but it was unable to reach the LN from the 
CFA injection site in the absence of CD40. 
Given that CD40 knockout mice primed with DC-s.c. had a recall response in both 
the spleen and inguinal LN, it seemed unlikely that explanations 2 and 3 could be 
correct. In experiments in which the antigen-specific response was compared 
following transfer of DC either S.C. or i.v., similarly percentages of tetramer positive 
cells were found in the spleens of each group, but tetramer positive cells were only in 
the LN of mice given DC-s.c., figure 5.7. Therefore, in the recall experiments 
described above, the site of immunisation, and thus the DLN, in both the primary and 
recall response was the same. Therefore, it was possible that memory cells primed in 
Table 5.1: Summary of site of recall response in C57BL/6 and CD40 knockout mice primed with 
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CD40 knockout mice could only migrate to the initial immunisation site: the spleen 
after DC-i.v. transfer; the inguinal LN and the spleen after DC-s.c injection. 
To investigate this, C57BL/6 and CD40 knockout mice were primed with DC-s.c. in 
the hind-leg. After 7 weeks, the mice were boosted with peptide-CFA injected in the 
back of the mouse, just below the shoulder blades. This site primarily drains to the 
axillary LN. 5 days later, tetramer staining was assessed in the spleen, inguinal and 
axillary LN. As detailed in figure 5.8, tetramer positive cells could be detected in all 
sites, and the responses were equivalent between C5713L/6 and CD40 knockout mice. 
These experiments ruled out explanations 2 and 3. APC in the lymph nodes of CD40 
knockout mice were able to present antigen to memory CD4 cells after CFA 
injection, and therefore, antigen must have reached the LN, either draining there 
iiself in the lymph, or carried by DC from the injection site. 
This left the remaining hypothesis: that Hl9env specific memory T cells in the DC-
i.v. primed CD40 knockout mice could not re-circulate through LN. The best way to 
test this hypothesis would be to transfer the memory cells from DC-primed CD40 
knockout mice into C57BL/6 mice and then examine the recall response. However, 
as detailed in chapter three, such transfer experiments proved to be inconsistent. 
Thus, an alternative way in which to track the migration of antigen-specific memory 
cells in the CD40 knockout mice was devised. As detailed in chapter three, it was not 
possible to detect tetramer positive cells ex vivo in DC immunised mice after day 20. 
However, by boosting DC-primed mice with peptide-CFA, the resultant memory 
pool could be tracked ex vivo. Therefore, the memory pool after the secondary 
immunisation was examined to establish both the size and the re-circulatory 
characteristics of the memory cells in C5713L/6 and CD40 knockout mice. 
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5.2.5. The size of the memory pool following the recall response is dependent 
on the original site of DC immunisation 
C57BL/6 and CD40 knockout mice, which had been immunised either i.v. or S.C. 
with wild-type DC, were left for 8 weeks, then re-challenged with peptide-CFA. 
Only after a further 8 weeks was tetramer staining of splenocytes, and the cells in the 
DLN and non-DLN carried out and the characteristics of this "secondary" memory 
pool examined. 
The results of this experiment are detailed in figure 5.9 and summarised in table 5.2. 
Tetramer positive cells were found in all test groups, demonstrating that the recall 
response in CD40 knockout mice resulted in the survival of the activated cells into 
the "secondary" memory pool. However, there were distinctions between the size 
and migration characteristics of the memory pools in the different groups. 
Strain Initial DC Tetramer +ve Tetramer +ve Tetramer +ve 
immunisation cells in spleen cells in DLN cells in non- 
route  DLN 
C57BL/6 S.C. I 	I I 	I 
(0.46) (0.67) (0.27) 
C57BL/6 i.v. ++ I - 
(0.30) (0.41) (0.046) 
CD40 KO S.C. ++ -H- + 
(0.26) (0.21) (0.088) 
CD40 KO i.v. + + - 
(0.1) (0.1) (0.031) 
C57BL16- - ++ +-i- - 
CFA only  (0.15) - 	(0.29) (0.054) 
Table 5.2: Summary of presence of tetramer positive cells in the secondary memory pool in 
C57BL/6 and CD40 knockout mice immunised with wild-type DC then boosted witSpeptide-
CFA: The relative percentage of tetramer positive cells in the different lymphoid organs have been 
compared using + symbol with increasing number of + indicating an increase in the percentage of 
tetramer positive cells present. The means of tetramer positive cells, given as a percentage of CD4 
cells, is shown in brackets. This data is from figure 5.9. 
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C57BL/6 mice that had been immunised s.c. with wild-type DC then boosted with 
peptide-CFA, had a larger memory pool in the spleen, DLN and non-DLN than mice 
that were only immunised with peptide in CFA once. This may be because the recall 
response is larger than the primary response and therefore more cells survive into the 
subsequent memory pool. This finding corresponds to several reports that the size of 
the memory pool is determined by the size of T cell expansion during the response 
(130), (131). 
However, C57BL/6 mice that had been initially immunised with DC-i.v., did not 
have a significantly larger memory pool after secondary immunisation than mice 
immunised with peptide-CFA alone. This agrees with the less dramatic increase in 
the secondary response after initial DC-i.v. priming compared to DC-s.c. priming 
(compare figure 5.5 and 5.6). Similarly, CD40 knockout mice immunised with DC-
i.v. had a smaller memory pool than CD40 knockout mice initially primed with DC-
s.c. Thus, the initial priming site determines the size of the secondary response and 
thereby determines the size of the "secondary" memory pooL 
5.2.6. CD40 expression determines the size and migratory patterns of memory 
cells 
This experiment also showed that there were differences in the size of the secondary 
memory pool between C57BL16 and CD40 knockout mice. Comparing the memory 
pool in C57BL/6 and CD40 knockout mice that had been initially immunised s.c. 
with wild-type DC, it can be seen (figure 5.9) that there was a bigger antigen-specific 
memory pool in the C57BL/6 mice in all lymphoid organs examined. This suggests 
that even though the recall response at day 5 after the re-challenge was equivalent in 
C57BL16 and CD40 knockout mice, either more cells were activated over the course 
of the recall response or more memory cells survived into the secondary memory 
pool in the C57BL/6 mice. Similarly, more tetramer positive cells were found in 
C57BL/6 mice initially immunised with DC-i.v. than in CD40 knockout mice 
immunised with the same DC-i.v. 
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There were also differences in the migratory patterns of the antigen-specific memory 
cells in the different groups of mice. Tetramer positive cells were clearly present in 
the DLN of both groups of C57BL/6 mice (immunised with DC either i.v. or s.c.) 
and also in CD40 knockout mice immunised with DC-s.c. However, very few 
tetramer positive cells were found in the DLN of CD40 knockout mice immunised 
with DC-i.v. and no tetramer positive cells were found in the non-DLN of these 
mice. Thus, the migration of the memory cells was deficient in CD40 knockout mice 
primed with DC-i.v. and boosted with peptide-CFA. 
5.2.7. Exogenous DC can be identified after s.c. but not after i.v. injection 
This distinction in the response depending on the route of transfer of DC was 
interesting. To investigate whether there were differences in the migration and 
survival of the DC following transfer by the two different routes, the injected DC 
were tracked using the Ly5.1 congenic marker. 
Preliminary experiments in C57BL/6 mice found that Ly5.1-DC could easily be 
detected in the DLN ex vivo at 2 days after s.c. transfer, figure 5.10. By day 5, 
however, very few, if any, DC could be identified even after the selection of CD 11 c 
positive cells using labelled magnetic beads (data not shown). No exogenous DC 
were identified in the spleen at either time point. After i.v. transfer, no exogenous 
DC could be found in the spleen, again, even after selection for CD  I  positive cells, 
figure 5.10. Given that the DC injected i.v. could not be identified, further 
experiments tracking them in CD40 knockout mice were not carried out. 
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5.2.8. IFN-y production by CD4 cells is reduced in CD40 knockout mice in 
both the primary and recall response 
T cell proliferation is only one component of the immune response. To establish 
whether the restored T cell proliferation in the CD40 knockout mice was 
accompanied by an equivalent cytokine response, intracellular cytokine staining was 
performed. No antigen-specific cytokine (IFN y, IL-2, TNF-a) could be measured 
after a peptide-pulse of splenocytes or LN cells ex vivo for between 6 to 72 hours. 
Presumably, this was because the number of specific cells was low. 
To provide an indication of the cytokine production in immunised C57BL/6 and 
CD40 knockout mice, cells were activated with PMA and ionomycin for 4 hours ex 
vivo in the presence of Golgi stop. The cytokine production by total CD4 cells was 
then examined. 
The production of IL-2 and the effector cytokine, IFN-y, was examined in mice that 
had received only peptide-DC, or had also been boosted with peptide-CFA. The 
production of IL-2 by total CD4 cells was equivalent in C57BL/6 and CD40 
knockout mice after priming with DC and boosting with CFA, figure 5.11 a, but in all 
cases the percentage of CD4 cells making IL-2 was greater than that from naïve 
splenocytes activated with PMA and ionomycin. 
In the primary response, the percentage of CD4 cells from C57BL/6 primed with 
peptide-pulsed DC making IFN-y was greater than that in naïve mice. However, the 
response in DC-primed CD40 knockout mice was reduced compared to response in 
the C57BL/6 mice and was not above that in naïve mice, figure 5.9b. This was true if 
the mice were injected with the DC-s.c. or —i.v. 
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In the recall response a similar result was found. The percentage of CD4 cells 
making WN-'y was much greater in the C57BL/6 mice that had initially been given 
DC then were boosted with peptide-CFA than that in the primary response (DC 
alone), figure 5.1 lb and 5.12. IFN-y production by CD4 cells from the boosted 
CD40 knockout mice was slightly above the primary response in CD40 knockout 
mice and above the level of IFN-y production in naïve splenocytes. However, the 
percentage of CD4 cells making IFN-y in the recall response in the CD40 knockout 
mice was greatly reduced compared to that in the recall response in C57BL/6 mice. 
5.2.9. T cell responses are normal in mice in which the CD40 defect is limited 
to B cells 
The above result suggested that although exogenous wild-type DC could restore T 
cell priming and memory cell generation in CD40 knockout mice, they were unable 
to induce full effector T cell differentiation. This suggested a role for endogenous 
APC in sustaining and amplifying the T cell response. B cells can play a role in T 
cell responses: some investigators have found either reduced T cell activation or 
deficient memory cell survival in IAMt mice (136), (137). Moreover, as the immune 
response progresses and DC begin to die, B cells may become the major APC 
population. B cell may, therefore, be important in the latter stages of the T cell 
response, including T cell differentiation. 
T cell CD40L signals to B cells are essential for productive B cell responses (313), 
(335). To investigate whether this interaction is also important for the CD4 T cell 
response, in particular for effector cell differentiation, bone marrow chimeras were 
made in which the CD40 defect was limited to B cells. These chimeras were made by 
first lethally irradiating C57BL/6 hosts and then reconstituting them with bone 
marrow from pMT mice (80%) and CD40 knockout mice (20%). This protocol is 
illustrated in figure 5.13. Thus, B cells can only develop from the CD40 deficient 
bone marrow while the majority of other APC, such as DC and macrophages, 
develop from the !tMT bone marrow and thus are CD40 sufficient (270), (60). 
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Control, wild-type chimeras were made by reconstituting irradiated C57BL/6 mice 
with 80% [tMT bone marrow and 20% C57BL/6 bone marrow. The chimeras were 
used after 8 weeks to allow for the loss of radiosensitive cells and for the 
establishment of transferred bone-marrow cells (see materials .and methods for, 
confirmation of chimerism). All the chimera experiments were carried out in 
collaboration with Alison Crawford, another PhD student in David Gray's 
laboratory. 
Initial experiments were carried out to establish whether DC transfer induced a 
population of tetramer positive cells. CD40 knockout B cell and wild-type control 
chimeras were immunised with wild-type DC-s.c. at the hind-leg. The primary 
response in the spleen at day 7 was equivalent in the two sets of chimeras, figure 
5.14. However, in the DLN, the response in the CD40 knockout B cell chimeras was 
greater than that in the control chimeras. This appeared to be because the response in 
the control chimeras was smaller than expected; it was not statistically above 
background staining. 
Subsequent experiments were unable to substantiate or explain this finding. In the 
following two experiments, the primary response in both sets of chimeras was very 
low, not even above background staining. This was true after various immunisation 
strategies: DC injected i.v. or s.c., or immunisation with peptide-CFA (data not 
shown). This poor priming was thought to be a consequence of the chimeras being 
reconstituted with 80% MT bone marrow. [LMT mice have small spleens and LN 
and this was also true of the chimeras (a typical spleen had approximately 3-4x10 7 
cells compared to 6-8x iø in a wild-type C57BL/6 mouse). This small number of 
cells may have meant that the number of tetramer positive cells activated following 
immunisation was much lower than in C57BL/6 mice and below the level of 
detection by the class II tetramers. 
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5.2.10. The recall response is equivalent in B cell CD40 knockout chimeras 
and wild-type chimeras 
Despite the poor primary response in the chimeras, the recall response was 
examined. As before, DC-primed mice were boosted with peptide-CFA 10 weeks 
after the initial DC-transfer, and the spleen and DLN stained with class II tetramers 5 
days later. The recall challenge established that T cell priming had taken place. As 
predicted from the experiments in complete CD40 knockout mice primed with DC-
s.c. the recall response was equivalent in the wild-type and B cell CD40 knockout 
chimeras in both the spleen and DLN, figure 5.15. The chimeras were also 
immunised with DC-i.v. to investigate the site of the recall response as this was 
defective in complete CD40 knockout mice primed with DC-i.v. Unfortunately, no 
recall response was apparent in either the spleen or the LN of these chimeras in the 
two experiments carried out (data not shown). 
5.2.11.IFN-y production by CD4 cells is similar in CD40 knockout B cell and 
wild-type chimeras 
Given the deficiency in IFN-y production by CD4 cells in the primary and recall 
response in the CD40 knockout mice, the cytokine response in the CD40 knockout B 
cell and wild-type chimeras was examined during both the primary and recall 
responses. The results for the primary immune response are from the one experiment 
in which tetramer positive cells were found. Splenocytes were activated ex vivo for 4 
hours with PMA and ionomycin in the presence of Golgi stop. The IL-2 response in 
the two sets of chimeras was the same in the primary and also in the secondary 
response, figure 5.16a. The IFN-y response after priming with wild-typebt was 
equal in CD40 knockout B cell chimeras and wild-type chimeras, figure 5.16b. 
Moreover, in CD40 knockout B cell and wild-type chimeras that had been 
immunised with DC then boosted with H 1 9env-CFA the IFN-y response was similar, 
figure 5.16b. This shows that interactions with CD40 sufficient B cells were not 
required for IFN-y production by CD4 T cells. 
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The role of ICOS-B7h interactions in T cell priming 
5.2.12.ICOS-B7h interactions are not required for T cell priming, memory cell 
generation or survival 
The ICOS knockout mice used in this PhD were generated in David Gray's 
laboratory by Ana Cevera in the 129 strain of mice. Most of the experiments were 
carried out when the mice were in the process of being back-crossed onto the 
C57BL/6 background and therefore the responses in the knockout mice were 
compared to those in wild-type littermates. However, some of the DC-priming 
experiments were carried out using knockout mice that had been back-crossed 7 
times onto the C57BL/6 background and thus C57BL/6 mice were used as wild-type 
controls. 
To examine the requirement for ICOS-B7h interactions in CD4 T cell priming, ICOS 
knockout mice were immunised with peptide-CFA and the tetramer positive cells 
examined at various times post-immunisation. The percentage of tetramer positive 
cells in the spleen and DLN of ICOS knockout mice was the same as that in wild-
type mice at day 8 and at day 15, figure 5.17à. Thus, I cell priming was not reduced 
in the absence of ICOS signalling. 
To investigate whether the generation and survival of long-lived memory cells was 
affected by the absence of ICOS signalling, tetramer staining in the spleens and LN 
- from mice that had been immunised 6 or 10 weeks earlier was examined. As shown 
in figure 5.1 7b, the survival of antigen specific memory cells 10 weeks after 
immunisation was unaffected by the lack of ICOS. 
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5.2.13. The primary immune response is normal, but the secondary response is 
slightly reduced, in the absence of ICOS after immunisation with wild-
type DC 
CFA is a potent Thi inducing adjuvant and it has been suggested that immunisation 
with CFA can bypass any defects in ICOS knockout mice (332). Thus, as with the 
CD40 and CD40L knockout mice, ICOS knockout mice were also primed with wild- 
type peptide-pulsed DC. 
The primary response to WT-DC in ICOS knockout mice was equivalent to that in 
C57BL/6 mice in both the spleen and DLN, figure 5.18. The recall response, which 
demonstrates the survival and functional response of memory cells, was measured by 
first priming the ICOS knockout mice with wild-type DC then resting the mice for 10 
weeks before boosting with peptide-CFA. This experiment was done twice with 
similar results. In the first experiment there was no significant difference in the 
percentage of tetramer positive cells in either the spleen or the DLN of the knockout 
and littermate controls. However, in both organs there was a trend towards a reduced 
response in the knockout mice. In the second experiment, carried out in back-crossed 
mice, this difference was significant in the DLN but not the spleen, although again 
there was trend towards less tetramer positive cells in the spleen of the knockout 
mice, figure 5.19. This suggests that ICOS-B7h interactions may play small role in - 
the reactivation of memory CD4 T cells. 
5.2.14. Cytokine production in the primary response is unaffected in the 
absence of ICOS, but is reduced in the recall response 
The cytokine response of CD4 cells in ICOS knockout mice either primed with wild-
type DC or also boosted with peptide-CFA was examined as before by activating 
cells ex vivo with PMA and ionomycin in the presence of Golgi stop. In the primary 
response to pepetide-pulsed DC there was no difference in the production of IL-2 or 
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IFN-y production by CD4 cells from C57BL/6 and ICOS knockout mice (data not 
shown). Similarly, after the recall response no differences were found in IL-2 or WN-
y production. However, in the second experiment, using the backcrossed mice, there 
was a general trend towards reduced cytokine production (IFN-y IL- 10, 1L-2) but this 
was only significant for IL-2 producing cells in both the spleen and LN and IFN-y 
producing cells in the DLN only, figure 5.20. 
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5.3. Discussion 
The ability to track activated and memory cells using class H tetramers provided the 
opportunity to ask questions about the requirements for costimulatory signals in T 
cell responses. Using the protocols established in chapter three and costimulation 
knockout mice, the requirements for CD40L-CD40 and ICOS-137h interactions were 
evaluated. 
The advantage of using class II tetramers is that priming and recall responses could 
be examined ex vivo rather than relying on indirect restimulation assays. Although 
experiments using TCR transgenic cells have examined the requirements for various 
costimulatory molecules ex vivo, this PhD has focussed on the requirements for 
CD40L-CD40 and ICOS-B7h costimulation on the activation of physiological 
numbers of endogenous antigen-specific T cells. This is important because a large 
precursor frequency may bypass the need for costimulation and a monoclonal 
population may not react in the same way as a polyclonal population made up of T 
cells with various TCRs with different affmities for the antigen. 
5.3.1. CD40-CD40L signals are required to prime naïve CD4 T cells 
Antigen-specific CD4 T cells could not be detected in either CD40 or CD40L 
knockout mice immunised with Hl9env-CFA at any of time points examined, or 
after in vitro restimulation. There are a number of possible explanations' for this 
defect. Moodycliffe et al have reported a requirement for a CD40L signal to DC in 
the skin to induce their migration to DLN (336). If DC are unable to migrate to LN, 
T cell activation would be much reduced. This explanation, however, is not sufficient 
to explain the results reported here. First, antigen may itself reach the DLN from 
immunisation sites (279), (22). Second, in the recall response in CD40 knockout 
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mice, the memory cells were reactivated, thus antigen presentation must take place in 
the absence of CD40-CD40L interactions. However, the APC that present antigen to 
naïve and memory cells may be distinct. Croft et al found that macrophages and B 
cells could present antigen to memory cells in vitro (16 1) and Crowe et al 
demonstrated that macrophages can play an important role as APC in the secondary 
response to influenza infection in vivo (237). 
The small recall response in CD40L knockout mice, which had been immunised with 
wild-type DC then boosted with peptide-CFA, suggests that these signals are not 
absolutely required for CD4 activation and memory cell generation. However, in the 
absence of this signal, priming was greatly deficient and very few memory cells were 
generated. These data may seem to contradict the peptide-CFA immunisation results. 
However, this difference could be because the injected DC provided increased 
costimulatory signals compared to endogenous DC in the peptide-CFA immunised 
CD40L knockout mice. 
Moreover, these differences may be because there are other ligands that bind CD40 
and thus substitute for CD40L. For example, Lazarevic et a! (35) and Wang et a! 
(337) have found that heat shock protein 70 can bind to CD40 on DC or monocytes 
and induce them to produce IL- 12 or chemokines, respectively. Also, Brodeur et al 
found that C4 binding protein, a regulatory component of the complement system, 
can bind to CD40 on human B cells and activate them (338). 
That a small population of tetramer positive cells were activated in CD40L knockout 
mice, supports a further explanation for the defect in priming in the knockout mice: 
that the T cell—DC interaction is curtailed in the absence of this costimulatory 
interaction. The CD40-CD40L interaction between DC and T cell is not an initial T 
cell activating event as CD40L is primarily expressed on activated T cells rather than 
naïve T cells (312). For example, the adoptive transfer of CD40L knockout 
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transgenic cells into wild-type mice followed by immunisation, results in a brief 
proliferative response followed by a crash of the transgenic cells (34). Miga et al 
argue that the CD40 signal to the DC is required for full activation and to keep the 
DC alive in the lymphoid organ and that this is necessary for sustained T cell 
activation (315). For example, CD40-CD40L signalling results in increased 
expression of costimulatory molecules such as CD80 and CD86 and also greatly 
enhance DC IL-12 production (32), (33). Moreover, Straw et al found that CD40 
signals to DC were required to maintain DC activation during both Schistosoma 
mansoni and Toxoplasma gondii infections (339). 
In this PhD, using tetramers to examine the T cell response, even this brief 
proliferative response was not observed. This may be because such a response was 
below the tetramer detection level. Furthermore, interactions between T cells and DC 
in the absence of CD40 are thought to lead to tolerance rather than productive T cell 
activation (320), (321). This may explain why, even if there was a small response in 
the knockout mice to peptide-CFA immunisation, this would not be measurable after 
in vitro restimulation as the specific cells would be tolerant. 
5.3.2. Proliferation of memory CD4 T cells does not require CD40-CD40L 
interactions 
Restoration of the primary response in CD40 knockout mice enabled the examination 
of the survival of memory cells and the recall response in a CD40 deficient 
environment. Both of these were examined by boosting the DC-primed mice with 
peptide-CFA as described in chapter three. 
There have been previous reports that CD4 memory cells require less costimulation 
than naïve cells, however the majority of these experiments have been carried out in 
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vitro (9), (161), (278). The findings reported in this PhD validate these studies, but 
advanced them as the work shown here was done entirely in vivo. 
A recall response was measurable in the CD40 knockout mice and was equal to that 
in similarly treated C57BL/6 mice. This demonstrates a number of points: 1. the cells 
activated in CD40 knockout mice in response to wild-type DC, developed into 
memory cells; 2. these memory cells survived in a CD40 deficient environment; 3. 
the memory cells were functional as they proliferated in response to antigen re-
challenge; and 4. the cells divided in the absence of CD40-CD40L signals, 
demonstrating a qualitative difference between naive and memory CD4 T cells. 
The reason why memory cells require less costimulation than naïve T cells may be 
because they have a lower activation threshold and this may be a consequence of 
changes at both an intra- and extracellular level. As discussed in chapter three, the 
memory cell population may have TCRs that interact with peptide-MHC with greater 
affinity than naïve cells (211), (208). However, Slifka and Whitton found that 
although activated and memory CD8 cells were more sensitive to activation than 
naïve cells, the affinity of the TCR for peptide-MHC remained unchanged (207). 
Rather, they argue, activated and memory cells had increased levels of the signalling 
kinase Lck, making TCR signalling faster and more efficient. 
Farber and colleagues have also reported alteration in the signalling complexes of 
memory CD4 cells including changes in the overall level of phospholylation of Zap-
70 and CD3t-associated proteins and this may allow memory cells to respond 
differently from naïve cells (340), (145), (341). Other intracellular changes also 
allow memory cells to respond faster. Veiga-Fernandes et al found that memory CD8 
T cells are at a different state in the cell cycle to naïve cells, allowing them to enter 
the cell cycle more rapidly (342). Memory and effector cells can also make effector 
responses without further division. This is due to the presence of pre-formed 
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messenger-RNA (mRNA) for effector molecules such as IFN-y and perform in the 
cytosol and changes at the DNA level that allow rapid transcription of mRNA for 
effector cytokines without further division (279), (343). 
5.3.3. The route of injection of DC affects the site of the recall response 
The T cell response in CD40 knockout mice immunised with wild-type DC did not, 
however, entirely correspond to similarly treated C57BL/6 mice. Specifically, the 
initial immunisation of CD40 knockout mice with wild-type DC-i.v resulted in a 
defective recall response in the DLN. The recall response in the spleen of these 
CD40 knockout mice was equal to that in similarly treated C57BL/6 mice and thus 
functional memory cells were present in these mice. This defect could be overcome 
by immunising the CD40 knockout mice with wild-type DC-s.c. 
This distinction was intriguing. As discussed in the results section, this defect was 
not a result of the failure of antigen presentation. Rather, it appeared that memory 
cells in DC-i.v. primed CD40 knockout mice were unable to traffic through LN. The 
most conclusive test of this would be to transfer memory cells from DC-i.v. primed 
CD40 knockout mice into wild-type hosts and then examine the site of the recall 
response in the recipient mice. However, such cell transfer experiments were not 
possible due to the problems with adoptively transferring tetramer positive cells as 
described in chapter three. 
-1 
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5.3.4. Migration of memory cells in DC-i.v. primed CD40 knockout mice is 
defective 
As these experimeiits could not be carried out, an alternative way in which to track 
the migration of the memory cells was devised. By boosting the DC-primed mice 
with peptide-CFA, it was possible to identify the tetramer positive memory cells ex 
vivo, enabling the examination of the migration of this "secondary" memory 
population. 
The results from this experiment substantiate the hypothesis that memory cells in 
CD40 knockout mice immunised with DC-i.v. were unable to migrate through LN. 
Very few memory cells were found in the DLN 8 weeks after boosting with Hl9env-
CFA in these mice. However, memory cells were clearly visible in LN of CD40 
knockout mice initially immunised with DC-s.c., or in C57BL/6 mice immunised 
with DC-i.v. or —s.c. 
This defective migration is comparable to results described by Mullins et a! (344). 
The authors have studied the use of peptide-pulsed DC as vaccines against tumours. 
After s.c. priming with DC, tumours at s.c. sites were rejected and this was mediated 
by tumour-specific CD8 T cells. However, if mice were first treated with DC injected 
i.v., s.c. tumours were not controlled. 
The tumour-specific memory cells could be reactivated by a recombinant vaccina 
virus that expressed the tumour peptide. In mice immunised with DC-s.c a recall 
response to the virus was found in various LN and the spleen. However, in mice 
given DC-i.v., T cell priming was only found in the spleen and the recall response to 
the virus was also restricted to this organ. 
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A similar finding was described by Eggert et al, however this group also report that 
in a tumour model in which the antigen was more immunogenic, i.v. injection of 
peptide-pulsed DC was protective (334). Therefore, perhaps the immunogenicity of 
the antigenic stimuli determines the pattern of migration of the memory cells. It is of 
note that Mullins et al only transferred 10 5  DC. It would be interesting to know if 
increasing the number of DC injected i.v., resulted in an increase in the primary 
response and a subsequent recall response at multiple sites. 
Mullins et al argue that their results indicated that different subsets of memory cells 
were generated after i.v. and s. c. injection of DC, such that memory cells primed in 
the spleen can only migrate back to the spleen (344). The generation of different 
subsets of memory cells has been an area of much research in recent years and the 
existence of tissue specific memory cells has also been investigated. For example, I 
cells primed by DC from Peyer's patches went on to express the gut homing 
intergrin, a4137 (67). Campbell and Butcher also found that cells primed in the 
intestine expressed a47 and those primed in the skin draining lymph nodes 
expressed the skin homing molecule CD62P ligand (68). Therefore, the site of T cell 
priming can determine the cell's re-circulatory characteristics by influencing which 
homing molecules are expressed on the activated or memory cell. However, in vivo 
work from the labs of Leo Lefrançois (CD8 memory (13)) and Marc Jenkins (CD4 
memory (14)) suggest that memory cells are able to migrate to any tissue. 
Lefrancois and colleagues have studied the migratory capacity of memory CD8 T 
cells either by tracking memory cells ex vivo (13), (345), (346). The results from 
these experiments have found that cells from any tissue were able to mi&ate to other 
tissues after transfer to naïve mice. Similarly, Reindhardt et al found transgenic 
memory CD4 cells distributed throughout the body after i.v. injection of antigen with 
adjuvant (14). Thus, CD4 cells can also enter various tissue sites. In similar 
experiments by the same group examining the distribution of activated cells 
following a localised injection of antigen in adjuvant, the transgenic cells were found 
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primarily in the injection site, although some transgenic cells were also present in the 
lung and other tissues (347). Activated cells, thus, tend to home back to the site of 
immunisation, however, as memory time-points were not examined in this study, the 
migration patterns of memory cells remains an area of debate. 
Reindhardt et al did determine what signals were required for the migration of 
activated I cells to the injection site by examining the response in CD62E and 
CD62P knockout mice (347). CD62E and CD62P are expressed on inflamed 
endothelial cells and are required for the migration of activated cells into the skin 
(348), (68), (349), (64). Reindhardt et al found the number of transgenic cells at the 
injection site was reduced in CD62E knockout mice, suggesting that this signal was 
required to allow the migration of activated T cells into the inflamed injection site. 
Moreover, the number of transgenic cells was also reduced in the DLN. The 
transgenic cells in the DLN are made up of two populations: those activated at this 
site and cells that have returned from the injection site via the afferent lymph. The 
authors argue the reduced number of transgenic cells in the DLN was not a result of 
reduced proliferation, but a result of the decreased accumulation of transgenic cells at 
the injection site and the subsequent diminished drainage back from the injection site 
in the afferent lymph. 
In this PhD, the memory cells found in C57BL16 and CD40 knockout mice following 
secondary immunisation were all CD62L 1° . Thus, these memory cells presumably 
enter LN via the afferent lymph draining from tissues rather than through HEV (350) 
and therefore, these cells, would be required to migrate into tissues. The memory 
cells, therefore, must enter tissue sites and then drain into the afferent lymph. This 
may require the expression of ligands that bind to CD62E and CD62P. 
Why memory cells in DC-i.v. primed CD40 knockout mice were unable to migrate 
into tissues was not examined in this PhD, however, it is interesting to speculate 
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what may cause this defect. Tiëtz et al found that the ligands for CD62E and CD62P 
were only expressed transiently on activated T cells and were not enriched in 
memory T cells (66) This suggests that the migration patterns of memory cells may 
not have been determined by the expression of these ligands. However, Lefrancois 
and Masopust suggest that entry of activated T cells into tissues may be required for 
the differentiation of memory cells that reside in tertiary tissues (154). Thus, if the 
ligands for CD62E and CD62P are not upregulated, T cells may be unable to enter 
tissues and acquire this phenotype. 
Therefore, the defect in the CD40 knockout mice primed with DC-i.v. may be due to 
an inability of the activated and memory T cells to migrate to tertiary tissues rather 
than a direct deficiency in migration through LN. That tetramer positive memory 
cells in C57BL/6 mice primed with DC-i.v. were found in LN suggests that the two 
routes of injection do not necessarily prime different sub-sets of memory cells as 
argued by Mullins et a! (344). Rather, the ability of memory cells to migrate out-with 
the secondary lymphoid system appears to be dependent on both the route of DC 
injection and the expression of CD40 on endogenous DC. 
5.3.5. Size of the memory pool is also determined by the immunisation site 
The route of injection of DC also affected the size of both the recall response and the 
size of the subsequent secondary memory pool. In C57BL/6 mice initially primed 
with DC-s.c., the recall response and the "secondary" memory pool was greater than 
that in C57BL/6 mice primed with DC-i.v. (see figures 5.5, 5.6, 5.9). 
In experiments in which the number of tetramer positive cells primed in C57BL/6 
mice after DC-i.v. or DC-s.c. transfer were directly compared (see figure 5.7), the 
response in the spleen was comparable. The cells in the spleen of DC-s.c. mice may 
have either been primed at this site by DC that migrated in the blood from the 
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injection site to the spleen, or activated I cells from the DLN may themselves 
migrate to the spleen. Tetramer positive cells were also found in the LN of mice 
primed s.c., while no tetramer positive cells were found in LN of DC-i.v. primed 
mice. Thus, in total, more tetramer positive cells were primed in DC-s.c. immunised 
mice. 
Attempts were made to track the injected DC to visualise whether they migrated, and 
or survived, differently after the two routes of injection and whether this may explain 
the differences in the levels of T cell priming. Pilot studies in C57BL/6 mice showed 
that although DC could be tracked after s.c.-transfer, even 2 days after i.v.-transfer, 
no DC could be detected in the spleen. This was presumably because of the massive 
size difference between LN and spleens with a typical LN containing 1-3x10 6 cells 
and a spleen containing 5-8x10 7  cells. It could be argued, therefore, that s.c. 
immunisation was more potent than i.v. immunisation as the responding T cells had 
more chance of making multiple contacts with the presenting DC in the LN than in 
the spleen. Recent studies using 2-photon microscopy to study T cell-DC interactions 
during the early stages of T cell activation, have indeed found that T cells form 
multiple contacts with APC (23), (24). 
The difference in the size of the secondary memory pool following the different 
routes of immunisation was probably a result of the increased size of the recall 
response in mice initially primed with DC-s.c. compared to that in DC-i.v. primed 
mice (compare figures 5.5 and 5.6). Consequently, the number of cells that survived 
into the secondary memory pool was greater in mice initially given DC-s.c. 
compared to mice given DC-i.v. These data (increased total number of ttramer 
positive cells in the primary response, increased recall response and increased size of 
the secondary memory pool) indicate that the transfer of DC-s.c. is a much more 
potent immunisation route than i.v. administration of DC. 
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5.3.6. CD40 on endogenous APC also affects the size of tetramer positive 
memory pool 
In addition to this difference in the size of the memory pool in C57BL/6 mice primed 
with DC-i.v. or DC-s.c, and boosted with peptide-CFA, there were differences in the 
memory pools in C57BL/6 and CD40 knockout mice regardless of the injection 
route. More tetramer positive cells were found in C57BL/6 mice compared to 
similarly treated CD40 knockout mice. This differences may be because the recall 
response in the C57BL/6 mice was more sustained than that in the CD40 knockout 
mice. This could be demonstrated by a close kinetic examination of the recall 
response, in particular of the contraction phase. 
There are two non-mutually exclusive reasons why the response may be more 
sustained in the C57BL/6 mice. First, the memory cells may proliferate more as they 
have access to more costimulation than memory cells in CD40 knockout mice. 
Second, naïve Hi 9env-specific T cells could be activated during the recall response 
in C57BL/6 mice and thereby increase the number of cells in the secondary response 
and the number of cells that could progress into the subsequent memory pool. 
Badovinac et al have described the activation of both memory and naïve CD8 T cells 
during re-challenge and, therefore, it is not surprising that both types of T cell could 
get activated (288). 
In CD40 knockout mice, naïve cells would be unlikely to participate in the recall 
response given that peptide-CFA could not prime naive antigen-specificcells in the 
absence of CD40-CD40L interactions (figure 5.2). This suggests that memory cells 
can proliferate in response to re-challenge and then become resting memory cells 
again. The most conclusive way to demonstrate this would be to transfer Ly5.1 
Hi9env-specific memory cells into C57BL16 or CD40 knockout mice, boost the 
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recipient mice, and then examine whether the memory pool contained a mixture of 
Ly5.1 positive and negative antigen-specific memory cells. 
5.3.7. IFN-y, but not IL-2 production by CD4 cells is reduced in CD40 
knockout mice during the primary and recall response 
Given that the exogenous DC were unable to fully restore the T cell response in 
terms of the number and migration capacity of primed cells in the CD40 knockout 
mice, it was interesting to establish whether full effector cell differentiation occurred. 
As described in the results section, peptide specific cytokines could not be measured. 
Moreover, attempts to perform both cytokine and tetramer staining on 
PMAllonomycin stimulated cells were unsuccessful. 
Therefore, the cytokine response of CD4 cells as a whole was examined ex vivo. IL-2 
production was found to be equivalent in C57BL/6 and CD40 knockout mice that 
had been primed with DC and in mice boosted with peptide-CFA. However, the 
effector cytokine response, as determined by WN-y production, was reduced in 
primed and boosted CD40 knockout mice. Thus, although similar numbers of 
antigen-specific cells were found, the effector response in the CD40 knockout mice 
was deficient. 
Although this does not show antigen-specific cytokine responses, there is a clear 
difference in IFN-y production after the recall response in C57BL/6 mice compared 
to the primary response in these mice (p 0.008). The IFN-y response th the CD40 
knockout mice is only slightly increased in the recall response compared to the 
primary response in CD40 knockout mice (p=0.032). Therefore, in C57BL/6 mice, 
the large proliferative response by the tetramer positive cells is accompanied by a 
large increase in IFN-y production by CD4 cells. However, in the CD40 knockout 
158 
Requirements for costimulation 
mice, despite a similar level of proliferation by antigen-specific T cells, the CD4 cell 
IFN-y response was greatly reduced compared to that in the C57BL/6 mice. 
As discussed in the introduction, the lineage of memory cells in an area of much 
debate (143), (144), (145), (146), (147). The results in this PhD do not rule out either 
the linear or the non-linear pathway of memory cell development (see figure 1.2) but 
imply that memory cells can be generated in the absence of full effector cell 
differentiation. 
Other investigators, who have studied polyclonal CD4 cells responding at similar 
levels to those described in this PhD, have examined cytokine production by CD4 
cells after in vitro restimulation with antigen. Reddy et al restimulated cells twice 
and then examined the production of cytokines by total CD4 cells after further 
stimulation for a few hours with anti-CD3 and anti-CD28 (253). Similarly, Bischofet 
al made short-term T cell lines by restimulating cells multiple times and then 
examining tetramer and cytokine staining by intracellular staining (257). 
PMA activates protein kinase C and ionomycin is a calcium ionophore that causes 
the mobilisation of intracellular calcium. These signals mimic those induced by TCR 
signals and the resultant cytokine production is from cells that were previously 
committed to making that particular cytokine. This ex vivo picture of cytokine 
production was considered to be more relevant for this PhD than the cytokine 
production of cells activated several times in vitro, which can alter their cytokine 
profile. 
An alternative way in which to examine cytokine production by antigen-specific cells 
has been described by Marc Jenkins and colleagues (14). OVA peptide was injected 
i.v. into mice containing OVA-specific memory cells and the cytokine production by 
these memory transgenic cells examined without further stimulation, two hours after 
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this injection. This, however, may not be a successful approach to determine 
cytokine production by the tetramer positive cells in this PhD for two reasons. First, 
even at the peak of the recall response only 1-2% of CD4 cells are tetramer positive 
and presumably not all of these cells would make cytokines. Thus, IC staining may 
not be sensitive enough to measure this response. Second, specific activation can 
cause the transient down-regulation of TCR (35 1) and thus cytokine production and 
tetramer staining could not be carried out on cells from the same mouse. 
A second approach would be to examine cytokine production using a more sensitive 
assay. ELISPOT assays enable the identification of the number of cells producing a 
particular cytokine and this would, therefore, be more useful than an ELISA assay. 
However, both these assays require an in vitro restimulation period and thus do not 
indicate cytokine production directly ex vivo. 
It is possible that I cells in CD40 knockout mice differentiated into Th2 cells rather 
than IFN-y producing Thi cells. For example, Stüber et al found an increase in IL-4 
production following the administration of a blocking anti-CD40L antibody to mice 
in a murine colitis model (352). Although staining for IL-4 production by CD4 cells 
was carried out, little or no positive cells were found in any of the experiments. 
However, as antigen specific cytokines could not be detected, no definite conclusions 
can be reached. 
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5.3.8. B cell CD46 is not required for T cell proliferation or cytokine 
production 
The differences in the responses in CD40 knockout and C57BL/6 mice immunised 
with wild-type DC, suggests that endogenous APC expressing CD40 may play a role 
in the subsequent immune response and memory cell generation. To investigate 
which APC may be important for this, experiments were carried out in chimeric mice 
in which the CD40 defect was limited to B cells. 
Unfortunately, the primary immune responses in both wild-type and B cell CD40 
knockout chimeric mice were low and thus it is difficult to draw firm conclusions 
from this data. This low priming may be a consequence of the small lymphoid organs 
and the primary response may have been below the level of detection by the class II 
tetramers. 
However, as the recall responses were much larger than the primary responses, 
tetramer positive cells could clearly been seen after re-challenge. Confirming the 
results in the complete CD40 knockout mice, the recall response in the B cell CD40 
knockout chimeras was similar to that in wild-type chimeras. 
In experiments in which the chimeras were given DC-i.v., no recall response was 
found in either the DLN or the spleen and thus, the potential role for endogenous DC 
in inducing the migratory capacity of memory T cells could not be ascertained. 
Again, any antigen-specific cells may have been below the level of detection by the 
tetramers and this result again demonstrates that DC-s.c. administration is a more 
potent immunisation route than the injection of DC-i.v. 
Full WN-y production was found in chimeric mice in which the CD40 defect was 
restricted to B cells alone. Thus, interactions with other APC, presumably 
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endogenous CD40 positive DC, were sufficient to allow full effector cell 
differentiation. However, interactions between T and B cells via CD40L:CD40, were 
not required at any stage of T cell differentiation. 
B cells may have played a more essential role in the T cell responses if a different 
type and form of antigen had been used. For example, B cell may pick up soluble 
antigen (353), (354) and interact with T cells, or coupling the peptide to a hapten, 
such as DNP, or using a protein antigen may have "encouraged" a more prominent 
role for B cells (355), (356). 
5.3.9. CD40 conclusion 
Taking together the above results (the defective recall response in DC-i.v. primed 
CD40 knockout mice and the reduced effector response in the complete knockout 
mice but normal cytokine production in the B cell CD40 knockout chimeras) 
suggests that there is a role for endogenous DC after immunisation with exogenous 
DC. The endogenous DC may not necessarily be required for the full expansion of 
antigen-specific cells as the primary responses in both s.c. and i.v. immunised 
C57BL/6 and CD40 knockout mice were generally the same. However, there may be 
a role for endogenous DC in providing sustained I cell activation allowing for full 
effector cell generation and acquirement of migratory potential. DC may not be the 
only APC involved, although the chimera experiments ruled out a role for B cells in 
this system, macrophages can be involved in the T cell responses (161), (237). 
IL-12 may responsible for the acquisition of both these phenotypes. In experiments 
involving the transfer of wild-type or IL-12 deficient DC into wild-type or IL-12 
deficient mice, MacDonald and Pearce found that IL-12 production by endogenous 
APC was more critical for the development of a Th 1 response than IL-12 production 
by the exogenous DC (357). Moreover, Miga eta! found that recombinant IL-12 
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restored IFN-y production by transgenic cells activated with CD40 deficient DC 
(3 15) and Stüber et al found that IL- 12 treatment reversed the protective effects of a 
blocking anti-CD40L antibody in a mouse model of murine colitis by increasing 
IFN-y production (352). 
IL-12 is also important in inducing the expression of ligands for CD62E and CD62P. 
The expression of these ligands, such as CD62P glycoprotein ligand-1 and CD62E 
ligand 1, is dependent on their glycosylation state and the enzymes required for this, 
such as fucosyltransferase-VII, are induced by IL-12 (358), (359). Thus, IL 12 can 
also determine the capacity of T cells to migrate to tertiary tissues (349), (64), (54). 
It would be interesting, therefore, to examine the priming of Hi 9env-specific T cells 
following immunisation with wild-type DC in mice deficient for IL-12. 
Alternatively, the DC-primed CD40 knockout mice could be given recombinant IL-
12 to investigate whether this resolved the defects describe above. 
Figure 5.21 illustrates a composite picture of the results discussed above and 
describes the potential roles of the exogenous and endogenous DC and the effect of 
the different routes of DC-transfer. The injected DC are probably the DC that 
initially activate the antigen-specific I cells. Once activated, the T cells will express 
CD40L and therefore will be able to interact with endogenous DC that constitutively 
express low levels of CD40. 
Endogenous DC could provide antigen-specific interactions with the aci'ivated I cells 
or just provide enhanced levels of costimulation. Antigen could be transferred to 
endogenous DC either by exosomes, or by endogenous DC picking up dying 
exogenous cells (360). Alternatively, as suggested by Reis é Sousa and colleagues, 
the activated T cells could release cytokines that mature bystander DC that can then 
participate in the immune response (361). This interaction may be important for the 
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full differentiation of the T cells in terms of cytokine production and the ability to 
migrate into tertiary tissues. Indeed, a recent paper from Williams and Bevan has 
shown that if antigen presentation of LM antigen is curtailed after 24 hours by 
treating infected mice with ampicillin, the CD4 effector and memory response is 
reduced (362). The authors argue that sustained antigen presentation is required for 
effector cell development. 
In CD40 knockout mice the activated T cells would be unable to interact with 
endogenous DC via CD40L and thus these DC will not be fully activated to express 
increased levels of costimulation molecules or produce high levels of IL- 12 (32), 
(33), (34), (35). 
Therefore, T cells primed in CD40 knockout mice by DC injected i.v., would receive 
the smallest signal from both the exogenous and endogenous DC. This reduced 
interaction may be sufficient for T cell expansion and memory cell generation, but 
not for effective effector cell development. In the CD40 knockout mice immunised 
with DC-s.c., normal migration of the tetramer positive cells was observed. Thus, 
this phenotype was not dependent on interactions with endogenous CD40 sufficient 
APC and this again demonstrates that the injection of DC-s.c. was a more potent 
immunisation route than the injection of DC-i.v. 
A number of approaches could be made to substantiate this hypothesis. First, it 
would important to establish whether the reduced IFN-y production in primed and 
boosted CD40 knockout mice was antigen-specific and thus determine whether 
antigen-specific effector cell development is diminished in these mice. Ways in 
which to do this were described above. 
Second, to determine whether sustained interactions were important in effector cell 
development, the CD40 knockout mice could be given further injections of wild-type 
164 
Requirements for costimulation 
DC. Furthermore, these DC could be activated via CD40 prior to transfer and, as this 
will activate the exogenous DC more than LPS alone, may enable effector cell 
differentiation in the absence of interactions with endogenous DC. 
In summary, the experiments described above have shown that T cell priming does 
not occur in the absence of CD40L-CD40 interactions. However, by restoring a 
primary immune response by injection of wild-type DC, memory cells were 
generated in CD40 knockout mice. These memory cells could proliferate in the 
absence of further CD40L-CD40 interactions and this demonstrates a qualitative 
difference between naive and memory T cells. 
-i 
165 
Requirements for costimulation 
5.3. 10.ICOS-B7h interactions are not required for T cell proliferation, 
memory cell generation or re-activation 
The CD4 I cell response in the absence of ICOS-B7h interactions was examined in 
similar ways to those described above in CD40 and CD40L deficient mice. However, 
only minor defects ere found in the T cell response in ICOS knockout mice. T cell 
priming, memory cell generation and survival were unaffected in the absence ICOS 
after immunisation with peptide-CFA. 
As mentioned above, Dong et al suggest that CFA, which is a very potent adjuvant, 
can bypass defects in ICOS knockout mice (332). However, after immunisation with 
DC, no significant defect was found in the primary immune response in ICOS 
knockout mice suggesting that even in less immunogenic responses, ICOS 
costimulation is not necessary for T cell activation. 
There was a trend towards a reduced recall response in the DC-primed knockout 
mice, although this was only significant in the DLN in the second of two 
experiments. Similarly, in this experiment, the IL-2 production of total CD4 cells 
was reduced in both the spleen and DLN of the ICOS knockout mice and this may 
explain the slightly reduced proliferation ofHl9env-specific T cells. The other 
cytokines examined, IFN-y and IL-10 were not significantly reduced, but in the 
second experiments there was a trend towards less cytokine in both the DLN and 
spleen of the knockout mice and IFN-y production was significantly reduced in the 
DLN of the ICOS knockout mice. 
It is surprising that there was a defect in IL-2 production, as other investigators have 
found no defect in IL-2 production in the absence of ICOS (42), (323) (328). 
However, Dong et al found that the reduced in vitro proliferation of ICOS knockout 
T cells was restored by the addition of exogenous IL-2 (332). Thus, ICOS 
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costimulation may enhance IL-2 production by T cells. The results from the second 
experiment also hint that the CD4 IFN-y and IL-10 response may be reduced in the 
recall response. This corresponds to findings by McAdam et al that ICOS 
costimulation enhances the production of effector cytokines (42). 
If the recall response is reduced in the absence of ICOS this may be because less 
memory cells were generated or because this signal plays a role in the expansion of 
memory cells. Interestingly, Coyle et al found a blocking ICOS fusion protein 
disrupted antibody production in the secondary response to a greater extent than that 
in the primary response (328). 
The question remains, however, as to what APC provides 137h costimulation. DC 
have been found to downregulate expression of 137h following interactions with I 
cells (326) and certainly they do not appear to upregulate 137h after activation with 
LPS (see materials and methods and refs (325), (326)). Thus, the memory T cell may 
interact with B cells, which constitutively express B7h during the secondary response 
and this may provide extra costimulation via ICOS-137h (327) (329). 
There is also an alternative explanation for the reduced response. In the second 
experiment, the response in the ICOS knockout mice was compared to that in 
C5713L/6 mice and both were immunised with C5713L/6 DC. In the first experiment, 
where no statistical difference was found, the DC were made from the bone marrow 
of littermates of the ICOS knockouts and the response compared to that in the 
littermates. Thus, the C5713L/6 DC may have been rejected from the ICQ$ knockout 
mice, which have only been backcrossed 7 times. This may have resulted in a 
reduction of memory tetramer positive cells as the response in these mice may have 
been curtailed. Further experiments in more fully backcrossed mice would resolve 
this issue. 
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Despite this slight defect, there was a clear recall response in the ICOS knockout 
mice, confirming the peptide-CFA immunisation data that memory cells can be 
generated in the absence of ICOS. This suggests that ICOS-B7h interactions are non-
essential for T cell proliferation, memory cell generation, survival and reactivation of 
memory cells. These results confirm some published studies (330), (333) but differ 
from others (45) and this may reflect the differences between studying responses in 
knockout mice compared to using blocking antibodies or fusion proteins. 
An additional reason why no major defect was found in the ICOS knockout mice 
either after DC or CFA immunisation may be because both types of immunisation 
primed Thi responses. As outlined in the introduction to this chapter, ICOS 
costimulation may be more critical for Th2 responses than Thi responses (328), 
(330), (331), (329). It would, therefore, be interesting to immunise mice with 
H19env-peptide and a Th2 inducing adjuvant, for example with bone marrow DC 
pulsed with Hl9env and incubated with the schistosome egg extract, SEA, which is 
known to induce a strong Th2 response (339). 
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5.3.11. Conclusion 
The two costimulatory interactions studied in this chapter have illustrated two of the 
important features of costimulatory molecules. The experiments in CD40 and CD40L 
knockout mice show how critical this interaction is between these two molecules in I 
cell activation, demonstrating that productive T cell responses are dependent on 
costimulation. On the other hand, the experiments in the ICOS knockout mice where 
T cells can proliferate, form memory cells and be reactivated, demonstrate that not 
all costimulatory molecules are essential for T cell activation, indicating a level of 
redundancy in the system. 
Why might these two interactions have such distinct roles? Both CD40L-CD40 and 
ICOS-B7h interactions provide critical communication links between T and B cells, 
enabling the generation of germinal centres and B cells isotype switching. However, 
although T cells can interact with DC via ICOS and B7h, this interaction is not 
critical for either cell. CD40L-CD40 interactions are vital for DC maturation and this 
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Figure 5.1 Expression and activity of the costimulatory pairs, CD40L-CD40 
and ICOS-B7h: Activated I cells can interact with both DC and B cells via 
ICR and CD4 (dark blue and red) that bind to peptide-MHC complexes (light 
blue). Activated T cells also express CD40L(dark pink) and ICOS (purple) 
which bind CD40 and 137h respectively, both expressed by DC and B cells. 
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Figure 5.2 CD40-CD40L signals are required for T cell 
activation a) Percentage of tetramer positive cells, out of CD4 
cells, in the spleens of C57BL/6, CD40 and CD40L knockout mice 
immunised with HI 9env-CFA 8 days previously. b) Representative 
FACS staining of USE labelled tetramer +ve cells after activation 
of splenocytes in vitro for 72 hours with Hl9env.OVA: C5713L/6 
mice immunised with OVA-CFA, and activated with HI 9env. The 
number shows the percentage of tetramer +ve cells, out of CD4 
cells, in the top left quadrant. c) Percentage of tetramer +ve cells, 
out of CD4 cells after in vitro activation as in b). Each point 
represents one mouse and the line shows the mean of the group. 
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Figure 5.3 Wild-type DC restore priming in CD40 knockout mice 
but not CD40L knockout: Percentage of tetramer positive cells, out of 
CD4 cells, in the a) DLN and b) the spleen of C57BL/6, CD40 and 
CD40L KO mice immunised with wild-type DC s.c. 6 days previously. 
OVA: C57BL/6 mice immunised with OVA pulsed DC. Each point 
represents one mouse and the line shows the mean of the group. 
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Figure 5.4. The recall 
response in DC primed CD40 knockout mice and 
C57BL/6 mice: Percentage of tetramer positive cells, out of CD4 cells, in 
the DLN 0fC57BL/6, CD40 KO, CD40L KO mice primed with WT DC Sc, 
rested for 5 weeks then boosted with 1-Il 9env-CFA 5 days prior to staining. 
Primary: C57BL/6 mice given HI 9env-CFA 5 days prior to staining. Cells 
are 
gated on CD4 positive live lymphocytes, excluding macrophages. The 
number express the percentage of tetramer +ve cells, out of CD4 cells, in 
the rectangle gate. 
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Figure 5.5 The recall responses in CD40 and CD40L knockout mice 
is equivalent: Percentage of tetramer positive cells, out of CD4 cells, in 
the DLN (a) and spleen (b) of C57BL16, CD40 KO, CD40L KO mice 
primed with WT DC s.c., rested for 5 weeks then boosted with Hi 9env-
CFA 5 days prior to staining. Primary: C5713L/6 mice given Hl9env-
CFA 5 days prior to staining. OVA: C5713L/6 mice primed with OVA 
pulsed DC then boosted with OVA-CFA. Each point represents one 
mouse and the line shows the mean of the group. Representative of 
several experiments carried out between 6-8 weeks post DC 
immunisation. 
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Figure 5.6 Immunisation of CD40 KO mice with DC iv. does not result 
in a recall response in the DLN: Percentage of tetramer positive cells, out 
of CD4 cells, in the spleen (a) and DLN (b) of C57BL/6 and CD40 KO 
mice primed with WT DC i.v, rested for 6 weeks then either boosted with 
Hl9env-CFA 5 days before staining (Boosted) or remaining cells examined 
ex vivo. Primary: C57BL/6 mice given HI 9env-CFA 5 days prior to 
staining. OVA: C57BL/6 mice primed with OVA pulsed DC then boosted 
with OVA-CFA. Each point represents one mouse and the line shows the 
mean of the group. Representative of 4 experiments carried out between 4-
18 weeks post-immunisation with DC. 
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Figure 5.7 T cell priming occurs in the spleen and LN 
after s.c. transfer of DC but only in the spleen after i..v. 
transfer of DC: lx 106  wild-type DC were injected either 
s.c. or i.v. into C57BL/6 mice and the percentage of 
tetramer positive cells (out of CD4 cells) measured after 6 
days. Each point represents an individual mouse and the 
line shows the mean of the group. OVA: tetramer staining 
in splenocytes or LN cells from mice immunised with 






















































Figure 5.8 The DC immunisation site does not affect the site of the 
recall response: C57BL/6 and CD40 knockout mice were immunised 
with wild-type DC s.c. in the hind-leg, 7 weeks later, the mice were 
boosted with Hi 9env-CFA in the back. 5 days after this, inguinal LN (a) 
and the axillary LN (b) and spleens (c) were taken for tetramer staining. 
Percentage of tetramer +ve cells out of CD4 cells is shown. Primary: 
C5713L/6 mice immunised with H19env-CFA 5 days before staining. 
OVA: C57BL/6 mice immunised with OVA-pulsed DC then boosted 
with OVA-CFA. Each point represents one mouse and the line shows 
the mean of the group. Representative of 2 experiments. 
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Figure 5.9 The initial immunisation site affects the size and migration 
patterns of the memory pool: Percentage of tetramer positive cells, out of 
CD4 cells, in C57BL/6 and CD40 KO mice primed with WT DC either s.c. 
or i.v., and left for 8 weeks, boosted with H 1 9env-CFA and left for a further 
8 weeks. CFA alone: C5713L/6 mice immunised with Hi 9env-CFA at the 
first 8 week time-point, OVA: C57BL/6 mice immunised with OVA-CFA. 
Staining in the DLN (a), spleen (b) and non-draining LN (c). Each point 
represents one mouse and the line shows the mean of the group. This 
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Figure 5.10 Exogenous DC can be tracked after S.0 but not i.v 
injection: Ly5. I bone marrow derived DC were activated with LPS 
overnight then transferred into naïve C5713L/6 mice S.C. or i.v. as 
indicated. 2 days later the DLN and spleens were taken, digested with 
collagenase as described in materials and methods, and CDII c positive 
cells enhanced by magnetic cell separation. The combined cells from 3 
mice were stained with anti-CD lIc, anti-MHC class II and anti-Ly5.1 and 
analysed by FACS. Cells are gated on live, CD  I  and MI-IC class II +ve 
cells. The number shows the percentage of CD1 Ic±ve, Ly5.I +ve cells 
out of total CD  I  cells. 
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Figure 5.11 IFN-'y production by CD4 cells is reduced in CD40 
knockout mice in the primary and secondary response: Percentage of 
IL-2 (a) or IFN-y (b) producing CD4 cells in C57BL/6 or CD40 KO mice 
primed with WT DC or primed with WT DC then boosted with HI 9env-
CFA. Naïve: cytokine production from naïve splenocytes. Each point 
represents one mouse and the line shows the mean of the group. 
Representative of 4 experiments. 
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Figure 5.12 IFN-y production by CD4 cells is reduced in 
the primary and secondary responses in CD40 knockout 
mice: Percentage of IFN gamma producing CD4 cells in 
C57BL/6 or CD40 KO mice primed with WT DC (primary) 
or primed with WT DC then boosted with HI 9env-CFA 
(recall). Cells are gated on CD4 positive live 
lymphocytes.The number expressed the percentage of cells 
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Figure 5.13 CD40 KO B cell chimeras: The chimeras were made by first 
lethally irradiating C57BL/6 mice (I). The following day, the mice were 
reconstituted with bone marrow from CD40 KO mice (20%) and[LMT mice 
(80%), (2). After 8 week to allow for reconstitution before the mice are 
immunised, (3). 
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Figure 5.14 The primary response in CD40 KO B cell chimeras is similar 
to that in wild-type chimeras: percentage of tetramer positive cells, out of 
CD4, in the DLN (a) and spleen (b) of CD40 B cell KU and WI chimeras 
immunised with WI DC S.C. 7 days before staining. Each point represents one 
mouse and the lines show the mean of each group. OVA: WI chimeras given 
OVA pulsed DC. 
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Figure 5.15 B cell CD40 expression is not required for T cell recall 
responses: Percentage of tetramer positive cells, out of CD4, in the 
DLN (a) and spleen (b) of CD40 KO B cell chimeras and control 
chimeras primed with WT DC s.c., rested for 10 weeks then boosted 
with Hl9env-CFA 5 days prior to staining. Primary: day 5 response in 
WT chimeras to H 1 9env-CFA. OVA: response in WT chimeras primed 
with OVA-DC then boosted with OVA-CFA. Each point represents 
one mouse and the lines show the mean of the groups. Representative 
of 2 experiments. 
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Figure 5.16 Cytokine production is similar in CD40 KO B cell 
chimeras and WT chimeras: percentage of IL-2 (a) or IFN-y (b) 
producing CD4 cells in CD40 KO B cell chimeras and WT chimeras 
after immunisation with WT DC s.c. (Primary), or primed with WT 
DC s.c. then boosted 10 weeks later with Hl9env-CFA 5 days 
before staining. Each point represents one mouse and the line shows 
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Figure 5.17 T cell priming and memory cell generation is unaffected in 
the absence of ICOS: percentage of tetramer positive cells, out of CD4 cells, 
in the spleens of C57BL/6 and ]COS KU mice 8 days (a) or 10 weeks (b) after 
immunisation with Hl9env-CFA. Each point represents one mouse and the 
line shows the mean of the each group. Representative of 2 experiments 
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Figure 5.18 The primary response in ICOS KO mice after DC 
immunisation is similar to that in wild-type mice: ICOS KO and C5713L/6 
mice were primed s.c. with WT DC. Spleens (a) and DLN (b) were taken on 
day 7 and stained with class II tetramers. The percentage of tetramer +ve 
cells, out of CD4 cells, is shown. OVA: C57BL/6 mice given OVA pulsed 
DC. Each point represents one mouse and the lines shows the mean of each 
group. 
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Figure 5.19 The recall response in the DLN of ICOS KO 
mice is reduced compared to that in WT mice: ICOS and 
C5713L/6 mice were primed with WT-DC then boosted with 
peptide-CFA after 10 weeks. The percentage of tetramer +ve 
cells, out of CD4 cells is shown in the spleen, (a) and DLN, (b). 
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Figure 5.20 The cytokine response in ICOS KO mice is reduced in 
the recall response: The percentage of CD4 splenocytes producing IL-
2 (a), IFN-y (b) and IL- 10 (c) in ICOS KO and C57BL/6 primed with 
WT-DC then boosted with peptide-CFA after 10 weeks. Naïve: 
cytokine production after PMAlionomycin stimulation of cells from 
naïve mice. Each point represents one mouse and the line shows the 
mean of the group. 
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Figure 5.21 Immunisation site and expression of CD40 on endogenous APC 
determines the effector characteristics of activated and memory T cells: After 
s.c. immunisation with DC, antigen-specific I cells have more chance of making 
multiple contacts with the exogenous DC than after DC-i.v. injection in both wild-
type and CD40 KO mice. in wild-type mice, the T cells can also interact with 
endogenous DC and activate them via CD4OL, resulting in DC IL- 12 production 




The phenomenon of immunological memory has been appreciated for thousands of 
years: Thucydides described in 430BC that only those who had recovered from the 
plague could tend to the sick without falling ill themselves. In more recent years this 
phenomenon has been explained by the survival of antigen-specific memory cells after 
exposure to infection or immunisation. The understanding of how memory cells form 
and how they survive underpins how vaccines work and, therefore, it is of critical, 
importance to elucidate the factors that determine the generation and survival of 
protective memory cells. 
This PhD has used a model system to track antigen-specific CD4 T cells through the 
processes of activation, memory cell generation and into the long-lived memory pool. 
The system was then utilised to examine the long-term survival of memory cells in the 
presence or absence of persistent antigen, and in mice exposed to other antigens to 
induce a competitive memory pool. Furthermore, by tracking the activation and memory 
characteristics of antigen-specific CD4 T cells in costimulation molecule knockout mice, 
the importance of CD40L-CD40 and ICOS-B7h interactions were defined. In this final 
discussion, the importance of some of these results will be discussed in terms of how 
memory cells can respond with different kinetics to naïve cell and with reference to the 




6.1. Memory cell survival 
In this PhD, tetramer positive memory cells were found to survive for over 200 days 
post-immunisation (chapter 3). This was probably not a consequence of the maintenance 
of long-lived cells. Rather, it is thought that memory cells have stem-cell-like qualities, 
dividing occasionally to maintain antigen-specific memory at a population, rather than a 
cellular, level. This basal proliferation may be controlled by cytokines (IL- 15 for CD8 T 
cells and IL-7 for CD4 T cells) rather than antigen (80), (83), (82). These signals were 
not, however, sufficient to maintain the memory cells studied in this PhD for the life-
time of the host. 
The decline in memory CD4 cells in this and other studies (19), (225) contrasts with the 
reports of stable populations of antigen-specific CD8 memory T cell populations (173), 
(287), (288), (19). However, the stable CD8 memory T cell pool can be disrupted by 
infections of new micro-organisms (198), (193). It is tempting to speculate, therefore, 
that the CD8 memory pool is regulated by exposure to new infections that act to prevent 
over-load of this pool, while the CD4 pool is regulated by the slow reduction of antigen-
specific cells. 
This prompts the question of whether this slow reduction is an active process or occurs 
by default. The CD8 memory pool is tightly regulated: despite periodic proliferation of 
memory cells, the number of specific cells does not increase over-time (144). Thus, the 
level of proliferation, must be matched with an equal level of cell death. McNally et al 
have described low levels of Annexin V staining on a proportion of memory CD8 cells, 
indicating a small level of continual cell death (201). Whether this death is an active 
process, for example, induced by a cytokine such as JFN-y, or a default route, remains 
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unknown. It would be important to understand this process as it may indicate what, if 
anything, controls the loss of CD4 memory cells over-time and this knowledge may 
enable some form of intervention to maintain specific memory cells in the T cell pool. 
The CD8 memory pool is also regulated by IL-2 and the mechanism for this regulation 
appears to involve regulatory CD4CD25 T cells as treatment with anti-IL-2 causes a 
reduction in the number of these regulatory T cells and an increase in the division rate of 
CD8 memory T cells (363). Whether this regulatory population also affects the CD4 
memory pool is not established, but given that IL-2 does not affect the CD4 memory 
pool (364), this may not be the case. However, regulatory I cells may be required to 
maintain antigen, in the form of low-levels of infections such as Leishmania, that is 
required to retain antigen-specific memory cells (218). This indicates the inter-
regulatory nature of the immune system, illustrating that for the design of future 
vaccines the response of the entire immune system should be considered. 
6.2. Why are recall responses different from primary responses? 
The gold standard of a vaccine is obviously protection from infection. Protection is 
either a result of the presence of neutralising antibody that prevents the pathogen from 
infecting the host, or a strong cellular response that stops the infection from developing. 
The recall response is an immunological measure of memory. Classically it is defined by 
two characteristics: an increase in both the size and in the speed of the response in 
comparison to the primary response to the same immunisation. 
The recall responses described in this PhD correspond to this classic description. The 
explanations for this change in the response are numerous. First, there are more antigen- 
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specific I cells present at the close of the primary response compared to that in the naïve 
pool. The importance of this increase in precursor number was demonstrated by the poor 
response in the Ly5. 1 transfer experiments in which the number of antigen-specific cells 
was small (figure 3.13-15) and also by the reduced size of the recall response in DC- 
primed mice after day 260 when the memory population had declined (figure 3.11). 
A second reason why recall responses have different kinetics to primary  responses is that 
memory cells are thought to respond to lower concentrations of antigen compared to 
naïve cells. This was not directly-tested in this PhD, primarily as it would have been 
difficult to compare the same number of naïve and memory cells, either in vitro or in 
vivo, as the number of naive antigen-specific cells could not be calculated; Such 
experiments will be possible in the future as a TCR transgenic has recently been made 
by Gitta Stockinger's group that recognises the Hl9env peptide. Thus, the activation 
requirements of these naïve cells could be compared to Hi 9env-specific memory cells. 
These differences in the activation requirements of memory cells may be because the 
proximal signalling events through the TCRJCD3 complex are different in memory and 
naive cells (340), (145). Thus, the activation threshold of memory cells may be reduced 
compared to that in naïve cells. Moreover, the presence of messenger RNA for 
molecules such as IFN-y and perforin in memory CD8 T cells enables them to make a 
faster effector response compared to a similar response from naïve T cells (365), (12).. It 
would be very informative to examine the gene expression of activated and memory 
tetramer positive T cells. Such analysis may provide information about molecules that 
are important for the survival of activated cells into the memory pool. However, this 
would require the purification of significant numbers of tetramer positive cells. 
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The changes in cell signalling that may result in reduced activation requirements could 
also explain why memory T cells can be activated in the absence of full costimulation. 
This characteristic of memory cells was demonstrated in chapter five: the recall response 
in the DC-primed C57BL/6 and CD40 knockout mice was the same, demonstrating that 
memory cells can proliferate in the absence of full costimulation. 
The changes in requirements of memory cells for costimulation may not just be a case of 
reduced requirements. The slightly reduced recall response in the ICOS knockout mice, 
which had no defect in the primary response, perhaps suggests that ICOS may be a 
costimulatoiy molecule utilised by memory cells more than naïve cells. This in turn may 
reflect the different APC populations with which memory cells can interact. For 
example, B cells may play a more significant role as APC in secondary responses (161). 
Although B cells have been reported to down-regulate 137h upon exposure to antigen, 
CD40-CD40L interaction can rescue this downregulation and thus activated B cells 
interacting with T cell could activate memory T cells (329). 
Bertram et al have found that, although CD8 memory cells were less dependent on 
costimulation by CD28 interactions with B7.1 and B7.2 than naïve cells, they were more 
dependent on 4-1BB-4-1BBL interactions than naïve cells (292). Moreover, Dawiicki et 
al found that, although there is a primary CD4 T cell response in the absence of 0X40-
OX40L interactions, no secondary response takes place in OX40L deficient mice (291). 
However, this defect may have been due to the decreased survival of activated cells in 
the absence of this costimulatory signal (139). It would be interesting, therefore, to 
immunise OX40L knockout mice with wild-type DC, as described for CD40 knockout 
mice in chapter five. This would restore a "normal" primary response and-the recall 
response in the absence of OX40L could be determined. 
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The increased size of the recall response may not just be a consequence of the increased 
capacity of memory cells to proliferate. Badovinac eta! have shown that naïve and 
memory cells can respond during the recall response and thereby increase the overall 
size of the response (288). However, the two populations remain distinct as the authors 
found that the memory cells contracted much more slowly than the newly activated T 
cells. 
In light of these studies in CD8 memory, it would be interesting to compare the kinetics 
of activation and contraction of memory and naïve antigen-specific CD4 T cells. In the 
experiments in which Ly5. 1 cells containing tetramer positive cells were transferred into 
naïve mice, which were then immunised (see chapter three), the tetramer positive 
population was composed of both the transferred cells and host cells. This suggests that, 
as for CD8 T cell responses, naïve and memory cells can respond in the recall response. 
If this transfer system could be optimised, it would provide the opportunity to study the 
contraction phase and also to determine if the secondary pool was made up of a mixed 
population of "new" and "old" memory cells, or only contained one of these 
populations. 
The experiment described in chapter five in which DC-primed C57BL/6 and CD40 
knockout mice were re-immunised with peptide-CFA and the "secondary" memory pool 
examined, also provides some insight into these questions. The "secondary" memory 
pool was greater in the C57BL/6 mice than in the CD40 knockout mice that had been 
similarly treated. This may have been because naïve cells were activated only in the 
wild-type mice, and these cells then formed part of the memory pool in conjuncture with 
the reactivated memory cells. On the other hand, in the CD40 knockout mice, the 
presence of a "secondary" memory pool demonstrates that the original memory cells can 
certainly become memory cells again after reactivation. Transfer experiments, for 
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example, of memory cells from DC-primed wild-type mice into CD40 knockout mice 
would provide more conclusive evidence that this was the case. 
A further difference between naïve and memory T cells is in their migratory patterns. 
Naïve cells are mainly restricted to secondary lymphoid organs, but memory cells can 
also be found in tertiary tissues where they can provide immediate protection to 
pathogens (80), (14), (13). Roberts and Woodland argue that Tern in the tissues can 
proliferate at these sites, perhaps reflecting their ability to interact with APC other than 
DC (153). 
The changes in costimulation requirements may enable proliferation at these sites and 
this quick, targeted response may prove critical in a recall response to an infection. Thus, 
the migratory pattern of memory cells is an important consideration in vaccine design. 
For example, as the experiments in chapter five demonstrated, the route of DC transfer 
affected both the size of the recall response and the migratory pattern of memory cells in 
the CD40 knockout mice. As Berzofsky et al argue, many pathogens enter hosts at 
mucosal sites and thus successful vaccines must induce memory T cells ,that patrol these 
sites; memory cells confined to the spleen and the blood would provide only limited 
protection (366), (216). 
The type of memory cell that should be induced by vaccines is an important issue. Some, 
but not all, investigators have found that Tern are not long-lived cells and thus vaccines 
should aim to generate longer-lived T ern cells (155), (143). However, Tern cells may not 
be present at the entry point of the pathogen and therefore could not provice immediate 
protection. This dilemma denotes the importance of boosting the immune system, 
providing a dual defence of long-lived cells and effector cells Boosting would provide a 
TCR specific signal for Tern cells, increasing their survival or could induce T ern cells to 
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turn into Tern cells. Moreover, this would also increase the overall size of the memory 
pool. 
6.3. Concluding remarks 
The development of new and better vaccines requires an intimate knowledge of memory 
immunology. Understanding how the immune system functions as a whole will provide 
the means to develop both more effective and safer vaccines. However, increasing the 
safety of vaccines can mean that they become less immunogenic. Berzofsky et al argue 
that understanding how the immune system functions should help to find a middle 
ground (366). For example, the addition of costimulatory molecules such as B7.1 into 
recombinant vaccines would increase the activation of responding cells (367), (368). In 
addition, combining IL-7 with a vaccine could "encourage" the transition of activated 
cells into the memory pool, for example the IL-7 gene could be incorporated into DNA 
vaccines. 
By tracking endogenous memory cells, this PhD has aimed to contribute towards the 
understanding of how memory C134 T cells are generated, survive and respond to re-
challenge. In summary, I have shown that antigen-specific CD4 memory cells can 
survive for 200 days post-immunisation. This memory pool does decline overtime in 
both the presence and the absence of persistent antigen, but it is not affected by the 
entrance of cells of other specificities into the memory pool. These memory cells can, 
however, rapidly respond to re-challenge, even in the absence of full costimulation, fully 
demonstrating their memory cell characteristics. 
W. 
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